
<html lang="en"     class="pb-page"  data-request-id="c1bb8dba-0895-4d4d-9ed7-8a3e995626cd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.6b01834;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-9;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents" /></meta><meta name="dc.Creator" content="Philippe  Panchaud" /></meta><meta name="dc.Creator" content="Thierry  Bruyère" /></meta><meta name="dc.Creator" content="Anne-Catherine  Blumstein" /></meta><meta name="dc.Creator" content="Daniel  Bur" /></meta><meta name="dc.Creator" content="Alain  Chambovey" /></meta><meta name="dc.Creator" content="Eric A.  Ertel" /></meta><meta name="dc.Creator" content="Markus  Gude" /></meta><meta name="dc.Creator" content="Christian  Hubschwerlen" /></meta><meta name="dc.Creator" content="Loïc  Jacob" /></meta><meta name="dc.Creator" content="Thierry  Kimmerlin" /></meta><meta name="dc.Creator" content="Thomas  Pfeifer" /></meta><meta name="dc.Creator" content="Lars  Prade" /></meta><meta name="dc.Creator" content="Peter  Seiler" /></meta><meta name="dc.Creator" content="Daniel  Ritz" /></meta><meta name="dc.Creator" content="Georg  Rueedi" /></meta><meta name="dc.Description" content="Our strategy to combat resistant bacteria consisted of targeting the GyrB/ParE ATP-binding sites located on bacterial DNA gyrase and topoisomerase IV and not utilized by marketed antibiotics. Scree..." /></meta><meta name="Description" content="Our strategy to combat resistant bacteria consisted of targeting the GyrB/ParE ATP-binding sites located on bacterial DNA gyrase and topoisomerase IV and not utilized by marketed antibiotics. Scree..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 24, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01834" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01834" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01834" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01834" /></link>
        
    
    

<title>Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01834" /></meta><meta property="og:title" content="Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0020.jpeg" /></meta><meta property="og:description" content="Our strategy to combat resistant bacteria consisted of targeting the GyrB/ParE ATP-binding sites located on bacterial DNA gyrase and topoisomerase IV and not utilized by marketed antibiotics. Screening around the minimal ethyl urea binding motif led to the identification of isoquinoline ethyl urea 13 as a promising starting point for fragment evolution. The optimization was guided by structure-based design and focused on antibacterial activity in vitro and in vivo, culminating in the discovery of unprecedented substituents able to interact with conserved residues within the ATP-binding site. A detailed characterization of the lead compound highlighted the potential for treatment of the problematic fluoroquinolone-resistant MRSA, VRE, and S. pneumoniae, and the possibility to offer patients an intravenous-to-oral switch therapy was supported by the identification of a suitable prodrug concept. Eventually, hERG K-channel block was identified as the main limitation of this chemical series, and efforts toward its minimization are reported." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01834"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01834">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01834&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01834&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01834&amp;href=/doi/10.1021/acs.jmedchem.6b01834" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3755-3775</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01811" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01831" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Panchaud">Philippe Panchaud</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-7823-7639" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Bruy%C3%A8re">Thierry Bruyère</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne-Catherine++Blumstein">Anne-Catherine Blumstein</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Bur">Daniel Bur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alain++Chambovey">Alain Chambovey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+A.++Ertel">Eric A. Ertel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Gude">Markus Gude</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Hubschwerlen">Christian Hubschwerlen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lo%C3%AFc++Jacob">Loïc Jacob</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Kimmerlin">Thierry Kimmerlin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Pfeifer">Thomas Pfeifer</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lars++Prade">Lars Prade</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Seiler">Peter Seiler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Ritz">Daniel Ritz</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Georg++Rueedi">Georg Rueedi</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +41 61 565 65 65. E-mail: <a href="/cdn-cgi/l/email-protection#abdbc3c2c7c2dbdbce85dbcac5c8c3cadecfebcac8dfcec7c2c4c585c8c4c6"><span class="__cf_email__" data-cfemail="c4b4acada8adb4b4a1eab4a5aaa7aca5b1a084a5a7b0a1a8adabaaeaa7aba9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01834&amp;href=/doi/10.1021%2Facs.jmedchem.6b01834" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3755–3775</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 13, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 December 2016</li><li><span class="item_label"><b>Published</b> online</span>24 April 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 May 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01834" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01834</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3755%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPhilippe%2BPanchaud%252C%2BThierry%2BBruy%25C3%25A8re%252C%2BAnne-Catherine%2BBlumstein%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D9%26contentID%3Dacs.jmedchem.6b01834%26title%3DDiscovery%2Band%2BOptimization%2Bof%2BIsoquinoline%2BEthyl%2BUreas%2Bas%2BAntibacterial%2BAgents%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3775%26publicationDate%3DMay%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01834"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2012</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">37</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01834" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Panchaud&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Bruyère&quot;},{&quot;first_name&quot;:&quot;Anne-Catherine&quot;,&quot;last_name&quot;:&quot;Blumstein&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Bur&quot;},{&quot;first_name&quot;:&quot;Alain&quot;,&quot;last_name&quot;:&quot;Chambovey&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;A. Ertel&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Gude&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Hubschwerlen&quot;},{&quot;first_name&quot;:&quot;Loïc&quot;,&quot;last_name&quot;:&quot;Jacob&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Kimmerlin&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Pfeifer&quot;},{&quot;first_name&quot;:&quot;Lars&quot;,&quot;last_name&quot;:&quot;Prade&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Seiler&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Ritz&quot;},{&quot;first_name&quot;:&quot;Georg&quot;,&quot;last_name&quot;:&quot;Rueedi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;3755-3775&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01834&quot;},&quot;abstract&quot;:&quot;Our strategy to combat resistant bacteria consisted of targeting the GyrB/ParE ATP-binding sites located on bacterial DNA gyrase and topoisomerase IV and not utilized by marketed antibiotics. Screening around the minimal ethyl urea binding motif led to the identification of isoquinoline ethyl urea 13 as a promising starting point for fragment evolution. The optimization was guided by structure-based design and focused on antibacterial activity in vitro and in vivo, culminating in the discovery of unprecedented substituents able to interact with conserved residues within the ATP-binding site. A detailed characterization of the lead compound highlighted the potential for treatment of the problematic fluoroquinolone-resistant MRSA, VRE, and S. pneumoniae, and the possibility to offer patients an intravenous-to-oral switch therapy was supported by the identification of a suitable prodrug concept. Eventually, hERG K-channel block was identified as the main limitation of this chemical series, and efforts toward its&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01834&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01834" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01834&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01834" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01834&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01834" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01834&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01834&amp;href=/doi/10.1021/acs.jmedchem.6b01834" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01834" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01834" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01834%26sid%3Dliteratum%253Aachs%26pmid%3D28406299%26genre%3Darticle%26aulast%3DPanchaud%26date%3D2017%26atitle%3DDiscovery%2Band%2BOptimization%2Bof%2BIsoquinoline%2BEthyl%2BUreas%2Bas%2BAntibacterial%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D9%26spage%3D3755%26epage%3D3775%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/jmcmar.2017.60.issue-9/20170511/jmcmar.2017.60.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Our strategy to combat resistant bacteria consisted of targeting the GyrB/ParE ATP-binding sites located on bacterial DNA gyrase and topoisomerase IV and not utilized by marketed antibiotics. Screening around the minimal ethyl urea binding motif led to the identification of isoquinoline ethyl urea <b>13</b> as a promising starting point for fragment evolution. The optimization was guided by structure-based design and focused on antibacterial activity in vitro and in vivo, culminating in the discovery of unprecedented substituents able to interact with conserved residues within the ATP-binding site. A detailed characterization of the lead compound highlighted the potential for treatment of the problematic fluoroquinolone-resistant MRSA, VRE, and <i>S. pneumoniae</i>, and the possibility to offer patients an intravenous-to-oral switch therapy was supported by the identification of a suitable prodrug concept. Eventually, hERG K-channel block was identified as the main limitation of this chemical series, and efforts toward its minimization are reported.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Antimicrobial resistance is a serious threat to public health with bacteria such as <i>Staphylococcus aureus</i>, <i>Enterococcus faecium</i>, and <i>Streptococcus pneumoniae</i> becoming increasingly resistant to currently available antibacterial agents.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The emergence of mutations in bacterial topoisomerases jeopardizing the efficacy of fluoroquinolones<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> is an example of such resistance development and highlights the urgent need to develop novel antibacterial agents devoid of cross-resistance to marketed antibiotics.</div><div class="NLM_p">DNA topoisomerases, i.e., DNA gyrase and topoisomerase IV (topo IV), are enzymes essential for cell viability. They are critical in resolving problems of DNA topology by performing reactions of supercoiling/relaxation, decatenation/catenation, and knotting/unknotting in processes such as DNA replication, transcription and recombination.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In particular, gyrase is unique in its ability to introduce negative supercoils into DNA, while topo IV is responsible for both decatenation of circular chromosomes after replication and relaxation of supercoiled DNA.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Their inhibition by fluoroquinolone antibiotics results in the accumulation of double-strand DNA breaks leading to bacterial cell death.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Even though resistance to fluoroquinolones has appeared since their introduction on the market, these two multidomain enzymes remain attractive targets due to their conservation across all bacteria.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Moreover, targeting two enzymes with one inhibitor is a superior strategy to reduce resistance development compared to single-target approaches.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Both gyrase and topo IV are homologous heterotetramers consisting of two GyrA and two GyrB subunits, which together form an A<sub>2</sub>B<sub>2</sub> complex for gyrase, or two ParC and two ParE subunits forming a C<sub>2</sub>E<sub>2</sub> complex for topo IV, respectively. This architecture distinguishes the bacterial topoisomerases from their related eukaryotic homodimer counterparts.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The N-terminal domains of the GyrB and ParE subunits form the ATP-binding site of gyrase and topo IV, respectively. Novobiocin <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) is a natural product inhibiting the ATPase activity of gyrase and topo IV with an ATP-competitive mechanism of inhibition<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> as confirmed by X-ray structures of <b>1</b> bound to the ATP site of <i>E. coli</i> GyrB and ParE.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Novobiocin was approved for clinical use in 1964 and was later withdrawn from the market mainly because of the successful development of more effective antibiotics.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> It suggests nevertheless that the GyrB/ParE ATPase domains constitute validated targets for identifying new antibiotics with a mode of inhibition different from the fluoroquinolones that act at the enzyme–DNA interface.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Surprisingly, no other antibiotics targeting the ATPase activity of gyrase or topo IV have been developed successfully so far despite the high attractiveness of the targets and the major efforts pursued by several pharmaceutical companies and academic laboratories.<a onclick="showRef(event, 'ref12 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref12 ref15 ref16 ref17 ref18">(12, 15-18)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of novobiocin <b>1</b>, benzimidazole urea <b>2</b>, and schematic representation of the H-bond network involving the conserved Asp73 residue and water molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We decided to investigate new GyrB/ParE inhibitors after compound <b>2</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) had been reported to have potent antibacterial activity.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Similarly to <b>1</b>, it interacts with a conserved Asp73 residue (<i>E. coli</i> GyrB numbering) and a structurally conserved water molecule in the ATP-binding sites, but unlike <b>1</b>, whose carbamate is involved in single H-bonds with Asp73 and this water, the urea moiety in <b>2</b> can establish two H-bonds with the aspartate residue while the benzimidazole receives an H-bond from the water molecule. This optimized H-bond network was assumed to lead to increased binding affinity and was already successfully used by several groups.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Herein, we report on a hit-to-lead program followed by lead optimization efforts toward the identification of a safe antibacterial agent for the treatment of Gram-positive and respiratory tract infection (RTI) pathogens via both oral and intravenous routes.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Ethyl Urea Screening and Hit Discovery</h3><div class="NLM_p">As only a limited number of 1-ethyl-2-heteroaryl urea derivatives <b>3</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) were commercially available, a synthesis and screening procedure was developed to generate such compounds and to evaluate their biological activity while avoiding extensive purification. To this end, readily available amines of generic formula <b>4</b> were dissolved in DMSO, incubated with ethyl isocyanate, and treated with an amine-based resin scavenger. After filtration and centrifugation, the supernatants were analyzed by LC-MS to determine the proportions of unreacted starting material and desired urea product, the latter being the only product detected in most cases. All supernatants were tested for inhibition of <i>E. coli</i> gyrase ATPase activity at 500 and 100 μM, and those displaying interesting inhibition levels were resynthesized and purified in a conventional way. A selection of urea derivatives, their estimated IC<sub>50</sub>s on ATPase inhibition, and associated ligand efficiencies (LE) are presented in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reaction scheme for producing ethyl ureas <b>3</b> from respective amines <b>4</b>. Estimated IC<sub>50</sub>s and LEs for <i>E. coli</i> gyrase ATPase inhibition are shown for selected derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The results proved most interesting for hits devoid of substitution and allowed the comparison with core scaffolds of a few inhibitors published since. For instance, the known benzothiazole scaffold <b>6</b><a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> was among the most potent molecules with an IC<sub>50</sub> of 20 μM. Its benzene ring increased inhibition by at least 10-fold when compared to that of <b>5</b>. A heteroatom was tolerated in <b>7</b>, while loss of the aromatic character of the 6-membered ring led to less potent <b>8</b> and <b>9</b>. However, introduction of a lactam moiety in <b>10</b> reestablished activity. The high LE of these low molecular weight compounds highlighted the contribution of the urea unit to binding affinity. A similar trend was observed in the corresponding 6-membered scaffolds starting from <b>11</b>, which was independently identified as a starting point for leads with potent antibacterial activity in both a fragment screening, using, however, a different assay with gyrase enzyme from other bacterial species,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and also following a de novo design strategy.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In our setting, <b>11</b> did not show gyrase ATPase inhibition up to 200 μM, but addition of a benzene ring had a positive effect for quinoline <b>12</b> and 3-isoquinolinyl urea <b>13</b>, while 1-isoquinolinyl urea <b>14</b> lost activity, likely due to unfavorable intramolecular steric interactions. The positioning of a second nitrogen atom turned out to be critical since it was well tolerated in <b>15</b> but detrimental in <b>16</b>. On the basis of these findings, the fragments with the lowest IC<sub>50</sub> were investigated in molecular modeling by replacing the ADPNP ligand in a published <i>E. coli</i> GyrB structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EI1">1EI1</a>). With the particular orientation of its two rings, 3-isoquinolinyl urea <b>13</b> was considered the most promising scaffold for a fragment evolution program. Indeed, positions 5 and 6 were ideally positioned to allow exploration of the territory which is occupied by the phosphate groups of ATP, while position 8 provided an exit vector pointing toward the space occupied by the coumarin ring of <b>1</b> and the 3-pyridyl substituent of <b>2</b>. Finally, positions 4 and 1 were considered inappropriate for substitution in order to avoid intramolecular clashes with the urea carbonyl (position 4) or intermolecular repulsion with the enzyme (position 1).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The chemistry strategy chosen for exploring the chemical space around the hit compound <b>13</b> consisted of the construction of isoquinoline urea intermediates followed by transition metal-catalyzed cross-coupling reactions to introduce the chemical diversity needed for our investigations. Isoquinolines <b>20a</b>–<b>e</b> were formed by reacting the corresponding benzyl amines <b>18a</b>–<b>e</b> with 2,2-diethoxy-ethanimidic acid methyl ester <b>17</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> followed by treatment with sulfuric acid (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Reaction with ethyl isocyanate gave the urea intermediates <b>21a</b>–<b>e</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-Ethyl Urea Isoquinoline Intermediates <b>21a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>17</b>, MeOH, rt–70 °C, 2–23 h. (b) H<sub>2</sub>SO<sub>4</sub>, rt–80 °C, 3–22 h. (c) EtNCO, dioxane, 50 °C, 1–6 days; or EtNCO, pyridine, 65 °C, 42 h.</p></p></figure><div class="NLM_p">Monosubstituted derivatives <b>22</b> and <b>23</b> were obtained by performing a Negishi-type reaction with dimethylzinc or a Suzuki coupling starting from <b>21a</b> and <b>21b</b>, respectively (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Similarly, <b>24</b>–<b>28</b> bearing a methyl substituent at position 8 were prepared from <b>21c</b>. The corresponding boronate ester <b>29</b> allowed for the preparation of <b>30</b> and <b>31</b> using aryl halides as coupling partners since the required boronate esters were not commercially available. The presence of both bromine and chlorine atoms in isoquinolines <b>21d</b> and <b>21e</b> allowed one to perform sequential cross-coupling reactions in a selective manner (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Compound <b>33</b> was prepared by two successive Suzuki coupling reactions. A Buchwald–Hartwig amination on <b>21e</b> with 3-aminopyridine derivatives using XPhos as ligand selectively yielded <b>34</b> and <b>35</b>, which were further functionalized at position 5 to give <b>36</b> and <b>37</b>, respectively. Compound <b>39</b> was prepared in a similar way, while an Ullmann-type reaction led to the formation of the corresponding ether <b>40</b> on the way to <b>41</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Derivatives <b>22</b>–<b>28</b>, <b>30</b>, and <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Me<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>·DCM, THF, 80 °C, 22 h. (b) py-3-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 4 h. (c) R<sup>5</sup>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90–110 °C, 2–4 h. (d) bis(neopentyl glycolato)diboron, KOAc, Pd(dppf)Cl<sub>2</sub>·DCM, DMSO, 90 °C, 2 h. (e) R<sup>5</sup>Br, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90–110 °C, 2–4 h.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of R<sup>8</sup>-Heteroaryl Derivatives <b>33</b>, <b>36</b>, <b>37</b>, <b>39</b>, and <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) py-4-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, 2 h. (b) py-3-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, 3 h. (c) ArNH<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, NaO<i>t</i>Bu, dioxane, 90 °C, 2–4 h. (d) 2-R-py-4-B(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 2–3 h. (e) TFA, rt, 2 h. (f) py-3-OH, CuI, <i>N</i>,<i>N</i>-dimethylGly, K<sub>3</sub>PO<sub>4</sub>, DMSO, 90 °C, 23 h.</p></p></figure><div class="NLM_p">Aliphatic side chains were introduced at position 8 starting with a selective carbonylation reaction on <b>21e</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Methyl ester <b>42</b> was reduced with LAH at low temperature to avoid reduction of the isoquinoline ring. After Suzuki coupling, primary alcohol <b>44</b> was activated with CDI and converted into carbamate <b>45</b> upon treatment with morpholine. We found that such derivatives would react with boronic acids under Suzuki conditions to give a formal substitution of the carbamate group and allowed accessing derivatives <b>46</b> and <b>47</b>. This reaction appeared to be of quite general scope provided a 4-pyridyl substituent was present at position 5, whereas the corresponding phenyl substituted derivative failed to react under these conditions. This may suggest that these reactions proceeded via a mechanism different from the recently described cross-coupling reaction of benzyl carbamates with arylboronic acids.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Finally, nucleophilic substitution of the hydroxyl group of <b>44</b> with 1,2,3-triazole under Mitsunobu-type conditions delivered <b>48</b> after separation of the two regioisomers.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of R<sup>8</sup>-Heteroaryl Derivatives <b>46</b>–<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CO (5 atm), Pd(dppf)Cl<sub>2</sub>·DCM, NaOAc, MeOH, 60 °C, 7 h. (b) LAH, THF, −40 °C, 5 h. (c) 2-Me-py-4-B(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 90 °C, 3 h. (d) (1) CDI, DIPEA, DMF, 40 °C, 4 h; (2) morpholine, DIPEA, DCM, rt, 18 h. (e) ArB(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 90 °C, 5–10 h. (f) 1<i>H</i>-1,2,3-triazole, PPh<sub>3</sub>, DIAD, THF, 0 °C to rt, 3 h.</p></p></figure><div class="NLM_p">Many carbamates and amides were prepared from the versatile amine intermediate <b>49</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>), which was prepared in a one-pot two-step reaction via a Staudinger reduction of the corresponding azide previously formed in situ after treatment of alcohol <b>43</b> with DPPA and DBU. Treatment of <b>49</b> either with a chloroformate or with an alcohol previously activated with CDI yielded carbamates which were next subjected to Suzuki coupling to introduce the pyridyl substituent in <b>50</b> and <b>51</b>. Analogues <b>52</b> and <b>53</b> bearing a basic amine were prepared in a similar manner followed by a final Boc deprotection. In the case of the latter, an additional reductive amination was performed to yield <b>54</b>. The order of the steps was also inverted, performing first the Suzuki coupling to prepare <b>55</b> and <b>56</b> which could be further reacted in order to provide carbamates <b>57</b>–<b>64</b> and amides <b>65</b>–<b>67</b>. The scope of these transformations was broad, and many derivatives were produced in the form of libraries.</div><div class="NLM_p">The phosphoryloxymethyl prodrug <b>68</b> was prepared in a one-pot two-step reaction sequence from <b>50</b> and di-<i>tert</i>-butyl chloromethyl phosphate in the presence of a stoichiometric amount of sodium iodide followed by hydrolysis of the <i>tert</i>-butyl phosphate with TFA (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of R<sup>8</sup>-Carbamate and Amide Derivatives <b>50</b>–<b>54</b> and <b>57</b>–<b>67</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) DPPA, DBU, THF, rt, 3 h; (2) PPh<sub>3</sub>, water, rt, 2 h. (b) R<sup>8</sup>OCOCl, Et<sub>3</sub>N, DCM, rt, 18 h. (c) (1) R<sup>8</sup>OH, CDI, DIPEA, DCM, rt, 3 h; (2) <b>49</b>, DIPEA, DMF, rt, 18 h. (d) 2-Me-py-4-B(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 90 °C, 2–3 h. (e) HCl, dioxane, rt, 2 h. (f) py-4-B(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 1 h. (g) TFA, DCM, rt, 1 h. (h) (1) pivaldehyde, 1:1 DCE/MeOH, rt, 16 h; (2) NaBH<sub>4</sub>, rt, 4 h. (i) (1) R<sup>8</sup>OH, CDI, DIPEA, DCM, rt, 3 h; (2) <b>55</b> or <b>56</b>, DIPEA, NMP, rt, 18 h. (j) TFA, 10:1 THF/water, rt, 1 h. (k) R<sup>8</sup>COOH, T3P, DIPEA, DMF, rt, 18 h.</p></p></figure><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Phosphoryloxymethyl Prodrug <b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) NaI, DCM, rt, 72 h; (2) TFA, 0 °C, 3 h.</p></p></figure><div class="NLM_p">Finally, inverted carbamates <b>69</b>–<b>74</b> were prepared similarly to <b>45</b> by treatment of CDI-activated <b>44</b> with an amine followed by a deprotection step when necessary (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>).</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of R<sup>8</sup>-Carbamate Derivatives <b>69</b>–<b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) CDI, DIPEA, DMF, 40 °C, 4 h; (2) R<sup>8</sup>NH<sub>2</sub>, DIPEA, DCM, rt–40 °C, 18–70 h. (b) TFA, DCM, rt, 1 h. (c) HCl, dioxane, rt, 2 h.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Fragment Evolution</h3><div class="NLM_p">The hit-to-lead program was initiated with the introduction of various chemotypes at positions 5, 6, 7, and 8 of <b>13</b>. Positions 5 and 8 were soon identified to be most attractive for further investigations (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Influence of R<sup>5</sup> on ATPase Inhibition, Gyrase, and Topo IV Inhibition and Antibacterial Activity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">ATPase inhibition assay.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Supercoiling inhibition assay.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Relaxation inhibition assay.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Minimal inhibitory concentration.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Mutant strain with the TolC efflux pump gene knocked-out.</p></div></div><div></div></div><div class="NLM_p">The addition of a methyl group at position 8 led to <b>22</b>, which displayed slightly improved inhibition of <i>E. coli</i> gyrase ATPase and supercoiling activities as well as <i>E. coli</i> topo IV relaxation. Interestingly, the better inhibition of <i>S. aureus</i> gyrase resulted in a high but measurable MIC of 32 μg/mL against <i>S. aureus</i> ATCC 29213. Introduction of a 3-pyridyl group at position 5 provided <b>23</b> with a similar outcome. The combination of both substituents yielded <b>24</b> with significantly increased inhibitory activities against gyrases from both <i>E. coli</i> and <i>S. aureus</i>, resulting in a much lower MIC against <i>S. aureus</i> (2 μg/mL). From this point on, gyrase supercoiling and topo IV relaxation inhibition assays were used to guide the potency optimization, while inhibition of <i>E. coli</i> gyrase ATPase activity served only as a control for the mode of inhibition. Variation of the heteroaryl group at position 5 led to the 4-pyridyl substituent in <b>25</b>, which displayed further improved inhibition of all four enzymes. In addition, <b>25</b> displayed a low MIC against both <i>S. aureus</i> (0.5 μg/mL) and an efflux-deficient <i>E. coli</i> strain (2 μg/mL). However, it remained inactive against a wild-type strain of <i>E. coli</i> (ATCC 25922, vide infra), suggesting that efflux limited the cytoplasmic accumulation of this chemotype in this Gram-negative bacterium. The beneficial effect of a nitrogen atom in the heteroaryl substituent at the position opposite to the attachment to the scaffold could also be observed when comparing pyrimidines <b>26</b> and <b>30</b>. Small substituents were tolerated next to the heteroatom, as shown with <b>27</b>. Phenyl groups substituted with various H-bond donors and acceptors as well as 5-membered heteroaryls were also examined. However, as exemplified by <b>28</b> and <b>31</b>, they were all less potent than <b>25</b> and <b>27</b>.</div><div class="NLM_p">The importance of the pyridyl-type substituent in general and of the nitrogen atom at the position opposite to the attachment to the scaffold in particular was revealed by an X-ray structure of <b>27</b> bound to a 24 kDa fragment of <i>E. coli</i> GyrB (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The 4-pyridyl nitrogen interacted with Val120 backbone nitrogen via a water-mediated H-bond. This X-ray structure also displayed the H-bond network between the two urea hydrogens and Asp73 as well as the H-bond donated by the conserved water to the isoquinoline nitrogen.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of <b>27</b> (yellow) bound to <i>E. coli</i> GyrB 24 kDa (gray). Residues 77–98 have been omitted for clarity. Residues engaged in key interactions (Asp73 and Val120) are represented in stick format. Hydrogen bonds are displayed as black dotted lines, and water molecules appear as red balls. PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMN">5MMN</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Lead Optimization</h3><div class="NLM_p">With a MIC of 0.5 μg/mL against <i>S. aureus</i> ATCC 29213, <b>25</b> demonstrated promising in vitro antibacterial activity. Our initial interest in this lead compound was further strengthened by the results obtained in a neutropenic murine screening model of thigh infection. As oral bioavailability was deemed an important property for a potential drug targeting treatment of Gram-positive and RTI infections, we decided to evaluate oral bioavailability and efficacy concomitantly by dosing the compounds orally. At the same time, we used a reduced experiment time of 6.5 h and administered the compounds twice to avoid missing the efficacy of those with high clearance. In this screening model, <b>25</b> showed efficacy against staphylococci after oral administration (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Colony forming units (CFU) of <i>S. aureus</i> A-1178 decreased by 1.3 logs in thighs of mice dosed orally with <b>25</b> (30 mg/kg, 2q2.75 h) as compared to those treated with vehicle only.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Influence of R<sup>8</sup> on Gyrase and Topo IV Inhibition, Antibacterial Activity, and Oral Efficacy</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0016.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Supercoiling inhibition assay.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Relaxation inhibition assay.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Minimal inhibitory concentration.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Oral efficacy in a neutropenic murine thigh infection model with <i>S. aureus</i> A-1178. Mice were treated orally (30 mg/kg, 2q2.75 h) starting at 1 h post-infection and sacrificed at 6.5 h post-infection. Median Δlog<sub>10</sub>CFU/thigh of animals treated with compounds compared to vehicle is reported. Vehicle-treated animals showed median Δlog<sub>10</sub>CFU/thigh about +3 compared to CFU/thigh at treatment start.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">nd: not determined.</p></div></div><div></div></div><div class="NLM_p">In order to further optimize the compounds, we kept the 4-pyridyl residue at position 5 as in <b>25</b> or <b>27</b> and further improved substituents at position 8. According to the X-ray structure of <b>27</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), the R<sup>8</sup> methyl group is pointing in the direction of Arg76, which is involved in a structurally important salt-bridge with Glu50. Our strategy consisted therefore of searching for interactions with this highly conserved arginine residue. Appending a heteroaryl directly on the isoquinoline core as in <b>33</b> was unfavorable probably due to sterical reasons, while the introduction of a nitrogen atom spacer as in <b>36</b> led to improved IC<sub>50</sub>s and MIC. In the X-ray structure of <b>36</b> in the 24 kDa fragment of <i>E. coli</i> GyrB (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and B), the 3-pyridyl substituent was located over Arg76 driven by a cation-π or a π-stacking interaction.<a onclick="showRef(event, 'ref12 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref17">(12, 17)</a></div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Crystal structure of <b>36</b> (yellow) in <i>E. coli</i> GyrB 24 kDa (gray). Residues 77–98 have been omitted for clarity. Residues engaged in key interactions (Val120, Asp73, Glu50, and Arg76) are represented in stick format. Hydrogen bonds are displayed as black dotted lines, and water molecules appear as red balls. PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMP">5MMP</a>. (B) Side view of <b>36</b>. (C) Crystal structure of <b>58</b> (yellow) in <i>E. coli</i> GyrB 24 kDa (gray). PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMO">5MMO</a>. (D) Side view of <b>58</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The methyl analogue <b>37</b> was one of the most active compounds in vitro with a MIC ≤ 0.03 μg/mL against <i>S. aureus</i> ATCC 29213, but it nevertheless did not display improved oral efficacy in vivo as compared to <b>25</b> in the screening model. At the enzyme level, <b>37</b> showed a potent inhibition of gyrases and a 16- to 60-fold weaker inhibition of topo IV. Compound <b>39</b> showed a similar level of enzyme inhibition but increased MIC, presumably due to the presence of a negatively charged carboxylate leading to limited membrane permeability. Modification of the spacer in R<sup>8</sup> by exchanging the nitrogen with an oxygen atom as in <b>41</b> or with a methylene group as in <b>46</b> and <b>47</b> resulted in some loss of potency in vitro. Introducing 5-membered heteroaryl groups containing a variety of heteroatoms also had unsatisfactory outcomes. Among all R<sup>8</sup> unsubstituted heteroaryls tested, triazole <b>48</b> was the best when considering IC<sub>50</sub> and MIC values, but its oral efficacy was still inadequate. Attempts to improve inhibitory activities by appending substituents on the triazole core resulted in marginally improved in vitro and in vivo results (data not shown). These heteroaryls groups could be successfully replaced by smaller carbamate moieties as seen in <b>50</b> and <b>57</b>. These compounds indeed remained potent inhibitors of both gyrases with in vitro antibacterial activity against <i>S. aureus</i> similar to the one observed for <b>37</b>. Remarkably, these compounds showed improved oral efficacy in the screening model with significant reduction of CFUs compared to that of vehicle-treated mice. Given these interesting antibacterial activities in vitro and in vivo, the carbamate series was selected as a new lead family and was subsequently characterized.</div><div class="NLM_p last">The binding mode of <b>58</b>, a close analogue of <b>57</b>, was determined by X-ray crystallography (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C and D). Similarly to the 3-pyridyl substituent in <b>36</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and B), the carbamate was located over Arg76 for a stacking interaction. However, it was also involved in an H-bond interaction with Arg136 similar to that of the coumarin carbonyl of <b>1</b>. However, in contrast to <b>1</b>, this interaction appeared to be weak in the case of carbamates since the mutation Arg136His did not significantly impact the inhibitory effect of <b>57</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, vide infra).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Antibacterial Spectrum and Inhibition of Enzymes</h3><div class="NLM_p">A few compounds with different substituents at position 8 were characterized in vitro against a panel of representative bacterial strains to assess their antibacterial activity (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Importantly, the potent antistaphylococcal activity was retained against the ciprofloxacin-resistant strain <i>S. aureus</i> A-798, a clinical isolate of MRSA containing the typical topoisomerase mutations associated with fluoroquinolone resistance. Activity was also retained against fluoroquinolone-resistant (QR) strains of <i>S. pneumoniae</i> and vancomycin-resistant <i>E. faecium</i> (VRE), highlighting the potential of this chemical series to control fluoroquinolone-resistant and other resistant strains. Low MICs were also measured against the fastidious Gram-negative bacteria <i>M. catarrhalis</i> and <i>H. influenzae</i> but not against Enterobacteriaceae exemplified by <i>E. coli</i>. Replacement of the R<sup>8</sup> methyl group of <b>25</b> with an aminopyridine in <b>37</b> led to improved MICs against all bacteria tested. The outcome was different for carbamates <b>50</b> and <b>57</b>, and only MIC against <i>S. aureus</i> and <i>S. pyogenes</i> were significantly improved. With the exception of <i>H. influenzae</i>, the compounds tested showed equal or superior potency compared to that of novobiocin <b>1</b>. None of the compounds showed meaningful activity against the wild-type <i>E. coli</i> strain, most probably due to efflux as evidenced by their good activity against the TolC efflux knockout mutant strain. The differences in MICs observed with these compounds were further investigated by measuring the inhibition of the corresponding enzymes (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The replacement of the methyl group at position 8 in <b>25</b> by an aminopyridine in <b>37</b> or a carbamate in <b>50</b> and <b>57</b> led to a 4- to 64-fold improvement on all enzymes tested, which mirrors relatively well the MIC differences. For <i>S. aureus</i> enzymes, all compounds were more potent on gyrase than on topo IV, as previously reported for <b>1</b>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The IC<sub>50</sub>s were not affected by gyrase and topo IV mutations known to be involved in fluoroquinolone-resistance in <i>S. aureus</i>, in line with the low MICs measured against the MRSA/QR strain. Surprisingly, compounds tended to display an enhanced inhibition of both QR gyrase and topo IV enzymes, but it cannot be excluded that this finding is the consequence of the lower apparent turnover number of the QR enzyme compared to that of the wild-type enzyme. For <i>S. pneumoniae</i> enzymes, a similar observation was made, and in contrast to novobiocin, our urea derivatives showed a slightly more potent inhibition of topo IV than of gyrase. For <i>H. influenzae</i> and <i>E. coli</i>, all compounds displayed an inhibition pattern similar to that for <i>S. aureus</i>. The compounds were also evaluated against a mutated <i>E. coli</i> gyrase enzyme, where Arg136 was exchanged for a His residue. This mutant was reported to confer resistance to <b>1</b>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which indeed suffered a 64-fold increase in IC<sub>50</sub> in our assay, whereas there was no significant difference in inhibitory activity for <b>25</b>, <b>37</b>, <b>50</b>, and <b>57</b>. While this was expected for <b>25</b> and <b>37</b>, it suggested that the H-bond interaction of the carbamate moiety with Arg136 observed in the X-ray structure (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C and D) was not adding to the binding of <b>57</b> as much as that for <b>1</b> and that the interactions of pyridyl and carbamate substituents with Arg76 were contributing to binding to a similar extent. Finally, all compounds were selective for bacterial topoisomerases since they did not show any inhibition of the human topoisomerase IIα homologue.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Antibacterial Activity (MIC in μg/mL) of Representative Compounds against Selected Bacterial Strains</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">bacterial strains</th><th class="colsep0 rowsep0" align="center"><b>25</b></th><th class="colsep0 rowsep0" align="center"><b>37</b></th><th class="colsep0 rowsep0" align="center"><b>50</b></th><th class="colsep0 rowsep0" align="center"><b>57</b></th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center">ciprofloxacin</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Staphylococcus aureus</i> ATCC 29213</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">≤0.03</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">≤0.03</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Staphylococcus aureus</i> A-798 (MRSA/QR)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">≤0.03</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">≤0.03</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">>16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus pneumoniae</i> ATCC 49619</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus pneumoniae</i> A-70 (QR)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus pyogenes</i> ATCC 19615</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Enterococcus faecalis</i> ATCC 29212</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">≤0.03</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Enterococcus faecium</i> A-949 (VRE/QR)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Moraxella catarrhalis</i> A-894</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Haemophilus influenzae</i> A-921</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">≤0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Escherichia coli</i> ATCC 25922</td><td class="colsep0 rowsep0" align="left">>16</td><td class="colsep0 rowsep0" align="left">>16</td><td class="colsep0 rowsep0" align="left">>16</td><td class="colsep0 rowsep0" align="left">>16</td><td class="colsep0 rowsep0" align="left">>16</td><td class="colsep0 rowsep0" align="left">≤0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Escherichia coli</i> ΔtolC<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">≤0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Fluoroquinolone-resistant, mutations in topoisomerase genes: <i>gyrA</i>, S84L; <i>grlA</i>, S80F, and Glu84V.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Fluoroquinolone-resistant, mutations in topoisomerase genes: <i>gyrA</i>, S81F; <i>parC</i>, S79F; <i>parE</i>, and I440V.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Fluoroquinolone-resistant, mutations in topoisomerase genes: <i>gyrA</i>, E88K; <i>parC</i>, S80R; and vancomycin-resistant (vanA).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Mutant strain with the TolC efflux pump gene knocked out.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory in Vitro Activities (IC<sub>50</sub> in μM) of Representative Compounds against Selected Enzymes<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center"><b>25</b></th><th class="colsep0 rowsep0" align="center"><b>37</b></th><th class="colsep0 rowsep0" align="center"><b>50</b></th><th class="colsep0 rowsep0" align="center"><b>57</b></th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center">ciprofloxacin</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. aureus</i> gyrase</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. aureus</i> gyrase QR<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left"><0.004</td><td class="colsep0 rowsep0" align="left"><0.004</td><td class="colsep0 rowsep0" align="left"><0.004</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">>256</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. aureus</i> topo IV</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. aureus</i> topo IV QR<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">>256</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. pneumoniae</i> gyrase</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>256</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. pneumoniae</i> gyrase QR<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">>256</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. pneumoniae</i> topo IV</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>H. influenzae</i> gyrase</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>H. influenzae</i> topo IV</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> gyrase</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> gyrase NovoR<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> topo IV</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human topo IIα</td><td class="colsep0 rowsep0" align="left">>256</td><td class="colsep0 rowsep0" align="left">>256</td><td class="colsep0 rowsep0" align="left">>256</td><td class="colsep0 rowsep0" align="left">>256</td><td class="colsep0 rowsep0" align="left">>256</td><td class="colsep0 rowsep0" align="left">>256</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Supercoiling inhibition assay for gyrases and relaxation inhibition assay for topo IV and human topo IIα.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Isolated from QR clinical isolate with mutation S84L in <i>gyrA</i>.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Isolated from QR clinical isolate with mutations S80F and E84V in <i>grlA</i>.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Isolated from strain A-70 with mutation S81F in <i>gyrA</i>.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">R136H in <i>gyrB</i> (generated by site-directed mutagenesis on the WT gene).</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Solubility and Prodrug Approach</h3><div class="NLM_p">The possibility to offer patients an iv-to-oral switch therapy was considered early in the program, and the in vivo efficacy achieved after oral administration was especially encouraging in this regard. Nevertheless, the development of a formulation adequate for iv infusion was required, and for this purpose, we were targeting a minimal solubility of 10 mg/mL. However, carbamate <b>50</b> showed a solubility of 20 μg/mL in phosphate buffer at pH 7.0 and of 340 μg/mL in citrate buffer at pH 4.0. In order to reach markedly higher solubility, we modified the 4-pyridyl moiety with an enzymatically cleavable phosphate group: such types of prodrugs had previously been reported<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and appeared to be readily cleaved in vitro and in vivo. The phosphoryloxymethyl prodrug <b>68</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) was soluble at 12.7 mg/mL in water at pH 6.3 and stable in solution at room temperature for several weeks. In vitro, the disappearance of <b>68</b> was fast as shown by the short half-lives measured in human, rat, and mouse blood.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structure of prodrug <b>68</b> at physiological pH and half-lives upon incubation in blood in vitro.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In rats, <b>50</b> and <b>68</b> were given orally (2 and 2.56 mg/kg) and intravenously (0.5 and 0.64 mg/kg) at equimolar doses (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). For both routes, the exposures of <b>50</b> were similar irrespective of the form administered, thus indicating a complete conversion of <b>68</b> to <b>50</b> in vivo. In addition, <b>68</b> (12.8 and 38.4 mg/kg, 2q2.75 h, iv) showed superior efficacy as compared to <b>50</b> (10 and 30 mg/kg, 2q2.75 h, po) in the neutropenic murine screening model of thigh infection (median Δlog<sub>10</sub>CFU/thigh of animal treated with compounds compared to vehicle: −3.6, resp. ≥ −4.8 (CFU below limit of detection) for <b>68</b> and −2.5, resp. −3.5 for <b>50</b>). All of these early observations suggested that this prodrug was an adequate prototype.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters of Compound <b>50</b> and Its Prodrug Derivative <b>68</b> in Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">cmpd <b>50</b> administered</th><th class="rowsep1 colsep0" colspan="2" align="center">prodrug <b>68</b> administered</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">iv (0.5 mg/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">po (2 mg/kg)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">iv (0.64 mg/kg)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">po (2.56 mg/kg)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cmpd <b>50</b> AUC (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">261</td><td class="colsep0 rowsep0" align="left">319</td><td class="colsep0 rowsep0" align="left">301</td><td class="colsep0 rowsep0" align="left">310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cmpd <b>50</b> Cl (mL/min·kg)</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cmpd <b>50</b><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cmpd <b>50</b><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">0.65</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cmpd <b>50</b><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">287</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cmpd <b>50</b><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cmpd <b>50</b><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prodrug <b>68</b> AUC (ng·h/mL)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">BLQ<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prodrug <b>68</b> Cl (mL/min·kg)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prodrug <b>68</b><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prodrug <b>68</b><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Solution in 30% propylene glycol in water at pH 4.2.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Suspension in 0.5% methyl cellulose in water.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Solution in 5% mannitol in water at pH 7.1.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">BLQ: below the limit of quantification.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> hERG K-Channel Block</h3><div class="NLM_p">A strong hERG K-channel block (hERG block) was observed in vitro with <b>50</b> at 10 μM (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). As could be expected, this block translated into prolongation of the QT interval of the electrocardiogram in vivo (vehicle-corrected prolongation of the Bazett-corrected QT interval in anesthetized guinea pigs using iv infusion: 0% and 6% at 0.4 μM and 1.5 μM free plasma concentration, respectively), which prevented further development of this compound.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We noticed that the corresponding pyridine des-methyl derivative <b>59</b> was slightly less lipophilic and produced less hERG block. We subsequently modulated compound lipophilicity by modifying the substituent on the R<sup>8</sup> carbamate. Compared to the methyl carbamate <b>59</b>, the isopropyl derivative <b>60</b> was more lipophilic with increased hERG block, whereas the more polar hydroxyethyl derivative <b>61</b> did not block hERG at 10 μM. Unfortunately, <b>61</b> showed a significantly reduced antibacterial activity compared to that of <b>59</b> or <b>60</b> despite similar enzyme inhibition.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Influence of Lipophilicity and Charge on hERG Block and Antibacterial Activity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0018.gif" alt="" id="GRAPHIC-d7e2629-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0019.gif" alt="" id="GRAPHIC-d7e2630-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">clogP was calculated using DataWarrior.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Percent K<sup>+</sup> current inhibition measured at 10 μM.</p></div><div class="footnote" id="t6fn3"><sup>Table c</sup><p class="last">Minimal inhibitory concentration.</p></div><div class="footnote" id="t6fn4"><sup>Table d</sup><p class="last">Gyrase supercoiling inhibition assay.</p></div><div class="footnote" id="t6fn5"><sup>Table e</sup><p class="last">Topo IV relaxation inhibition assay.</p></div></div><div></div></div><div class="NLM_p last">We then introduced substituents carrying a positive charge and measured logD at pH 7.4 as well as p<i>K</i><sub>a</sub>. The p<i>K</i><sub>a</sub> values for pyridyl and isoquinoline nitrogens (see general structure above <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) varied less than those of the R<sup>8</sup> substituents. The influence of an ionizable nitrogen in side chains of inverted carbamates <b>69</b>–<b>71</b> illustrated a dichotomy between logD and p<i>K</i><sub>a</sub>: increasing lipophilicity (logD and clogP) led to stronger hERG block, whereas the antibacterial activity was governed by the proportion of neutral species since decreasing p<i>K</i><sub>a</sub> values improved the MIC. In this respect, <b>70</b> displayed an optimal balance of lipophilicity versus ionizability, and we further fine-tuned logD and p<i>K</i><sub>a</sub> by preparing <b>52</b> and <b>72</b>–<b>74</b>. Compound <b>52</b> had the lowest p<i>K</i><sub>a</sub> (6.5) and a MIC of 0.5 μg/mL against <i>S. aureus</i> but displayed only minor hERG block despite significant lipophilicity, thereby contradicting our first hypothesis. Actually, it appeared that a hydrophilic part at the distal end of the molecule was sufficient to strongly reduce hERG block, ruling out the need for a positive charge as further illustrated by <b>54</b>, <b>62</b>, and <b>63</b>. Neutral hydroxyl or ether groups were further studied, and while the hydroxyl derivative <b>64</b> displayed moderate antibacterial activity, the corresponding methyl ether <b>51</b> represented a better compromise. Finally, amides <b>65</b> and <b>66</b> blocked hERG to a much lesser extent but were also less potent against bacteria compared to carbamates <b>50</b> and <b>51</b>. Increasing the lipophilicity at the distal end in amide <b>67</b> resulted in a better antibacterial activity but also in an unacceptable hERG block as previously noticed in the carbamate series.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Pharmacology</h3><div class="NLM_p">A few compounds with minor hERG block were evaluated for oral efficacy against <i>S. aureus</i> A-1178 in the 6.5 h screening model of thigh infection (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>), except for carbamate <b>52</b> which was not studied in vivo due to prohibitively high intrinsic clearances measured in mouse and rat liver microsomes. Neither carbamates <b>51</b> and <b>70</b> nor amide <b>65</b> exhibited comparable oral efficacies relative to lead compound <b>50</b>, which can be explained by the lower free exposure of these compounds in addition to the higher MIC.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Oral Efficacy in the Neutropenic Murine Thigh Infection Screening Model against <i>S. aureus</i> A-1178 for Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">oral efficacy<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (Δlog<sub>10</sub>CFU/thigh)</th><th class="colsep0 rowsep0" align="center">mean calcd AUC<sub>24h</sub> (μg·h/mL)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">PPB (%)</th><th class="colsep0 rowsep0" align="center">mean calcd fAUC<sub>24h</sub> (μg·h/mL)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">MIC (μg/mL)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">–3.5</td><td class="colsep0 rowsep0" align="left">45.3</td><td class="colsep0 rowsep0" align="left">96.5</td><td class="colsep0 rowsep0" align="left">1.59</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">–1.3</td><td class="colsep0 rowsep0" align="left">14.0</td><td class="colsep0 rowsep0" align="left">95.5</td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">0.125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">87.7</td><td class="colsep0 rowsep0" align="left">0.015</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">–0.3</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">94.8</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Mice were treated orally (30 mg/kg, 2q2.75 h) starting at 1 h post-infection and sacrificed at 6.5 h post-infection. Median Δlog<sub>10</sub>CFU/thigh of animal treated with compounds compared to vehicle is reported. Vehicle-treated animals showed median Δlog<sub>10</sub>CFU/thigh about +3 compared to CFU/thigh at treatment start.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Calcd AUC<sub>24h</sub> were calculated from PK experiments in mice dosed po at 30 mg/kg for <b>50</b> and <b>65</b>, and at 100 mg/kg for <b>51</b> and <b>70</b>.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Minimal inhibitory concentration of <i>S. aureus</i> A-1178.</p></div></div></div><div class="NLM_p">In the standard 24 h neutropenic murine thigh infection model,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><b>50</b> exhibited oral efficacy comparable to that of linezolid, a drug used to treat infections caused by Gram-positive bacteria (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). The vehicle-treated control exhibited about 1.8 log<sub>10</sub> CFU/thigh increase until the end of treatment. Both <b>50</b> and linezolid caused a dose-dependent reduction of bacterial growth after oral administration. At 40 mg/kg/day, both compounds displayed a minimal effect while net stasis was obtained with 120 mg/kg/day of <b>50</b>.</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Oral efficacy in a 24 h neutropenic murine thigh infection model with <i>S. aureus</i> A-1178. Mice were treated orally at 40 and 120 mg/kg (1q22h for linezolid and 4q5.5h for <b>50</b>) starting at 2 h post-infection and sacrificed at 24 h post-infection. Bars and error bars represent median and interquartile ranges.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A new series of GyrB/ParE inhibitors based on the ethyl urea binding motif has been described. A focused screening around this moiety followed by molecular modeling led to the selection of the isoquinoline core as a promising starting point. The subsequent fragment evolution program was guided by structure-based design, and the optimization efforts focused both on antibacterial activity in vitro and on oral efficacy in a mouse thigh infection model. These investigations resulted in the identification of carbamates as novel chemotypes interacting with an Arg residue in a salt-bridge conserved in all bacterial type II topoisomerases. These new isoquinoline ethyl urea derivatives displayed antibacterial activity in vitro against fluoroquinolone-resistant Gram-positive and RTI pathogens. Interestingly, inhibition of gyrase or topo IV was stronger depending on the bacteria from which the enzymes were isolated, and we report data where both enzymes are inhibited to a similar extent as well as cases where a 250-fold difference exists despite the relative structural homologies between the ATP-binding sites of all these topoisomerases. More work will be needed to assess the relative contribution of gyrase and topo IV inhibition to the observed effects in these bacteria.</div><div class="NLM_p last">The carbamate lead compound <b>50</b> showed oral efficacy similar to that of linezolid against <i>S. aureus</i> in the neutropenic murine thigh infection model. The possibility to offer patients a safe iv-to-oral switch therapy was deemed important, and the identification of a suitable phosphate prodrug concept supported the potential for developing an adequate iv formulation. On the other hand, the cardiovascular safety limitation proved more difficult to solve: hERG K-channel block could be reduced by introducing either a charge or a heteroatom at the distal end of the carbamate but only at the expense of both antibacterial activity in vitro and exposure after oral administration, which together compromised efficacy in vivo. At this point, none of the compounds exhibits an interesting pharmacological profile overall to justify progression toward preclinical development, and further optimization efforts are required.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Chemistry</h3><div class="NLM_p last">All solvents and chemicals were used as purchased without further purification. Analytical TLC characterizations were performed with 0.2 mm plates: Merck, Silica gel 60 F<sub>254</sub>. Column chromatography (CC) was performed using Brunschwig 60A silica gel (0.032–0.63 mm), SNAP KP-Sil cartridges from Biotage, or EasyVarioFlash cartridges from Merck; elution was performed with EtOAc, Heptane, DCM, MeOH, or mixtures thereof. In the cases of compounds containing a basic function (e.g., amine), 1% of NH<sub>4</sub>OH (25% aq) was added to the eluent(s). Prep-HPLCs were performed on XBridge Prep C18 columns from Waters. Eluents: A, H<sub>2</sub>O + 0.5% acidic or basic additive; B, MeCN; gradient, 5% B to 95% B over 5 min. Detection: UV/vis and/or MS and/or ELSD. Prep-HPLC (acidic conditions): additive in A is HCO<sub>2</sub>H. Prep-HPLC (basic conditions): additive in A is NH<sub>4</sub>OH (25% aq). In case an amine-containing compound was purified under acidic conditions, HCl was added prior to evaporation to avoid the possible formation of the formamide and usually yielded the corresponding hydrochloride salt. NMR spectra were recorded on a Varian Mercury 300 (300 MHz) or a Bruker Avance 400 (400 MHz for <sup>1</sup>H; 100 MHz for <sup>13</sup>C) spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) relative to deuterated solvent as the internal standard (δH: CDCl<sub>3</sub> 7.26 ppm, <i>d</i><sub>6</sub>-DMSO 2.50 ppm); multiplicities, s = singlet, d = doublet, t = triplet, q = quadruplet, m = multiplet, and br = broad signal; coupling constants are given in Hz. LC-HRMS was performed on Waters Acquity UPLC-MS; pump, Waters Acquity Binary, Solvent Manager; MS, SYNAPT G2MS; DAD, Acquity UPLC PDA detector; column, Acquity UPLC CSH C18 1.7 μm 2.1 × 50 mm from Waters, thermostated in the Acquity UPLC Column Manager at 60 °C. Eluents: A, H<sub>2</sub>O + 0.05% formic acid; B, MeCN + 0.05% formic acid; gradient, 2% B to 98% B over 2.0 min; flow, 0.6 mL/min; detection, UV 214 nm and MS; the retention time <sup><i>t</i></sup><i>R</i> is given in min. The purity of all final compounds was ≥95%. Other LC-MS data were obtained on Sciex API 2000 with Agilent 1100 Binary Pump with DAD and ELSD; Agilent quadrupole MS 6140 with Agilent 1200 Binary Pump, DAD, and ELSD; Thermo Finnigan MSQ Surveyor MS with Agilent 1100 Binary Pump, DAD, and ELSD; or Thermo MSQ Plus with Dionex GHP 3200 Binary Pump, DAD, and ELSD. The number of decimals given for the corresponding [M + H<sup>+</sup>] peak(s) of each tested compound depends upon the accuracy of the LC-MS device actually used.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Treatment with Scavengers</h3><div class="NLM_p last">In cases where the Pd catalyst was used in the last step before biological testing, the crude product was treated with scavengers before performing the purification: the crude residue (0.1 mmol-scale reaction) was dissolved in 9:1 DCM/MeOH (2.0 mL) and treated with a 1:1 mixture (40 mg) of triamine ethyl sulfide amide silica (PhosphonicS STA3; loading, 0.8 mmol/g; particle size, 60–200 μm; pore diameter, 60 Å) and methyl thiourea ethylsulfide ethyl silica (PhosphonicS MTCf; loading, 0.6 mmol/g; particle size, 60–200 μm; pore diameter, 90 Å). The mixture was shaken at rt overnight and filtered. The scavengers were washed with 9:1 DCM/MeOH, and the filtrate was concentrated under reduced pressure.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure 1 (Addition of Benzyl Amine on Imidate Derivatives)</h3><div class="NLM_p">To a solution of the required benzyl amine derivative (10 mmol, 1.0 equiv) in dry MeOH (25 mL) was added a solution of 2,2-diethoxy-ethanimidic acid methyl ester <b>17</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (1.2 equiv) in dry MeOH (25 mL) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was stirred at rt and monitored by LC-MS. Upon reaction completion, the reaction mixture was concentrated under reduced pressure. The residue was dissolved in DCM, and the organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was dried in vacuo and used without further purification in the next step.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(2-Bromo-benzyl)-2,2-diethoxy-acetamidine (<b>19a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 1 from 2-bromobenzylamine <b>18a</b> (25.0 g, 134 mmol) at rt for 2 h. Concentration under reduced pressure gave <b>19a</b> as an orange oil (43.45 g). MS (ESI, <i>m</i>/<i>z</i>): 315.2 and 317.0 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(3-Bromobenzyl)-2,2-diethoxyacetimidamide (<b>19b</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 1 from 3-bromobenzylamine hydrochloride <b>18b</b> (25.0 g, 112 mmol) at 70 °C for 2 h. Concentration under reduced pressure gave <b>19b</b> as an orange oil (24.47 g). MS (ESI, <i>m</i>/<i>z</i>): 315.2 and 317.2 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-(5-Bromo-2-methyl-benzyl)-2,2-diethoxy-acetamidine (<b>19c</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 1 from 5-bromo-2-methyl-benzylamine <b>18c</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (21.21 g, 106 mmol) at 50 °C for 3 h. Concentration under reduced pressure gave <b>19c</b> as a beige solid (37.19 g). MS (ESI, <i>m</i>/<i>z</i>): 329.2 and 331.2 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(5-Bromo-2-chloro-benzyl)-2,2-diethoxy-acetamidine (<b>19d</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 1 from 5-bromo-2-chlorobenzylamine <b>18d</b> (15.09 g, 68.4 mmol) at rt for 10 h. Concentration under reduced pressure gave <b>19d</b> as an orange viscous oil (23.95 g). MS (ESI, <i>m</i>/<i>z</i>): 349.2 and 351.0 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(2-Bromo-5-chloro-benzyl)-2,2-diethoxy-acetamidine (<b>19e</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 1 from <b>18e</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (84.01 g, 381 mmol) at rt for 23 h. Concentration under reduced pressure gave <b>19e</b> as a yellow oil (129.10 g). MS (ESI, <i>m</i>/<i>z</i>): 348.7 and 350.8 [M + H<sup>+</sup> of the two main isotopes].</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure 2 (Isoquinoline Formation)</h3><div class="NLM_p">To the crude product of General Procedure 1 was added concd H<sub>2</sub>SO<sub>4</sub> (45 equiv) at 0 °C. The reaction mixture was stirred at rt or at 80 °C and monitored by LC-MS. Upon reaction completion, the reaction mixture was slowly poured into water at 0 °C. The resulting acidic aqueous solution was then treated with a 12 N aq NaOH solution at 0 °C until a pH of 12 was obtained. The resulting suspension was filtered and the cake washed with warm water, collected, and dried in vacuo. Purification of the residue gave the desired product.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 8-Bromo-isoquinolin-3-yl-amine (<b>20a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 2 from <b>19a</b> (43.45 g) at rt for 22 h. Purification by CC (heptane/EtOAc 100:0 to 30:70) gave <b>20a</b> as a yellow solid (11.85 g, 40% yield over 2 steps). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 8.92 (s, 1H); 7.55–7.50 (m, 1H); 7.41–7.37 (m, 1H); 7.33–7.26 (m, 1H); 6.61 (s, 1H); 6.18 (br, 2H). MS (ESI, <i>m</i>/<i>z</i>): 223.1 and 225.4 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-Bromoisoquinolin-3-amine (<b>20b</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 2 from <b>19b</b> (24.47 g) at rt for 22 h. Purification by CC (heptane to heptane/EtOAc 1:1) gave <b>20b</b> as a brown solid (3.34 g, 13% yield over 2 steps). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 8.82 (s, 1H); 7.86–7.75 (m, 2H); 7.04 (dd, <i>J</i> = 8.0, 7.4 Hz, 1H); 6.78–6.73 (m, 1H); 6.27 (br, 2H). MS (ESI, <i>m</i>/<i>z</i>): 223.0 and 225.3 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-Bromo-8-methyl-isoquinolin-3-ylamine (<b>20c</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 2 from <b>19c</b> (37.19 g, 113 mmol) at rt for 15 h. Purification by CC (DCM/MeOH 100:0 to 97:3) gave <b>20c</b> as a yellow solid (9.70 g, 39% yield over 2 steps). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 8.93 (d, <i>J</i> = 0.6 Hz, 1H); 7.66 (d, <i>J</i> = 7.3 Hz, 1H); 6.84 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H); 6.79 (d, <i>J</i> = 0.9 Hz, 1H); 6.24 (br, 2H); 2.57 (d, <i>J</i> = 0.9 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 237.1 and 239.0 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-Bromo-8-chloro-isoquinolin-3-ylamine (<b>20d</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 2 from <b>19d</b> (23.95 g) at rt for 22 h. Purification by CC (heptane/EtOAc 10:0 to 0:10) gave <b>20d</b> as a yellow solid (11.29 g, 64% yield over 2 steps). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.02 (d, <i>J</i> = 0.9 Hz, 1H); 7.76 (d, <i>J</i> = 7.9 Hz, 1H); 7.14 (d, <i>J</i> = 7.9 Hz, 1H); 6.82 (d, <i>J</i> = 0.6 Hz, 1H); 6.58 (br, 2H). MS (ESI, <i>m</i>/<i>z</i>): 257.2 and 259.1 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 8-Bromo-5-chloro-isoquinolin-3-ylamine (<b>20e</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 2 from <b>19e</b> (114.69 g, 328 mmol) at 80 °C for 3 h. Drying the precipitate under reduced pressure gave <b>20e</b> as a brown solid (75.0 g, 88% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 8.97 (s, 1H); 7.52 (d, <i>J</i> = 7.9 Hz, 1H); 7.37 (d, <i>J</i> = 7.9 Hz, 1H); 6.82 (s, 1H); 6.57 (s, 2H). MS (ESI, <i>m</i>/<i>z</i>): 256.9 and 259.0 [M + H<sup>+</sup> of the two main isotopes].</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> General Procedure 3 (Ethyl Urea Formation)</h3><div class="NLM_p">To a solution of the required amine (1.0 mmol, 1.0 equiv) in dry dioxane (10 mL) was added ethyl isocyanate (2.5 equiv). The reaction mixture was stirred at 50 °C and monitored by LC-MS. Upon reaction completion, the reaction mixture was cooled to 10 °C. The precipitate formed was filtered, washed with a minimum amount of dioxane, collected, and dried in vacuo to give the desired product. Additional purification might have been performed to isolate the desired product.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(8-Bromo-isoquinolin-3-yl)-3-ethyl-urea (<b>21a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 3 from <b>20a</b> (10.84 g, 49 mmol) and ethyl isocyanate (11.50 mL, 145 mmol) at 50 °C for 5 days. A first batch of product was obtained (6.93 g), and the mother liquors were concentrated under reduced pressure. The residue was purified by CC (DCM/MeOH 100:0 to 95:5) to give a second batch of product (4.68 g). Combining the two batches gave <b>21a</b> as a yellow solid (11.62 g, 81% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.19 (s, 1H); 9.14 (s, 1H); 8.09 (s, 1H); 7.81 (d, <i>J</i> = 8.5 Hz, 1H); 7.69 (d, <i>J</i> = 7.6 Hz, 1H); 7.51 (dd, <i>J</i> = 8.5, 7.6 Hz, 1H); 6.94 (t, <i>J</i> = 5.6 Hz, 1H); 3.22–3.11 (m, 2H); 1.08 (t, <i>J</i> = 7.3 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 294.4 and 296.6 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(5-Bromoisoquinolin-3-yl)-3-ethylurea (<b>21b</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 3 from <b>20b</b> (1.18 g, 5.3 mmol) at 50 °C for 24 h. A first batch of product was obtained (340 mg), and the mother liquors were concentrated under reduced pressure. The residue was purified by CC (heptane to heptane/EtOAc 1:1) to give a second batch of product (1.14 g). Combining the two batches gave <b>21b</b> as a white solid (1.48 g, 96% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.17 (br, 1H); 9.05 (d, <i>J</i> = 0.5 Hz, 1H); 8.34 (s, 1H); 8.03–7.97 (m, 2H); 7.32 (t, <i>J</i> = 7.7 Hz, 1H); 6.94 (t, <i>J</i> = 5.4 Hz, 1H); 3.23–3.10 (m, 2H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 294.5 and 296.6 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(5-Bromo-8-methylisoquinolin-3-yl)-3-ethylurea (<b>21c</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 3 from <b>20c</b> (5.66 g, 23.9 mmol) at 50 °C for 5 days. Drying the precipitate under reduced pressure gave <b>21c</b> as a yellow solid (6.07 g, 82% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.20 (s, 1H); 9.15 (s, 1H); 8.33 (s, 1H); 7.85 (d, <i>J</i> = 7.6 Hz, 1H); 7.12 (dd, <i>J</i> = 7.6, 0.9 Hz, 1H); 7.01 (t, <i>J</i> = 5.6 Hz, 1H); 3.23–3.12 (m, 2H); 2.66 (s, 3H); 1.08 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 155.0; 150.7; 149.4; 137.1; 136.3; 134.6; 126.3; 125.0; 118.0; 103.1; 34.4; 18.2; 15.9. MS (ESI, <i>m</i>/<i>z</i>): 308.4 and 310.4 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(5-Bromo-8-chloro-isoquinolin-3-yl)-3-ethyl-urea (<b>21d</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 3 from <b>20d</b> (5.00 g, 19.4 mmol) at 50 °C for 6 days. Drying the precipitate under reduced pressure gave <b>21d</b> as a pale yellow solid (4.25 g, 67% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.37 (s, 1H); 9.24 (d, <i>J</i> = 0.6 Hz, 1H); 8.45 (d, <i>J</i> = 0.9 Hz, 1H); 7.97 (d, <i>J</i> = 8.2 Hz, 1H); 7.45 (d, <i>J</i> = 8.2 Hz, 1H); 6.91 (t, <i>J</i> = 5.3 Hz, 1H); 3.23–3.12 (m, 2H); 1.08 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 154.8; 151.7; 148.7; 138.3; 134.9; 131.7; 125.6; 122.4; 119.4; 103.0; 34.4; 15.8. MS (ESI, <i>m</i>/<i>z</i>): 328.3 and 330.1 [M + H<sup>+</sup> of the two main isotopes].</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-(8-Bromo-5-chloro-isoquinolin-3-yl)-3-ethyl-urea (<b>21e</b>)</h4><div class="NLM_p last">To a solution of <b>20e</b> (39.9 g, 155 mmol) in dry pyridine (1 L) at rt was added ethyl isocyanate (18.2 mL, 230 mmol). The reaction mixture was stirred at 65 °C for 42 h, and pyridine was removed under reduced pressure. Dioxane (500 mL) was added to the residue, and the suspension was stirred at rt for 1 h and cooled to 10 °C. The precipitate was filtered, washed with a minimum amount of dioxane, and dried to give <b>21e</b> as a yellow solid (40.5 g, 80% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.38 (s, 1H); 9.18 (s, 1H); 8.42 (s, 1H); 7.73 (d, <i>J</i> = 7.9 Hz, 1H); 7.67 (d, <i>J</i> = 7.9 Hz, 1H); 6.92 (t, <i>J</i> = 5.5 Hz, 1H); 3.22–3.12 (m, 2H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 154.8; 151.5; 151.0; 137.2; 131.7; 129.4; 128.7; 123.4; 121.1; 100.2; 34.4; 15.8. MS (ESI, <i>m</i>/<i>z</i>): 328.1 and 330.2 [M + H<sup>+</sup> of the two main isotopes].</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> General Procedure 4 (Negishi-Type Coupling)</h3><div class="NLM_p">To a solution of the appropriate aromatic halide (0.1 mmol, 1.0 equiv) and Pd(dppf)Cl<sub>2</sub>·DCM (0.01 equiv) in dry THF (0.5 mL) was added dimethylzinc (1.2 M in toluene, 1.6 equiv) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was purged with N<sub>2</sub> for 5 min, stirred at 80 °C, and monitored by LC-MS. Upon reaction completion, the reaction mixture was cooled down to rt and diluted with 9:1 DCM/MeOH and water. The two layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-Ethyl-3-(8-methylisoquinolin-3-yl)urea (<b>22</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 4 from <b>21a</b> (50 mg, 0.17 mmol) at 80 °C for 22 h. Purification by prep-HPLC (basic) gave <b>22</b> as a white solid (5 mg, 14% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.13 (s, 1H); 9.01 (s, 1H); 7.95 (s, 1H); 7.56 (d, <i>J</i> = 8.5 Hz, 1H); 7.52–7.44 (m, 1H); 7.21–7.15 (m, 1H); 7.15–7.07 (m, 1H); 3.22–3.11 (m, 2H); 2.67 (s, 3H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>13</sub>H<sub>15</sub>N<sub>3</sub>O 229.1215, found 230.1291 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 1.01 min.</div></div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedure 5 (Suzuki Coupling with Pd(PPh<sub>3</sub>)<sub>4</sub>)</h3><div class="NLM_p">To the aromatic halide (0.1 mmol, 1.0 equiv), the required boronic acid (1.5–2.0 equiv) and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.1 equiv) were added dioxane (0.8 mL) and an aq 1 N K<sub>2</sub>CO<sub>3</sub> solution (0.2–0.3 mL, 2.0 equiv for 1.5 equiv boronic acid, resp. 3.0 equiv for 2.0 equiv boronic acid) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was purged with N<sub>2</sub> for 5 min, stirred at 80 °C–110 °C, and monitored by LC-MS. Upon reaction completion, the reaction mixture was diluted with DCM and a saturated aq NaHCO<sub>3</sub> solution. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with a saturated aq NaHCO<sub>3</sub> solution, water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-Ethyl-3-(5-(pyridin-3-yl)isoquinolin-3-yl)urea (<b>23</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>21b</b> (30 mg, 0.1 mmol) and pyridine-3-boronic acid (25.2 mg, 0.2 mmol) at 80 °C for 4 h. Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>23</b> as a white solid (12 mg, 40% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.10 (s, 1H); 9.00 (s, 1H); 8.70–8.64 (m, 2H); 8.09–8.00 (m, 2H); 7.94–7.90 (m, 1H); 7.65–7.45 (m, 3H); 6.98 (t, <i>J</i> = 5.5 Hz, 1H); 3.17–3.01 (m, 2H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O 292.1324, found 293.1404 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.83 min.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-Ethyl-3-(8-methyl-5-(pyridin-3-yl)isoquinolin-3-yl)urea (<b>24</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>21c</b> (38.5 mg, 0.125 mmol) and pyridine-3-boronic acid (30.7 mg, 0.25 mmol) at 110 °C for 4 h. Purification by prep-HPLC (acidic) gave <b>24</b> as a yellow solid (6 mg, 15% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.22 (d, <i>J</i> = 0.8 Hz, 1H); 9.04 (s, 1H); 8.67–8.61 (m, 2H); 8.01 (d, <i>J</i> = 0.5 Hz, 1H); 7.90–7.84 (m, 1H); 7.58–7.51 (m, 1H); 7.48 (d, <i>J</i> = 7.2 Hz, 1H); 7.30 (dd, <i>J</i> = 7.2, 0.8 Hz, 1H); 7.14–7.07 (m, 1H); 3.17–3.02 (m, 2H); 2.73 (s, 3H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O 306.1481, found 307.1559 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.90 min.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-Ethyl-3-(8-methyl-5-(pyridin-4-yl)isoquinolin-3-yl)urea (<b>25</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>21c</b> (60 mg, 0.195 mmol) and pyridine-4-boronic acid (35.9 mg, 0.29 mmol) at 90 °C for 2 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 98:2) gave <b>25</b> as a yellow solid (51 mg, 86% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.22 (s, 1H); 9.03 (s, 1H); 8.70 (d, <i>J</i> = 5.9 Hz, 2H); 8.06 (s, 1H); 7.51–7.46 (m, 3H); 7.30 (d, <i>J</i> = 7.1 Hz, 1H); 7.07 (t, <i>J</i> = 5.0 Hz, 1H); 3.16–3.05 (m, 2H); 2.73 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 155.0; 150.3 (2CH); 150.0; 149.0; 147.3; 136.9; 135.9; 133.7; 131.8; 125.3; 125.1 (2CH); 124.1; 101.8; 34.3; 18.6; 15.9. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O 306.1481, found 307.1557 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.80 min.</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-Ethyl-3-(8-methyl-5-(pyrimidin-5-yl)isoquinolin-3-yl)urea (<b>26</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>21c</b> (38.5 mg, 0.125 mmol) and pyrimidine-5-boronic acid (31 mg, 0.25 mmol) at 110 °C for 4 h. Purification by prep-HPLC (acidic) gave <b>26</b> as a yellow solid (7 mg, 17% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.27 (s, 1H); 9.23 (s, 1H); 9.05 (s, 1H); 8.92 (s, 2H); 7.96 (s, 1H); 7.57 (d, <i>J</i> = 7.4 Hz, 1H); 7.34 (d, <i>J</i> = 7.4 Hz, 1H); 7.16–7.08 (m, 1H); 3.18–3.02 (m, 2H); 2.97 (s, 3H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O 307.1433, found 308.1509 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.99 min.</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-Ethyl-3-[8-methyl-5-(2-methyl-pyridin-4-yl)-isoquinolin-3-yl]-urea (<b>27</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>21c</b> (100 mg, 0.324 mmol) and 2-methylpyridine-4-boronic acid (88.9 mg, 0.649 mmol) at 90 °C for 2 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 96:4) gave <b>27</b> as a beige solid (44 mg, 43% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.22 (s, 1H); 9.03 (s, 1H); 8.55 (d, <i>J</i> = 5.1 Hz, 1H); 8.02 (s, 1H); 7.47 (d, <i>J</i> = 7.2 Hz, 1H); 7.33 (s, 1H); 7.31–7.23 (m, 2H); 7.16 (t, <i>J</i> = 5.4 Hz, 1H); 3.17–3.06 (m, 2H); 2.73 (s, 3H); 2.54 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O 320.1637, found 321.1714 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.74 min.</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(5-(4-Cyanophenyl)-8-methylisoquinolin-3-yl)-3-ethylurea (<b>28</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>21c</b> (38.5 mg, 0.125 mmol) and 4-cyanophenylboronic acid (36.7 mg, 0.25 mmol) at 110 °C for 4 h. Purification by prep-HPLC (acidic) gave <b>28</b> as a beige solid (12 mg, 24% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.24 (s, 1H); 9.06 (s, 1H); 8.06–7.98 (m, 3H); 7.68 (d, <i>J</i> = 8.2 Hz, 2H); 7.50 (d, <i>J</i> = 7.2 Hz, 1H); 7.32 (d, <i>J</i> = 7.3 Hz, 1H); 7.10–7.01 (m, 1H); 3.17–3.06 (m, 2H); 2.75 (s, 3H); 1.05 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>20</sub>H<sub>18</sub>N<sub>4</sub>O 330.1481, found 331.1563 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 1.26 min.</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-[5-(5,5-Dimethyl-[1,3,2]dioxaborinan-2-yl)-8-methyl-isoquinolin-3-yl]-3-ethyl-urea (<b>29</b>)</h4><div class="NLM_p last">To a mixture of <b>21c</b> (679 mg, 2.2 mmol), bis(neopentyl glycolato)diboron (597 mg, 2.65 mmol), KOAc (649 mg, 6.6 mmol), and Pd(dppf)Cl<sub>2</sub>·DCM (180 mg, 0.22 mmol) was added degassed DMSO (15.0 mL) at rt under inert atmosphere (N<sub>2</sub>). The resulting reaction mixture was stirred at 90 °C for 2 h. The reaction mixture was concentrated under reduced pressure and the residue diluted with 9:1 DCM/MeOH, and a saturated aq NH<sub>4</sub>Cl solution was added. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by CC (DCM/MeOH 100:0 to 96:4) followed by trituration in EtOAc gave <b>29</b> as a yellow solid (544 mg, 72% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.12 (d, <i>J</i> = 0.5 Hz, 1H); 9.03 (s, 1H); 8.67 (s, 1H); 7.90 (d, <i>J</i> = 7.0 Hz, 1H); 7.53 (t, <i>J</i> = 5.2 Hz, 1H); 7.16 (dd, <i>J</i> = 7.0, 0.7 Hz, 1H); 3.82 (s, 4H); 3.24–3.13 (m, 2H); 2.67 (s, 3H); 1.09 (t, <i>J</i> = 7.2 Hz, 3H); 1.00 (s, 6H). MS (ESI, <i>m</i>/<i>z</i>): 274.0 [M + H<sup>+</sup> of the corresponding boronic acid].</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-Ethyl-3-(8-methyl-5-pyrimidin-4-yl-isoquinolin-3-yl)-urea (<b>30</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>29</b> (210 mg, 0.32 mmol) and 4-bromo-pyrimidine hydrobromide (154 mg, 0.64 mmol) at 90 °C for 2 h. Purification by CC (DCM/MeOH 100:0 to 96:4) gave <b>30</b> as a yellow solid (40 mg, 40% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.33 (d, <i>J</i> = 1.3 Hz, 1H); 9.25 (d, <i>J</i> = 0.8 Hz, 1H); 9.06 (s, 1H); 8.93 (d, <i>J</i> = 5.2 Hz, 1H); 8.37 (d, <i>J</i> = 0.7 Hz, 1H); 7.79 (dd, <i>J</i> = 5.2, 1.4 Hz, 1H); 7.76 (d, <i>J</i> = 7.3 Hz, 1H); 7.34 (dd, <i>J</i> = 7.3, 0.9 Hz, 1H); 7.16 (t, <i>J</i> = 5.4 Hz, 1H); 3.18–3.07 (m, 2H); 2.75 (d, <i>J</i> = 0.4 Hz, 3H); 1.05 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O 307.1433, found 308.1514 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.97 min.</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-Ethyl-3-[8-methyl-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)-isoquinolin-3-yl]-urea Hydrochloride (<b>31</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>29</b> (34.1 mg, 0.1 mmol) and 4-bromo-1-methyl-1<i>H</i>-pyrazole (32.2 mg, 0.2 mmoL) at 110 °C for 4 h. Purification by prep-HPLC (acidic conditions) and treatment with HCl gave <b>31</b> as an amorphous solid (7.6 mg, 25% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.70 (br, 1H); 9.22 (s, 1H); 8.27 (s, 1H); 8.05 (s, 1H); 7.74 (s, 1H); 7.58 (d, <i>J</i> = 7.2 Hz, 1H); 7.48–7.25 (m, 1H); 7.30 (d, <i>J</i> = 7.2 Hz, 1H); 3.95 (s, 3H); 3.19 (q, <i>J</i> = 7.1 Hz, 2H); 2.70 (s, 3H); 1.10 (t, <i>J</i> = 7.1 Hz, 3H); N<sup>+</sup>H missing. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>17</sub>H<sub>19</sub>N<sub>5</sub>O 309.159, found 310.1668 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 1.04 min.</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-(8-Chloro-5-(pyridin-4-yl)isoquinolin-3-yl)-3-ethylurea (<b>32</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>21d</b> (3.00 g, 9.13 mmol) and pyridine-4-boronic acid (2.24 g, 18.3 mmol) at 90 °C for 2 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 96:4) gave <b>32</b> as a pale yellow solid (2.19 g, 74% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.32 (s, 1H); 9.20 (br, 1H); 8.75–8.70 (m, 2H); 8.15 (s, 1H); 7.62 (d, <i>J</i> = 7.6 Hz, 1H); 7.59 (d, <i>J</i> = 7.6 Hz, 1H); 7.53–7.47 (m, 2H); 6.92 (t, <i>J</i> = 5.4 Hz, 1H); 3.17–3.03 (m, 2H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 327.2 [M + H<sup>+</sup>].</div></div><div id="sec4_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-Ethyl-3-(8-(pyridin-3-yl)-5-(pyridin-4-yl)isoquinolin-3-yl)urea (<b>33</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 5 from <b>32</b> (60 mg, 0.184 mmol) and pyridine-3-boronic acid (45.1 g, 0.367 mmol) at 90 °C for 3 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 97:3) gave <b>33</b> as a pale yellow solid (43 mg, 63% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.11 (br, 1H); 8.84 (s, 1H); 8.78–8.70 (m, 4H); 8.15 (s, 1H); 8.06–8.00 (m, 1H); 7.70 (d, <i>J</i> = 7.3 Hz, 1H); 7.63–7.58 (m, 1H); 7.57–7.54 (m, 2H); 7.45 (d, <i>J</i> = 7.3 Hz, 1H); 7.06–6.97 (m, 1H); 3.15–3.04 (m, 2H); 1.02 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>19</sub>N<sub>5</sub>O 369.1589, found 370.1668 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.58 min.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> General Procedure 6 (Buchwald–Hartwig Amination)</h3><div class="NLM_p">To the aromatic halide (0.1 mmol, 1.0 equiv), the required amine derivative (1.5 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.05 equiv), XPhos (0.1 equiv), and NaO<i>t</i>Bu (1.2 equiv) was added dry dioxane (0.5 mL) at rt under inert atmosphere (N<sub>2</sub>). The resulting reaction mixture was purged with N<sub>2</sub> for 5 min, stirred at 90 °C, and monitored by LC-MS. Upon reaction completion, the reaction mixture was diluted with DCM and a saturated aq NaHCO<sub>3</sub> solution. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with a saturated aq NaHCO<sub>3</sub> solution, water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-[5-Chloro-8-(pyridin-3-ylamino)-isoquinolin-3-yl]-3-ethyl-urea (<b>34</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 6 from <b>21e</b> (1.50 g, 4.6 mmol) and 3-aminopyridine (644 mg, 6.8 mmol) at 90 °C for 2 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 96:4) gave <b>34</b> as a yellow solid (1.26 g, 81% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.34 (s, 1H); 9.23 (s, 1H); 8.81 (s, 1H); 8.47 (d, <i>J</i> = 2.6 Hz, 1H); 8.29 (s, 1H); 8.14 (dd, <i>J</i> = 4.6, 1.3 Hz, 1H); 7.61 (d, <i>J</i> = 8.3 Hz, 1H); 7.55 (ddd, <i>J</i> = 8.3, 2.7, 1.4 Hz, 1H); 7.29 (dd, <i>J</i> = 8.4, 4.6 Hz, 1H); 7.03 (d, <i>J</i> = 8.3 Hz, 1H); 6.99 (t, <i>J</i> = 5.5 Hz, 1H); 3.22–3.12 (m, 2H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 342.1 [M + H<sup>+</sup>].</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-[5-Chloro-8-(6-methyl-pyridin-3-ylamino)-isoquinolin-3-yl]-3-ethyl-urea (<b>35</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 6 from <b>21e</b> (200 mg, 0.609 mmol) and 5-aminopicoline (98.7 mg, 0.913 mmol) at 90 °C for 2 h, and using BrettPhos as a ligand instead. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 95:5) gave <b>35</b> as a yellow solid (86 mg, 40% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.35 (s, 1H); 9.20 (s, 1H); 8.69 (s, 1H); 8.35 (d, <i>J</i> = 2.5 Hz, 1H); 8.27 (s, 1H); 7.56 (d, <i>J</i> = 8.3 Hz, 1H); 7.50 (dd, <i>J</i> = 8.3, 2.8 Hz, 1H); 7.18 (d, <i>J</i> = 8.4 Hz, 1H); 6.99 (t, <i>J</i> = 5.6 Hz, 1H); 6.88 (d, <i>J</i> = 8.3 Hz, 1H); 3.22–3.13 (m, 2H); 2.41 (s, 3H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 356.0 [M + H<sup>+</sup>].</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> General Procedure 7 (Suzuki Coupling with PCy<sub>3</sub>/K<sub>2</sub>CO<sub>3</sub>)</h3><div class="NLM_p">To the aromatic halide (0.1 mmol, 1.0 equiv), the required boronic acid (1.1–2.0 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.1 equiv), and PCy<sub>3</sub> (0.2 equiv) were added dioxane (0.8 mL) and an aq 1 N K<sub>2</sub>CO<sub>3</sub> solution (0.2 mL, 2.0 equiv) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was purged with N<sub>2</sub> for 5 min, stirred at 100 °C, and monitored by LC-MS. Upon reaction completion, the reaction mixture was diluted with DCM and a saturated aq NaHCO<sub>3</sub> solution. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with a saturated aq NaHCO<sub>3</sub> solution, water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 1-Ethyl-3-[5-pyridin-4-yl-8-(pyridin-3-ylamino)-isoquinolin-3-yl]-urea (<b>36</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 7 from <b>34</b> (100 mg, 0.293 mmol) and pyridine-4-boronic acid (72 mg, 0.585 mmol) at 100 °C for 2 h. Purification by prep-HPLC (basic conditions) gave <b>36</b> as a yellow solid (65 mg, 58% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.39 (d, <i>J</i> = 0.4 Hz, 1H); 9.07 (s, 1H); 8.90 (s, 1H); 8.70–8.64 (m, 2H); 8.52 (d, <i>J</i> = 2.6 Hz, 1H); 8.17 (dd, <i>J</i> = 4.6, 1.3 Hz, 1H); 8.11 (s, 1H); 7.62 (ddd, <i>J</i> = 8.3, 2.7, 1.4 Hz, 1H); 7.51–7.46 (m, 3H); 7.32 (ddd, <i>J</i> = 8.2, 4.7, 0.4 Hz, 1H); 7.15 (d, <i>J</i> = 8.0 Hz, 1H); 7.03 (t, <i>J</i> = 5.6 Hz, 1H); 3.17–3.06 (m, 2H); 1.04 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 155.0; 150.5; 150.3 (2CH); 147.5; 147.4; 142.8; 141.9; 141.8; 140.0; 137.0; 133.1; 127.4; 126.1; 125.0 (2CH); 124.4; 117.7; 109.2; 101.4; 34.3; 15.9. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>20</sub>N<sub>6</sub>O 384.1699, found 385.1772 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.56 min.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-Ethyl-3-[5-(2-methyl-pyridin-4-yl)-8-(6-methyl-pyridin-3-ylamino)-isoquinolin-3-yl]-urea (<b>37</b>)</h4><div class="NLM_p last">Starting according to General Procedure 7 from <b>35</b> (83 mg, 0.233 mmol) and 2-methylpyridine-4-boronic acid (63.9 mg, 0.467 mmol) at 100 °C for 3 h. Purification by prep-HPLC (basic conditions) gave <b>37</b> as a yellow solid (64 mg, 67% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.40 (s, 1H); 9.06 (s, 1H); 8.76 (s, 1H); 8.51 (d, <i>J</i> = 5.1 Hz, 1H); 8.40 (d, <i>J</i> = 2.6 Hz, 1H); 8.05 (s, 1H); 7.54 (dd, <i>J</i> = 8.3, 2.7 Hz, 1H); 7.42 (d, <i>J</i> = 8.0 Hz, 1H); 7.31 (s, 1H); 7.24 (dd, <i>J</i> = 5.0, 1.2 Hz, 1H); 7.20 (d, <i>J</i> = 8.4 Hz, 1H); 7.13 (t, <i>J</i> = 5.2 Hz, 1H); 6.99 (d, <i>J</i> = 8.0 Hz, 1H); 3.18–3.06 (m, 2H); 2.53 (s, 3H); 2.42 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>24</sub>N<sub>6</sub>O 412.2012, found 413.2087 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.55 min.</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 3-[5-Chloro-3-(3-ethyl-ureido)-isoquinolin-8-ylamino]-benzoic Acid <i>tert</i>-Butyl Ester (<b>38a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 6 from <b>21e</b> (2.00 g, 6.09 mmol) and <i>tert</i>-butyl 3-aminobenzoate (1.79 g, 9.23 mmol) at 90 °C for 4 h using BrettPhos as ligand instead. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 98:2) gave <b>38a</b> as a yellow solid (609 mg, 23% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.32 (s, 1H); 9.22 (s, 1H); 8.85 (s, 1H); 8.29 (s, 1H); 7.69 (s, 1H); 7.62 (d, <i>J</i> = 8.3 Hz, 1H); 7.50–7.34 (m, 3H); 7.05 (d, <i>J</i> = 8.3 Hz, 1H); 6.98 (t, <i>J</i> = 5.7 Hz, 1H); 3.23–3.09 (m, 2H); 1.52 (s, 9H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 440.9 [M + H<sup>+</sup>].</div></div><div id="sec4_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 3-[3-(3-Ethyl-ureido)-5-(2-methyl-pyridin-4-yl)-isoquinolin-8-ylamino]-benzoic Acid <i>tert</i>-Butyl Ester (<b>38</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 7 from <b>38a</b> (300 mg, 0.68 mmol) and 2-methylpyridine-4-boronic acid (186 mg, 1.36 mmol) at 100 °C for 3 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 95:5) gave <b>38</b> as a yellow solid (283 mg, 84% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.36 (s, 1H); 9.06 (s, 1H); 8.92 (s, 1H); 8.52 (d, <i>J</i> = 5.1 Hz, 1H); 8.06 (s, 1H); 7.76–7.72 (m, 1H); 7.51–7.37 (m, 4H); 7.34 (s, 1H); 7.27 (dd, <i>J</i> = 5.2, 1.4 Hz, 1H); 7.16 (d, <i>J</i> = 7.9 Hz, 1H); 7.14–7.07 (m, 1H); 3.17–3.07 (m, 2H); 2.53 (s, 3H); 1.53 (s, 9H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 498.1 [M + H<sup>+</sup>].</div></div><div id="sec4_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-[3-(3-Ethyl-ureido)-5-(2-methyl-pyridin-4-yl)-isoquinolin-8-ylamino]-benzoic Acid (<b>39</b>)</h4><div class="NLM_p last">Compound <b>38</b> (280 mg, 0.563 mmol) was dissolved in TFA (3.5 mL) and stirred at rt for 2 h, and the reaction mixture was concentrated under reduced pressure. Purification by prep-HPLC (basic conditions) gave <b>39</b> as a yellow solid (217 mg; 87% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.37 (s, 1H); 9.06 (s, 1H); 8.90 (s, 1H); 8.52 (d, <i>J</i> = 5.2 Hz, 1H); 8.06 (s, 1H); 7.81–7.77 (m, 1H); 7.52–7.38 (m, 4H); 7.35 (s, 1H); 7.27 (dd, <i>J</i> = 5.1, 1.4 Hz, 1H); 7.19 (d, <i>J</i> = 7.9 Hz, 1H); 7.14–7.10 (m, 1H); 3.18–3.06 (m, 2H); 2.53 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H); COOH proton missing. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub> 441.1801, found 442.1881 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.76 min.</div></div><div id="sec4_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-[5-Chloro-8-(pyridin-3-yloxy)-isoquinolin-3-yl]-3-ethyl-urea (<b>40</b>)</h4><div class="NLM_p last">To <b>21e</b> (200 mg, 0.609 mmol), 3-hydroxypyridine (87 mg, 0.913 mmol), CuI (11.6 mg, 0.061 mmol), K<sub>3</sub>PO<sub>4</sub> (258 mg, 1.22 mmol), and <i>N</i>,<i>N</i>-dimethylglycine (12.9 mg, 0.122 mmol) was added dry DMSO (1.4 mL) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was purged with N<sub>2</sub> for 5 min and stirred at 90 °C for 5 h. 3-Hydroxypyridine (87 mg, 0.913 mmol), CuI (11.6 mg, 0.061 mmol), K<sub>3</sub>PO<sub>4</sub> (258 mg, 1.22 mmol), and <i>N</i>,<i>N</i>-dimethylglycine (12.9 mg, 0.122 mmol) were added again and the reaction mixture further stirred at 90 °C for 18 h. The reaction mixture was cooled down to rt and diluted with 9:1 DCM/MeOH and a saturated aq NaHCO<sub>3</sub> solution. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by CC (Heptane/EtOAc 100:0 to 50:50) gave <b>40</b> as a yellow solid (144 mg, 69% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.32 (s, 1H); 9.30 (s, 1H); 8.55 (d, <i>J</i> = 2.7 Hz, 1H); 8.46 (dd, <i>J</i> = 4.5, 1.0 Hz, 1H); 8.40 (s, 1H); 7.72 (d, <i>J</i> = 8.2 Hz, 1H); 7.66–7.60 (m, 1H); 7.48 (dd, <i>J</i> = 8.4, 4.6 Hz, 1H); 6.95 (t, <i>J</i> = 5.5 Hz, 1H); 6.69 (d, <i>J</i> = 8.3 Hz, 1H); 3.23–3.12 (m, 2H); 1.08 (t, <i>J</i> = 7.1 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 343.0 [M + H<sup>+</sup>].</div></div><div id="sec4_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 1-Ethyl-3-[5-pyridin-4-yl-8-(pyridin-3-yloxy)-isoquinolin-3-yl]-urea (<b>41</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 7 from <b>40</b> (50 mg, 0.146 mmol) and pyridine-4-boronic acid (35.9 mg, 0.292 mmol) at 100 °C for 2 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 97:3) gave <b>41</b> as a yellow solid (33 mg, 60% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.36 (s, 1H); 9.16 (s, 1H); 8.71 (d, <i>J</i> = 5.9 Hz, 2H); 8.59 (d, <i>J</i> = 2.8 Hz, 1H); 8.48 (d, <i>J</i> = 4.6 Hz, 1H); 8.17 (s, 1H); 7.71–7.65 (m, 1H); 7.55 (d, <i>J</i> = 8.0 Hz, 1H); 7.54–7.47 (m, 3H); 6.97 (t, <i>J</i> = 5.6 Hz, 1H); 6.77 (d, <i>J</i> = 8.0 Hz, 1H); 3.17–3.05 (m, 2H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 154.9; 154.8; 152.9; 151.7; 150.4 (2CH); 146.8; 146.5; 146.4; 142.5; 137.2; 132.8; 130.7; 127.8; 125.4; 125.0 (2CH); 117.5; 109.9; 101.5; 34.3; 15.8. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub> 385.1539, found 386.1621 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.79 min.</div></div><div id="sec4_8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-Chloro-3-(3-ethyl-ureido)-isoquinoline-8-carboxylic Acid Methyl Ester (<b>42</b>)</h4><div class="NLM_p last">To a solution of <b>21e</b> (9.99 g, 30.4 mmol) in MeOH (150 mL) were added Pd(dppf)Cl<sub>2</sub>·DCM (500 mg, 2 mol %) and NaOAc (3.0 g, 36.5 mmol). The reaction mixture was stirred under CO atmosphere (3 atm) at 60 °C for 7 h. The reaction mixture was concentrated under reduced pressure, and the residue dissolved in EtOAc (1 L). The organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. Trituration of the residue in MeOH (100 mL) gave <b>42</b> as a yellow solid (5.93 g, 63% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.80 (d, <i>J</i> = 0.9 Hz, 1H); 9.32 (s, 1H); 8.48 (d, <i>J</i> = 0.9 Hz, 1H); 7.92 (s, 2H); 6.94 (t, <i>J</i> = 5.5 Hz, 1H); 3.94 (s, 3H); 3.23–3.12 (m, 2H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 308.0 [M + H<sup>+</sup>].</div></div><div id="sec4_8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-(5-Chloro-8-hydroxymethyl-isoquinolin-3-yl)-3-ethyl-urea (<b>43</b>)</h4><div class="NLM_p last">To a solution of <b>42</b> (13.69 g, 44.5 mmol) in dry THF (1 L) at −50 °C was added a 2 M solution of LAH (66 mL, 132 mmol) over 30 min. The reaction mixture was stirred at −40 °C for 5 h, and water (70 mL) was added and the reaction mixture stirred overnight at rt. It was concentrated under reduced pressure, and the residue suspended in 1 M HCl (500 mL). The solid was filtered off, washed with water, and dried under reduced pressure. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 95:5) followed by recrystallization from dioxane (200 mL) gave <b>43</b> as a yellow solid (8.17 g, 66% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.25 (s, 1H); 9.21 (s, 1H); 8.36 (s, 1H); 7.76 (d, <i>J</i> = 7.7 Hz, 1H); 7.36 (d, <i>J</i> = 7.5 Hz, 1H); 7.00 (t, <i>J</i> = 4.8 Hz, 1H); 5.45 (t, <i>J</i> = 5.2 Hz, 1H); 4.98 (d, <i>J</i> = 5.2 Hz, 2H); 3.23–3.11 (m, 2H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 155.0, 150.3, 148.9, 139.4, 135.8, 130.7, 128.3, 123.4, 123.3, 100.6, 60.6, 34.4, 15.8. MS (ESI, <i>m</i>/<i>z</i>): 280.1 [M + H<sup>+</sup>].</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> General Procedure 8 (Suzuki Coupling with PCy<sub>3</sub>/K<sub>3</sub>PO<sub>4</sub>)</h3><div class="NLM_p">To the aromatic halide (1.0 mmol, 1.0 equiv), the required boronic acid (1.0–2.0 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.05 equiv), and PCy<sub>3</sub> (0.12 equiv) were added degassed dioxane (3.3 mL) and a degassed aq 1 N K<sub>3</sub>PO<sub>4</sub> solution (1.7 mL, 1.7 equiv) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was stirred at 90 °C and monitored by LC-MS. Upon reaction completion, the reaction mixture was either directly concentrated to give the crude product or diluted with 9:1 DCM/MeOH and a saturated aq NaHCO<sub>3</sub> solution. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with a saturated aq NaHCO<sub>3</sub> solution, water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-Ethyl-3-(8-(hydroxymethyl)-5-(2-methylpyridin-4-yl)isoquinolin-3-yl)urea (<b>44</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 8 from <b>43</b> (2.20 g, 7.86 mmol) and 2-methylpyridine-4-boronic acid (1.62 g, 11.8 mmol) at 90 °C for 3 h. Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>44</b> as a yellow solid (2.13 g, 81% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.27 (s, 1H); 9.03 (s, 1H); 8.55 (d, <i>J</i> = 5.1 Hz, 1H); 8.02 (s, 1H); 7.54 (d, <i>J</i> = 7.0 Hz, 1H); 7.47 (d, <i>J</i> = 7.0 Hz, 1H); 7.34 (d, <i>J</i> = 0.8 Hz, 1H); 7.26 (dd, <i>J</i> = 0.8, 4.9 Hz, 1H); 7.13 (t, <i>J</i> = 5.6 Hz, 1H); 5.45 (t, <i>J</i> = 5.6 Hz, 1H); 5.03 (d, <i>J</i> = 5.5 Hz, 2H); 3.18–3.03 (m, 2H); 2.54 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 337.1 [M + H<sup>+</sup>].</div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> General Procedure 9 (Carbamate Formation from Hydroxyl Derivative with CDI)</h3><div class="NLM_p">To a solution of the required alcohol (0.1 mmol, 1.0 equiv) in dry DMF (0.3 mL) were added CDI (1.2 equiv) and DIPEA (1.3 equiv) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was stirred at 40 °C for 4 h, and a solution of the amine (1.5 equiv) and DIPEA (1.5 equiv) in dry DCM (0.2 mL) was added. The reaction mixture was stirred at rt overnight and then concentrated to dryness. Purification of the residue gave the desired product.</div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl Morpholine-4-carboxylate (<b>45</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 9 from <b>44</b> (750 mg, 2.23 mmol) and morpholine (0.29 mL, 3.34 mmol). Et<sub>2</sub>O (10 mL) was added to the reaction mixture, and the precipitate was filtered off, washed, and dried in vacuo to give <b>45</b> as a yellow solid (850 mg, 84% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.27 (s, 1H); 9.10 (s, 1H); 8.60 (d, <i>J</i> = 5.0 Hz, 1H); 8.09 (s, 1H); 7.59 (d, <i>J</i> = 7.3 Hz, 1H); 7.51 (d, <i>J</i> = 7.3 Hz, 1H); 7.38 (d, <i>J</i> = 1.2 Hz, 1H); 7.31 (dd, <i>J</i> = 1.2, 5.0 Hz, 1H); 7.08 (t, <i>J</i> = 5.5 Hz, 1H); 5.66 (s, 2H); 3.66–3.48 (m, 4H); 3.44–3.36 (m, 4H); 3.19–3.08 (m, 2H); 2.57 (s, 3H); 1.06 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub> 449.2063, found 450.2145 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.73 min.</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 1-Ethyl-3-(5-(2-methylpyridin-4-yl)-8-(pyridin-3-ylmethyl)isoquinolin-3-yl)urea Hydrochloride (<b>46</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 8 from <b>45</b> (32 mg, 0.07 mmol) and 3-pyridineboronic acid (13 mg, 0.11 mmol) at 90 °C for 5 h. Purification by prep-HPLC (basic conditions) followed by HCl treatment gave <b>46</b> as a yellow solid (16 mg, 59% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.44 (s, 1H); 9.35 (s, 1H); 9.02 (s, 1H); 8.94 (d, <i>J</i> = 6.1 Hz, 1H); 8.84 (d, <i>J</i> = 5.5 Hz, 1H); 8.50 (d, <i>J</i> = 8.2 Hz, 1H); 8.18 (s, 1H); 8.15 (s, 1H); 8.09–7.97 (m, 2H); 7.79 (d, <i>J</i> = 7.3 Hz, 1H); 7.53 (d, <i>J</i> = 7.4 Hz, 1H); 7.40–7.16 (m, 1H); 4.85 (s, 2H); 3.11 (q, <i>J</i> = 7.1 Hz, 2H); 2.85 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H); N<sup>+</sup>H missing. <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 156.0; 155.2; 154.3; 150.6; 149.0; 146.3; 141.7; 141.2; 140.5 (2CH); 139.2; 135.9; 133.0; 132.5; 128.8; 127.6; 126.2; 125.6; 122.9; 101.5; 34.3; 33.8; 19.7; 15.8. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O 397.1903, found 398.1984 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.59 min.</div></div><div id="sec4_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 3-((3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl)benzoic Acid (<b>47</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 8 from <b>45</b> (840 mg, 1.87 mmol) and 3-carboxyphenylboronic acid (620 mg, 3.74 mmol) at 90 °C for 10 h. However, an additional portion of boronic acid, catalyst, and ligand were added after 3 and 7 h. Purification by CC (DCM/MeOH 100:0 to 90:10 to DCM/MeOH + 1% NH<sub>4</sub>OH 90:10 to 80:20) gave <b>47</b> as a yellow solid (481 mg, 58% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.26 (s, 1H); 8.98 (s, 1H); 8.57–8.52 (m, 1H); 8.03 (s, 1H); 7.84 (s, 1H); 7.76 (d, <i>J</i> = 7.5 Hz, 1H); 7.58–7.51 (m, 2H); 7.45–7.32 (m, 3H); 7.31–7.25 (m, 1H); 7.16–7.10 (m, 1H); 4.60 (s, 2H); 3.13–3.04 (m, 2H); 2.54 (s, 3H); 1.02 (t, <i>J</i> = 7.1 Hz, 3H); COOH proton missing. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub> 440.1848, found 441.1929 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.82 min.</div></div><div id="sec4_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-(8-((1<i>H</i>-1,2,3-Triazol-1-yl)methyl)-5-(2-methylpyridin-4-yl)isoquinolin-3-yl)-3-ethylurea (<b>48</b>)</h4><div class="NLM_p last">To a suspension of <b>44</b> (85 mg, 0.25 mmol) and PPh<sub>3</sub> (100 mg, 0.38 mmol) in THF (2.6 mL) at rt was added 1<i>H</i>-1,2,3-triazole (0.02 mL, 0.34 mmol). The reaction mixture was cooled to 0 °C, and DIAD (0.08 mL, 0.38 mmol) was added. The reaction mixture was stirred for 1 h at 0 °C and 1.5 h at rt and became homogeneous during that time. The reaction mixture was concentrated to dryness, and the residue was diluted with 9:1 DCM/MeOH and a saturated aq NaHCO<sub>3</sub> solution. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 96:4) and by prep-HPLC (acidic conditions) gave <b>48</b> as a yellow solid (29 mg, 30% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.41 (s, 1H); 9.07 (s, 1H); 8.56 (d, <i>J</i> = 5.0 Hz, 1H); 8.24 (s, 1H); 8.05 (s, 1H); 7.76 (s, 1H); 7.56 (d, <i>J</i> = 7.3 Hz, 1H); 7.33 (s, 1H); 7.26 (d, <i>J</i> = 4.5 Hz, 1H); 7.22 (d, <i>J</i> = 7.3 Hz, 1H); 7.11–7.02 (m, 1H); 6.22 (s, 2H); 3.16–3.04 (m, 2H); 2.54 (s, 3H); 1.03 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 158.8; 154.9; 150.2; 149.5; 148.3; 147.1; 136.5; 136.3; 134.1 (2CH); 131.4; 125.9; 125.1; 124.2; 122.5; 122.2; 102.2; 49.9; 34.3; 24.6; 15.8. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>21</sub>N<sub>7</sub>O 387.1808, found 388.1880 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.63 min.</div></div><div id="sec4_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 1-[8-(Aminomethyl)-5-chloro-isoquinolin-3-yl]-3-ethyl-urea (<b>49</b>)</h4><div class="NLM_p last">To a suspension of <b>43</b> (4.0 g, 14.3 mmol) in dry THF (30 mL) in a round-bottomed flask under inert atmosphere (N<sub>2</sub>) at rt were added DPPA (3.7 mL, 17.2 mmol) and DBU (2.56 mL, 17.2 mmol). The reaction mixture was stirred at rt for 3 h and became a solution during that time. The reaction mixture was treated with water (8 mL) and PPh<sub>3</sub> (4.8 g, 18.3 mmol), further stirred at rt for 2 h, and concentrated under reduced pressure. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) followed by trituration from EtOAc (250 mL) gave <b>49</b> as a white solid (2.93 g, 74% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.30 (d, <i>J</i> = 0.8 Hz, 1H); 9.18 (s, 1H); 8.33 (d, <i>J</i> = 0.7 Hz, 1H); 7.73 (d, <i>J</i> = 7.7 Hz, 1H); 7.37 (d, <i>J</i> = 7.7 Hz, 1H); 7.03 (t, <i>J</i> = 5.6 Hz, 1H); 4.20 (s, 2H); 3.22–3.12 (m, 2H); 1.92 (br, 2H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 155.1, 150.2, 149.0, 141.1, 135.8, 130.8, 127.8, 123.6, 123.5, 100.6, 42.4, 34.4, 15.9. MS (ESI, <i>m</i>/<i>z</i>): 279.0 [M + H<sup>+</sup>].</div></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> General Procedure 10 (Carbamate Formation from Amino Derivative with Chloroformate)</h3><div class="NLM_p">A solution of the amine (0.1 mmol, 1.0 equiv) in dry DCM (1.0 mL) was treated with Et<sub>3</sub>N (1.2 equiv) and the required chloroformate (1.5 equiv) at 0 °C under inert atmosphere (N<sub>2</sub>). The reaction mixture was stirred at rt overnight and then diluted with DCM and water. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> [5-Chloro-3-(3-ethyl-ureido)-isoquinolin-8-ylmethyl]-carbamic Acid Methyl Ester (<b>50a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 10 from <b>49</b> (2.93 g, 10.5 mmol) and methyl chloroformate (1.23 mL, 15.8 mmol). The crude product was triturated in 2:1 Et<sub>2</sub>O/EtOAc (300 mL), filtered, and dried in vacuo to give <b>50a</b> as a yellow solid (1.91 g, 54% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.27 (s, 1H); 9.22 (s, 1H); 8.37 (s, 1H); 7.81 (t, <i>J</i> = 6.2 Hz, 1H); 7.76 (d, <i>J</i> = 7.6 Hz, 1H); 7.23 (d, <i>J</i> = 7.7 Hz, 1H); 6.99 (t, <i>J</i> = 5.0 Hz, 1H); 4.67 (d, <i>J</i> = 5.9 Hz, 2H); 3.54 (s, 3H); 3.23–3.11 (m, 2H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 337.0 [M + H<sup>+</sup>].</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> [3-(3-Ethyl-ureido)-5-(2-methyl-pyridin-4-yl)-isoquinolin-8-ylmethyl]-carbamic Acid Methyl Ester (<b>50</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 8 from <b>50a</b> (842 mg, 2.5 mmol) and 2-methylpyridine-4-boronic acid (514 mg, 3.75 mmol) at 90 °C for 2 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 95:5) gave <b>50</b> as a yellow solid (886 mg, 90% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.30 (s, 1H); 9.04 (s, 1H); 8.56 (d, <i>J</i> = 5.0 Hz, 1H); 8.03 (s, 1H); 7.84 (t, <i>J</i> = 5.9 Hz, 1H); 7.54 (d, <i>J</i> = 7.3 Hz, 1H); 7.38–7.32 (m, 2H); 7.26 (dd, <i>J</i> = 5.1, 1.3 Hz, 1H); 7.11 (t, <i>J</i> = 5.9 Hz, 1H); 4.73 (d, <i>J</i> = 5.9 Hz, 2H); 3.56 (s, 3H); 3.17–3.05 (m, 2H); 2.55 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 158.8; 157.3; 155.0; 149.9; 149.5; 148.3; 147.4; 137.5; 136.2; 135.1; 131.4; 124.3; 123.7; 122.7; 122.2; 102.2; 52.0; 41.5; 34.3; 24.6; 15.9. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub> 393.1801, found 394.1879 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.66 min.</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> General Procedure 11 (Carbamate Formation from Amino Derivative with CDI)</h3><div class="NLM_p">To a solution of CDI (2.0 equiv) in dry DCM (0.5 mL) were added DIPEA (2.0 equiv) and the required alcohol (2.0 equiv) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was stirred at rt for 3 h, and a solution of the amine (0.1 mmol, 1.0 equiv) and DIPEA (1.0 equiv) in dry NMP (0.5 mL) was added. The reaction mixture was stirred at rt overnight. A 2 M solution of dimethylamine in THF (10 equiv) was added, and the reaction mixture was further stirred at rt for 2 h. It was then concentrated under reduced pressure, and purification of the residue gave the desired product.</div><div id="sec4_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> [5-Chloro-3-(3-ethyl-ureido)-isoquinolin-8-ylmethyl]-carbamic Acid 2-Methoxy-ethyl Ester (<b>51a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 11 from <b>49</b> (1.00 g, 3.59 mmol) and 2-methoxyethanol (0.6 mL, 7.6 mmol). However, DMF was used instead of NMP. Purification by CC (DCM/MeOH 100:0 to 95:5) gave <b>51a</b> as a white solid (1.08 g, 79% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.28 (d, <i>J</i> = 0.7 Hz, 1H); 9.21 (s, 1H); 8.38 (d, <i>J</i> = 0.5 Hz, 1H); 7.95–7.84 (m, 1H); 7.76 (d, <i>J</i> = 7.7 Hz, 1H); 7.23 (d, <i>J</i> = 7.7 Hz, 1H); 7.04–6.95 (m, 1H); 4.66 (d, <i>J</i> = 6.0 Hz, 2H); 4.11–4.03 (m, 2H); 3.51–3.43 (m, 2H); 3.22 (s, 3H); 3.20–3.11 (m, 2H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 381.1 [M + H<sup>+</sup>].</div></div><div id="sec4_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> [3-(3-Ethyl-ureido)-5-(2-methyl-pyridin-4-yl)-isoquinolin-8-ylmethyl]-carbamic Acid 2-Methoxy-ethyl Ester (<b>51</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 8 from <b>51a</b> (230 mg, 0.57 mmol) and 2-methylpyridine-4-boronic acid (117 mg, 0.86 mmol) at 90 °C for 2 h. Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>51</b> as a beige solid (209 mg, 83% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.30 (s, 1H); 9.04 (s, 1H); 8.55 (d, <i>J</i> = 5.0 Hz, 1H); 8.03 (s, 1H); 7.99–7.86 (m, 1H); 7.54 (d, <i>J</i> = 7.3 Hz, 1H); 7.38–7.31 (m, 2H); 7.29–7.21 (m, 1H); 7.16–7.04 (m, 1H); 4.72 (d, <i>J</i> = 5.9 Hz, 2H); 4.12–4.04 (m, 2H); 3.52–3.43 (m, 2H); 3.23 (s, 3H); 3.18–3.04 (m, 2H); 2.54 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 158.8; 156.8; 155.0; 149.9; 149.5; 148.3; 147.4; 137.5; 136.2; 135.1; 131.3; 124.3; 123.7; 122.7; 122.2; 102.2; 70.8; 63.7; 58.5; 41.5; 34.3; 24.6; 15.9. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub> 437.2063, found 438.2147 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.65 min.</div></div><div id="sec4_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>tert</i>-Butyl 4-((((5-Chloro-3-(3-ethylureido)isoquinolin-8-yl)methyl)carbamoyl)oxy)-3,3-difluoropiperidine-1-carboxylate (<b>52a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 11 from <b>49</b> (60 mg, 0.215 mmol) and <i>tert</i>-butyl 3,3-difluoro-4-hydroxypiperidine-1-carboxylate (102 mg, 0.43 mmol). However, DMF was used instead of NMP. Purification by CC (DCM/MeOH 100:0 to 95:5) gave <b>52a</b> as a white solid (34 mg, 29% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.29 (s, 1H); 9.27 (s, 1H); 8.41 (s, 1H); 8.23 (t, <i>J</i> = 5.9 Hz, 1H); 7.80 (d, <i>J</i> = 7.7 Hz, 1H); 7.25 (d, <i>J</i> = 7.7 Hz, 1H); 7.00 (t, <i>J</i> = 5.3 Hz, 1H); 5.16–5.04 (m, 1H); 4.73 (d, <i>J</i> = 5.9 Hz, 2H); 3.99–3.85 (m, 1H); 3.74–3.45 (m, 3H); 3.25–3.12 (m, 2H); 1.98–1.87 (m, 1H); 1.70–1.57 (m, 1H); 1.40 (s, 9H); 1.10 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 542.1 [M + H<sup>+</sup>].</div></div><div id="sec4_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>tert</i>-Butyl 4-((((3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl)carbamoyl)oxy)-3,3-difluoropiperidine-1-carboxylate (<b>52b</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 8 from <b>52a</b> (34 mg, 0.063 mmol) and 2-methylpyridine-4-boronic acid (13 mg, 0.094 mmol) at 90 °C for 3 h. Purification by CC (DCM/MeOH 100:0 to 95:5) gave <b>52b</b> as a white solid (29 mg, 77% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.32 (s, 1H); 9.09 (s, 1H); 8.59 (d, <i>J</i> = 5.0 Hz, 1H); 8.26 (t, <i>J</i> = 5.9 Hz, 1H); 8.07 (s, 1H); 7.58 (d, <i>J</i> = 7.2 Hz, 1H); 7.40–7.34 (m, 2H); 7.29 (d, <i>J</i> = 4.5 Hz, 1H); 7.15–7.08 (m, 1H); 5.18–5.07 (m, 1H); 4.84–4.71 (m, 2H); 3.98–3.87 (m, 1H); 3.74–3.66 (m, 1H); 3.65–3.50 (br, 1H); 3.30–3.19 (m, 1H); 3.17–3.09 (m, 2H); 2.57 (s, 3H); 1.98–1.91 (m, 1H); 1.71–1.62 (m, 1H); 1.41 (s, 9H); 1.06 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 599.1 [M + H<sup>+</sup>].</div></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> General Procedure 12 (NBoc Deprotection with HCl in Dioxane)</h3><div class="NLM_p">A solution of the protected amine (0.1 mmol, 1.0 equiv) in 4 M solution of HCl in dioxane (1.0 mL, 40 equiv) was stirred at rt for 2 h and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 3,3-Difluoropiperidin-4-yl ((3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl)carbamate (<b>52</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 12 from <b>52b</b> (29 mg, 0.048 mmol). Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>52</b> as a beige solid (7 mg, 29% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.32 (s, 1H); 9.10 (s, 1H); 8.58 (d, <i>J</i> = 5.1 Hz, 1H); 8.21 (t, <i>J</i> = 6.0 Hz, 1H); 8.07 (s, 1H); 7.57 (d, <i>J</i> = 7.3 Hz, 1H); 7.38–7.34 (m, 2H); 7.29 (d, <i>J</i> = 5.0 Hz, 1H); 7.15–7.08 (m, 1H); 5.04–4.95 (m, 1H); 4.77 (d, <i>J</i> = 5.8 Hz, 2H); 3.18–3.10 (m, 2H); 3.10–3.01 (m, 1H); 2.90–2.78 (m, 2H); 2.67–2.58 (m, 1H); 2.56 (s, 3H); 1.93–1.85 (m, 1H); 1.68–1.57 (m, 1H); 1.06 (t, <i>J</i> = 7.2 Hz, 3H); piperidine NH missing. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>F<sub>2</sub> 498.2191, found 499.2271 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.53 min.</div></div><div id="sec4_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> <i>tert</i>-Butyl (2-((((5-Chloro-3-(3-ethylureido)isoquinolin-8-yl)methyl)carbamoyl)oxy)ethyl)carbamate (<b>53a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 11 from <b>49</b> (150 mg, 0.538 mmol) and <i>N</i>-(tert-butoxycarbonyl)ethanolamine (0.17 mL, 1.08 mmol). However, DMF was used instead of NMP. In addition, another portion of activated alcohol was added after 3 d, and the reaction mixture was further stirred at rt for 18 h. Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>53a</b> as a white solid (152 mg, 61% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.28 (s, 1H); 9.20 (s, 1H); 8.37 (d, <i>J</i> = 0.5 Hz, 1H); 7.84–7.77 (m, 1H); 7.75 (d, <i>J</i> = 7.7 Hz, 1H); 7.25 (d, <i>J</i> = 7.7 Hz, 1H); 6.99 (t, <i>J</i> = 5.5 Hz, 1H); 6.88–6.80 (m, 1H); 4.66 (d, <i>J</i> = 5.9 Hz, 2H); 3.93 (t, <i>J</i> = 5.6 Hz, 2H); 3.22–3.07 (m, 4H); 1.34 (s, 9H); 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 466.1 [M + H<sup>+</sup>].</div></div><div id="sec4_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>tert</i>-Butyl (2-((((3-(3-Ethylureido)-5-(pyridin-4-yl)isoquinolin-8-yl)methyl)carbamoyl)oxy)ethyl)carbamate (<b>53b</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 7 from <b>53a</b> (150 mg, 0.322 mmol) and pyridine-4-boronic acid (48 mg, 0.354 mmol) at 100 °C for 1 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>53b</b> as a yellow solid (123 mg, 75% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.31 (s, 1H); 9.05 (s, 1H); 8.73–8.67 (m, 2H); 8.07 (s, 1H); 7.91–7.84 (m, 1H); 7.55 (d, <i>J</i> = 7.3 Hz, 1H); 7.49–7.45 (m, 2H); 7.40–7.35 (m, 1H); 7.08–7.01 (m, 1H); 6.91–6.84 (m, 1H); 4.75–4.69 (m, 2H); 3.98–3.90 (m, 2H); 3.17–3.05 (m, 4H); 1.34 (s, 9H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 509.2 [M + H<sup>+</sup>].</div></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> General Procedure 13 (NBoc Deprotection with TFA)</h3><div class="NLM_p">To a solution of the protected amine (0.1 mmol, 1.0 equiv) in dry DCM (1.0 mL) was added TFA (40 equiv). The reaction mixture was stirred at rt for 1 h and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 2-Aminoethyl ((3-(3-Ethylureido)-5-(pyridin-4-yl)isoquinolin-8-yl)methyl)carbamate (<b>53</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 13 from <b>53b</b> (120 mg, 0.236 mmol). Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>53</b> as a white solid (85 mg, 88% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.31 (s, 1H); 9.05 (s, 1H); 8.71 (d, <i>J</i> = 5.6 Hz, 2H); 8.08 (s, 1H); 7.88–7.80 (m, 1H); 7.57 (d, <i>J</i> = 7.3 Hz, 1H); 7.48 (d, <i>J</i> = 5.7 Hz, 2H); 7.37 (d, <i>J</i> = 7.4 Hz, 1H); 7.07–6.99 (m, 1H); 4.77–4.69 (m, 2H); 3.97–3.88 (m, 2H); 3.15–3.03 (m, 2H); 2.77–2.67 (m, 2H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H); NH<sub>2</sub> missing. MS (ESI, <i>m</i>/<i>z</i>): 409.1 [M + H<sup>+</sup>].</div></div><div id="sec4_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 2-(Neopentylamino)ethyl ((3-(3-Ethylureido)-5-(pyridin-4-yl)isoquinolin-8-yl)methyl)carbamate (<b>54</b>)</h4><div class="NLM_p last">To a solution of <b>53</b> (40 mg, 0.098 mmol) in 1:1 DCE/MeOH (1.0 mL) was added pivaldehyde (0.010 mL, 0.098 mmol), and the reaction mixture was stirred at rt overnight. NaBH<sub>4</sub> (5.92 mg, 0.156 mmol) was added cautiously to the reaction mixture which was further stirred at rt for 4 h. It was then diluted with DCM and treated with a saturated aq NaHCO<sub>3</sub> solution. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>54</b> as a white solid (26 mg, 55% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.31 (s, 1H); 9.04 (s, 1H); 8.71 (d, <i>J</i> = 5.9 Hz, 2H); 8.07 (s, 1H); 7.91–7.84 (m, 1H); 7.55 (d, <i>J</i> = 7.2 Hz, 1H); 7.47 (d, <i>J</i> = 5.7 Hz, 2H); 7.35 (d, <i>J</i> = 7.3 Hz, 1H); 7.08–7.00 (m, 1H); 4.75–4.68 (m, 2H); 4.05–3.96 (m, 2H); 3.27 (s, 1H); 3.15–3.04 (m, 2H); 2.74–2.65 (m, 2H); 2.24 (s, 2H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H); 0.81 (s, 9H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>26</sub>H<sub>34</sub>N<sub>6</sub>O<sub>3</sub> 478.2692, found 479.2769 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.58 min.</div></div><div id="sec4_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 1-[8-(Aminomethyl)-5-(2-methyl-pyridin-4-yl)-isoquinolin-3-yl]-3-ethyl-urea (<b>55</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 8 from <b>49</b> (500 mg, 1.79 mmol) and 2-methylpyridine-4-boronic acid (368 mg, 2.69 mmol) at 90 °C for 2 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>55</b> as a yellow solid (478 mg, 80% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.33 (d, <i>J</i> = 0.5 Hz, 1H); 9.02 (s, 1H); 8.55 (d, <i>J</i> = 5.1 Hz, 1H); 8.00 (s, 1H); 7.55–7.45 (m, 2H); 7.33 (s, 1H); 7.26 (dd, <i>J</i> = 5.1, 1.4 Hz, 1H); 7.18 (t, <i>J</i> = 5.4 Hz, 1H); 4.26 (s, 2H); 3.17–3.06 (m, 2H); 2.55 (s, 3H); 1.95 (br, 2H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 336.1 [M + H<sup>+</sup>].</div></div><div id="sec4_14_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 1-[8-(Aminomethyl)-5-(pyridin-4-yl)-isoquinolin-3-yl]-3-ethyl-urea (<b>56</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 7 from <b>49</b> (2.30 g, 8.23 mmol) and pyridine-4-boronic acid (1.11 g, 9.06 mmol) at 100 °C for 1 h. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>56</b> as a yellow solid (1.93 g, 73% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.34 (d, <i>J</i> = 0.8 Hz, 1H); 9.01 (s, 1H); 8.72–8.68 (m, 2H); 8.05 (d, <i>J</i> = 0.7 Hz, 1H); 7.57–7.53 (m, 1H); 7.51–7.46 (m, 3H); 7.09 (t, <i>J</i> = 5.5 Hz, 1H); 4.27 (s, 2H); 3.16–3.05 (m, 2H); 1.96 (br, 2H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 322.1 [M + H<sup>+</sup>].</div></div><div id="sec4_14_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> [3-(3-Ethyl-ureido)-5-(2-methyl-pyridin-4-yl)-isoquinolin-8-ylmethyl]-carbamic Acid Prop-2-ynyl Ester (<b>57</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 10 from <b>55</b> (125 mg, 0.37 mmol) and propargyl chloroformate (0.05 mL, 0.49 mmol). Purification by CC (DCM/MeOH 100:0 to 95:5) and prep-HPLC (basic conditions) gave <b>57</b> as a beige solid (48 mg, 31% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.29 (s, 1H); 9.06 (s, 1H); 8.56 (d, <i>J</i> = 5.0 Hz, 1H); 8.09 (t, <i>J</i> = 5.6 Hz, 1H); 8.04 (s, 1H); 7.55 (d, <i>J</i> = 7.3 Hz, 1H); 7.38–7.32 (m, 2H); 7.26 (d, <i>J</i> = 5.3 Hz, 1H); 7.10 (t, <i>J</i> = 5.3 Hz, 1H); 4.78–4.71 (m, 2H); 4.65 (d, <i>J</i> = 2.4 Hz, 2H); 3.48 (t, <i>J</i> = 2.4 Hz, 1H); 3.16–3.05 (m, 2H); 2.54 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub> 417.1801, found 418.1878 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.71 min.</div></div><div id="sec4_14_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> [3-(3-Ethyl-ureido)-5-pyridin-4-yl-isoquinolin-8-ylmethyl]-carbamic Acid Methyl Ester (<b>59</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 10 from <b>56</b> (119 mg, 0.37 mmol) and methyl chloroformate (0.043 mL, 0.55 mmol). Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>59</b> as an amorphous solid (95 mg, 68% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.30 (s, 1H); 9.05 (s, 1H); 8.71 (dd, <i>J</i> = 1.4, 4.5 Hz, 2H); 8.08 (s, 1H); 7.85 (t, <i>J</i> = 5.7 Hz, 1H); 7.56 (d, <i>J</i> = 7.3 Hz, 1H); 7.48 (dd, <i>J</i> = 1.5, 4.5 Hz, 2H); 7.36 (d, <i>J</i> = 7.3 Hz, 1H); 7.06 (t, <i>J</i> = 5.4 Hz, 1H); 4.73 (d, <i>J</i> = 5.9 Hz, 2H); 3.56 (s, 3H); 3.17–2.96 (m, 2H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>20</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub> 379.1644, found 380.1731 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.67 min.</div></div><div id="sec4_14_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> [3-(3-Ethyl-ureido)-5-pyridin-4-yl-isoquinolin-8-ylmethyl]-carbamic Acid Isopropyl Ester (<b>60</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 11 from <b>56</b> (32 mg, 0.1 mmol) and 2-propanol (12 mg, 0.2 mmol). Purification by prep-HPLC (acidic conditions) gave <b>60</b> as an amorphous solid (11 mg, 27% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.33 (s, 1H); 9.09 (s, 1H); 8.76–8.72 (m, 2H); 8.11 (s, 1H); 7.80 (t, <i>J</i> = 5.9 Hz, 1H); 7.59 (d, <i>J</i> = 7.3 Hz, 1H); 7.53–7.49 (m, 2H); 7.37 (d, <i>J</i> = 7.3 Hz, 1H); 7.07–7.01 (m, 1H); 4.85–4.75 (m, 1H); 4.74 (d, <i>J</i> = 5.9 Hz, 2H); 3.17–3.08 (m, 2H); 1.19 (d, <i>J</i> = 6.2 Hz, 6H); 1.05 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>25</sub>N<sub>5</sub>O<sub>3</sub> 407.1957, found 408.2041 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.83 min.</div></div><div id="sec4_14_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> [3-(3-Ethyl-ureido)-5-pyridin-4-yl-isoquinolin-8-ylmethyl]-carbamic Acid 2-(<i>tert</i>-Butyl-dimethyl-silanyloxy)-ethyl Ester (<b>61a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 11 from <b>56</b> (120 mg, 0.373 mmol) and 2-((<i>tert</i>-butyldimethylsilyl)oxy)ethanol (138 mg, 0.784 mmol). However, DMF was used instead of NMP, and the reaction mixture was stirred 4 d at rt. Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>61a</b> as a yellow solid (170 mg, 87% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.32 (s, 1H); 9.03 (s, 1H); 8.74–8.68 (m, 2H); 8.06 (s, 1H); 7.93–7.82 (m, 1H); 7.55 (d, <i>J</i> = 7.3 Hz, 1H); 7.50–7.43 (m, 2H); 7.36 (d, <i>J</i> = 7.3 Hz, 1H); 7.12–7.01 (m, 1H); 4.72 (d, <i>J</i> = 6.0 Hz, 2H); 4.05–3.97 (m, 2H); 3.77–3.67 (m, 2H); 3.18–3.03 (m, 2H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H); 0.81 (s, 9H); 0.00 (s, 6H). MS (ESI, <i>m</i>/<i>z</i>): 524.3 [M + H<sup>+</sup>].</div></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> General Procedure 14 (OTBS Deprotection with TFA)</h3><div class="NLM_p">To a solution of the TBS protected alcohol (0.1 mmol, 1.0 equiv) in 10:1 THF/water (1.0 mL) at 0 °C was added TFA (20 equiv). The reaction mixture was stirred at rt for 1 h and concentrated under reduced pressure. It was diluted with DCM and treated with a saturated aq NaHCO<sub>3</sub> solution. The layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3×). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_15_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> [3-(3-Ethyl-ureido)-5-pyridin-4-yl-isoquinolin-8-ylmethyl]-carbamic Acid 2-Hydroxy-ethyl Ester (<b>61</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 14 from <b>61a</b> (196 mg, 0.373 mmol). Purification by CC (DCM/MeOH 100:0 to 90:10) followed by prep-HPLC (basic conditions) gave <b>61</b> as a white solid (89 mg, 58% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.32 (s, 1H); 9.04 (s, 1H); 8.74–8.67 (m, 2H); 8.07 (s, 1H); 7.91–7.79 (m, 1H); 7.56 (d, <i>J</i> = 7.3 Hz, 1H); 7.51–7.45 (m, 2H); 7.37 (d, <i>J</i> = 7.4 Hz, 1H); 7.07–6.99 (m, 1H); 4.77–4.66 (m, 3H); 3.99 (t, <i>J</i> = 5.0 Hz, 2H); 3.53 (q, <i>J</i> = 5.3 Hz, 2H); 3.17–3.04 (m, 2H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub> 409.1750, found 410.1824 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.60 min.</div></div><div id="sec4_15_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> <i>tert</i>-Butyl (2-((((3-(3-Ethylureido)-5-(pyridin-4-yl)isoquinolin-8-yl)methyl)carbamoyl)oxy)ethyl) (methyl)carbamate (<b>62a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 11 from <b>56</b> (200 mg, 0.554 mmol) and <i>tert</i>-butyl 2-hydroxyethyl(methyl)carbamate (194 mg, 1.11 mmol). Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) followed by trituration from Et<sub>2</sub>O (3 mL) gave <b>62a</b> as a white solid (147 mg, 51% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.34 (s, 1H); 9.08 (s, 1H); 8.73 (d, <i>J</i> = 5.6 Hz, 2H); 8.10 (s, 1H); 7.95 (br, 1H); 7.58 (d, <i>J</i> = 7.2 Hz, 1H); 7.50 (d, <i>J</i> = 5.6 Hz, 2H); 7.39 (d, <i>J</i> = 7.2 Hz, 1H); 7.07 (t, <i>J</i> = 4.9 Hz, 1H); 4.75 (d, <i>J</i> = 5.8 Hz, 2H); 4.12–4.06 (m, 2H); 3.38 (t, <i>J</i> = 5.5 Hz, 2H); 3.16–3.08 (m, 2H); 2.85–2.77 (m, 3H); 1.40–1.30 (m, 9H); 1.05 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 523.2 [M + H<sup>+</sup>].</div></div><div id="sec4_15_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 2-(Methylamino)ethyl ((3-(3-Ethylureido)-5-(pyridin-4-yl)isoquinolin-8-yl)methyl)carbamate (<b>62</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 12 from <b>62a</b> (147 mg, 0.281 mmol). Purification by prep-HPLC (basic conditions) gave <b>62</b> as a white solid (58 mg, 49% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.33 (s, 1H); 9.08 (s, 1H); 8.76–8.70 (m, 2H); 8.10 (s, 1H); 7.89 (t, <i>J</i> = 5.9 Hz, 1H); 7.59 (d, <i>J</i> = 7.3 Hz, 1H); 7.51 (m, 2H); 7.38 (d, <i>J</i> = 7.3 Hz, 1H); 7.09–7.03 (m, 1H); 4.75 (d, <i>J</i> = 5.9 Hz, 2H); 4.02 (t, <i>J</i> = 5.8 Hz, 2H); 3.17–3.08 (m, 2H); 2.67 (t, <i>J</i> = 5.8 Hz, 2H); 2.28 (s, 3H); 1.05 (t, <i>J</i> = 7.2 Hz, 3H); side chain NH missing. <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 157.0; 155.0:150.4 (2CH); 150.1; 148.4; 147.2; 137.7; 136.1; 134.9; 131.5; 125.1 (2CH); 123.7; 122.7; 102.0; 64.0; 50.8; 41.5; 36.5; 34.3; 15.9. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub> 422.2066, found 423.2141 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.49 min.</div></div><div id="sec4_15_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> [3-(3-Ethyl-ureido)-5-pyridin-4-yl-isoquinolin-8-ylmethyl]-carbamic Acid 2-Morpholin-4-yl-ethyl Ester Hydrochloride (<b>63</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 11 from <b>56</b> (32 mg, 0.1 mmol) and 4-(2-hydroxyethyl)morpholine (26 mg, 0.2 mmol). Purification by prep-HPLC (acidic conditions) followed by HCl treatment gave <b>63</b> as an amorphous solid (36 mg, 75% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 11.41 (br, 1H); 9.37 (s, 1H); 9.23 (s, 1 H); 8.99 (d, <i>J</i> = 6.4 Hz, 2H); 8.17 (s, 1 H); 8.17–8.11 (m, 1H); 8.00 (d, <i>J</i> = 6.2 Hz, 2H); 7.72 (d, <i>J</i> = 7.3 Hz, 1H); 7.47 (d, <i>J</i> = 7.4 Hz, 1H); 7.18–7.09 (m, 1H); 4.81 (d, <i>J</i> = 5.7 Hz, 2H); 4.43 (t, <i>J</i> = 4.9 Hz, 2H); 4.04–3.76 (m, 4H); 3.51–3.32 (m, 4H); 3.26–3.05 (m, 4H); 1.05 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>30</sub>N<sub>6</sub>O<sub>4</sub> 478.2328, found 479.2409 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.51 min.</div></div><div id="sec4_15_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl ((3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl)carbamate (<b>64a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 11 from <b>55</b> (195 mg, 0.581 mmol) and 2-(<i>tert</i>-butyldimethylsiloxy)ethanol (215 mg, 1.22 mmol). However, DMF was used instead of NMP, and the reaction mixture was stirred at rt for 4 d. Purification by CC (DCM/MeOH 100:0 to 95:5) gave <b>64a</b> as a white solid (375 mg, unpure). MS (ESI, <i>m</i>/<i>z</i>): 538.3 [M + H<sup>+</sup>].</div></div><div id="sec4_15_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 2-Hydroxyethyl ((3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl)carbamate (<b>64</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 14 from <b>64a</b> (375 mg, unpure). Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>64</b> as a white solid (108 mg, 44% yield over 2 steps). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.31 (s, 1H); 9.04 (s, 1H); 8.56 (d, <i>J</i> = 5.0 Hz, 1H); 8.03 (s, 1H); 7.88–7.83 (m, 1H); 7.54 (d, <i>J</i> = 7.3 Hz, 1H); 7.39–7.32 (m, 2H); 7.26 (dd, <i>J</i> = 0.6, 5.0 Hz, 1H); 7.15–7.07 (m, 1H); 4.76–4.67 (m, 3H); 4.02–3.95 (m, 2H); 3.57–3.50 (m, 2H); 3.16–3.05 (m, 2H); 2.54 (s, 3H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub> 423.1906, found 424.1982 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.59 min.</div></div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> General Procedure 15 (Amide Formation)</h3><div class="NLM_p">To a solution of the amine (0.1 mmol, 1.0 equiv) in dry DMF (0.5 mL) were added dropwise the required acid (1.5 equiv), DIPEA (3.0 equiv), and a 50 wt % solution of T3P in EtOAc (1.2 equiv) at rt under inert atmosphere (N<sub>2</sub>). The reaction mixture was stirred at rt overnight, and the reaction mixture was concentrated under reduced pressure. Purification of the residue gave the desired product.</div><div id="sec4_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> <i>N</i>-[3-(3-Ethyl-ureido)-5-(2-methyl-pyridin-4-yl)-isoquinolin-8-ylmethyl]-acetamide (<b>65</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 15 from <b>55</b> (70 mg, 0.209 mmol) and acetic acid (0.018 mL, 0.313 mmol). Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>65</b> as a pale yellow solid (55 mg, 69% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.26 (d, <i>J</i> = 0.6 Hz, 1H); 9.02 (s, 1H); 8.56 (dd, <i>J</i> = 5.0, 0.6 Hz, 1H); 8.45 (t, <i>J</i> = 5.8 Hz, 1H); 8.03 (s, 1H); 7.55–7.52 (m, 1H); 7.36 (d, <i>J</i> = 7.3 Hz, 1H); 7.33 (br, 1H); 7.26 (dd, <i>J</i> = 5.2, 1.2 Hz, 1H); 7.12 (t, <i>J</i> = 5.3 Hz, 1H); 4.77 (d, <i>J</i> = 5.7 Hz, 2H); 3.16–3.05 (m, 2H); 2.54 (s, 3H); 1.88 (s, 3H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub> 377.1852, found 378.1934 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.57 min.</div></div><div id="sec4_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> <i>N</i>-[3-(3-Ethyl-ureido)-5-(2-methyl-pyridin-4-yl)-isoquinolin-8-ylmethyl]-3-methoxy-propionamide (<b>66</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 15 from <b>55</b> (70 mg, 0.209 mmol) and 3-methoxypropionic acid (0.030 mL, 0.313 mmol). Purification by two successive CCs (DCM/MeOH 100:0 to 90:10) gave <b>66</b> as a white solid (59 mg, 67% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.25 (d, <i>J</i> = 0.4 Hz, 1H); 9.03 (s, 1H); 8.56 (d, <i>J</i> = 5.0 Hz, 1H); 8.48 (t, <i>J</i> = 5.8 Hz, 1H); 8.03 (s, 1H); 7.56–7.52 (m, 1H); 7.37 (d, <i>J</i> = 7.3 Hz, 1H); 7.33 (br, 1H); 7.26 (dd, <i>J</i> = 5.1, 1.2 Hz, 1H); 7.13 (t, <i>J</i> = 5.3 Hz, 1H); 4.80 (d, <i>J</i> = 5.7 Hz, 2H); 3.56 (t, <i>J</i> = 6.3 Hz, 2H); 3.21 (s, 3H); 3.17–3.06 (m, 2H); 2.55 (s, 3H); 2.39 (t, <i>J</i> = 6.2 Hz, 2H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 170.6; 158.8; 155.0; 149.9; 149.5; 148.5; 147.4; 137.3; 136.2; 135.2; 131.3; 124.3; 124.1; 122.8; 122.2; 102.1; 68.8; 58.4; 36.5; 34.3; 24.6; 15.9. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>3</sub> 421.2114, found 422.2193 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.60 min.</div></div><div id="sec4_16_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Cyclopropanecarboxylic Acid [3-(3-Ethyl-ureido)-5-(2-methyl-pyridin-4-yl)-isoquinolin-8-ylmethyl]-amide (<b>67</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 15 from <b>55</b> (70 mg, 0.209 mmol) and cyclopropanecarboxylic acid (0.025 mL, 0.313 mmol). Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>67</b> as a colorless solid (50 mg, 59% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.25 (d, <i>J</i> = 0.7 Hz, 1H); 9.04 (s, 1H); 8.67 (t, <i>J</i> = 5.7 Hz, 1H); 8.56 (d, <i>J</i> = 5.0 Hz, 1H); 8.04 (s, 1H); 7.58–7.52 (m, 1H); 7.37 (d, <i>J</i> = 7.3 Hz, 1H); 7.33 (br, 1H); 7.26 (dd, <i>J</i> = 5.1, 1.3 Hz, 1H); 7.09 (t, <i>J</i> = 5.4 Hz, 1H); 4.81 (d, <i>J</i> = 5.7 Hz, 2H); 3.16–3.05 (m, 2H); 2.55 (s, 3H); 1.67–1.56 (m, 1H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H); 0.76–0.62 (m, 4H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub> 403.2008, found 404.2084 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.64 min.</div></div><div id="sec4_16_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> (4-(3-(3-Ethylureido)-8-(((methoxycarbonyl)amino)methyl)isoquinolin-5-yl)-2-methylpyridin-1-ium-1-yl)methyl Hydrogen Phosphate (<b>68</b>)</h4><div class="NLM_p last">To a yellow suspension of <b>50</b> (590 mg, 1.5 mmol) and sodium iodide (480 mg, 3.2 mmol) in DCM (15 mL) at rt under inert atmosphere (N<sub>2</sub>) was added di-<i>tert</i>-butyl chloromethyl phosphate (4.14 g, 16 mmol). The reaction mixture was stirred at rt for 72 h and then cooled down to 0 °C. TFA (2.9 mL, 37.5 mmol) was added dropwise, and the reaction mixture was stirred at 0 °C for 2 h. Additional TFA (1.5 mL, 19 mmol) was added, the reaction mixture further stirred at 0 °C for 1 h, and then concentrated under reduced pressure. The residue was taken up in water and 9:1 DCM/MeOH and cooled down to 0 °C. Aqueous 8 M NaOH was added until pH 11, and the two layers were separated. The aqueous layer was washed twice with 9:1 DCM/MeOH and then neutralized with aq 2 M HCl until pH 7. The aqueous layer was then concentrated until about 20 mL was remaining. Purification by prep-HPLC (acidic conditions) gave <b>68</b> as a yellow solid (115 mg, 15% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.42 (s, 1H); 9.39–9.36 (m, 1H); 9.18 (d, <i>J</i> = 6.5 Hz, 1H); 8.21 (d, <i>J</i> = 0.6 Hz, 1H); 8.16–8.07 (m, 2H); 7.92–7.89 (m, 1H); 7.76 (d, <i>J</i> = 7.5 Hz, 1H); 7.42–7.38 (m, 2H); 6.10 (d, <i>J</i> = 12.7 Hz, 2H); 4.76 (d, <i>J</i> = 5.8 Hz, 2H); 3.56 (s, 3H); 3.18–3.19 (m, 2H); 2.95 (s, 3H); 1.05 (t, <i>J</i> = 7.2 Hz, 3H); POH proton missing. MS (ESI, <i>m</i>/<i>z</i>): 504.1 [M + H<sup>+</sup>].</div></div><div id="sec4_16_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> (3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl Piperazine-1-carboxylate (<b>69</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 9 from <b>44</b> (47 mg, 0.138 mmol) and piperazine (18 mg, 0.207 mmol). Purification by two successive CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>69</b> as a white solid (30 mg, 49% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.23 (d, <i>J</i> = 0.7 Hz, 1H); 9.06 (s, 1H); 8.57 (d, <i>J</i> = 5.3 Hz, 1H); 8.06 (d, <i>J</i> = 0.5 Hz, 1H); 7.56 (d, <i>J</i> = 7.3 Hz, 1H); 7.47 (d, <i>J</i> = 7.3 Hz, 1H); 7.36 (s, 1H); 7.28 (dd, <i>J</i> = 1.3, 5.0 Hz, 1H); 7.07–7.03 (m, 1H); 5.61 (s, 2H); 3.33–3.25 (m, 4H); 3.16–3.05 (m, 2H); 2.66–2.58 (m, 4H); 2.55 (s, 3H); 1.04 (t, <i>J</i> = 7.3 Hz, 3H); piperazine NH missing. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub> 448.2223, found 449.2288 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.50 min.</div></div><div id="sec4_16_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> (3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl 4-Methylpiperazine-1-carboxylate (<b>70</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 9 from <b>44</b> (100 mg, 0.297 mmol) and 1-methylpiperazine (0.050 mL, 0.446 mmol). Purification by CC (DCM/MeOH 100:0 to 90:10) gave <b>70</b> as a white solid (110 mg, 80% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.23 (s, 1H); 9.06 (s, 1H); 8.58 (s, 1H); 8.06 (s, 1H); 7.56 (d, <i>J</i> = 7.3 Hz, 1H); 7.47 (d, <i>J</i> = 7.3 Hz, 1H); 7.35 (d, <i>J</i> = 0.4 Hz, 1H); 7.28 (dd, <i>J</i> = 1.2, 4.9 Hz, 1H); 7.08–7.04 (m, 1H); 5.61 (s, 2H); 3.39–3.34 (m, 4H); 3.15–3.06 (m, 2H); 2.55 (s, 3H); 2.26–2.20 (m, 4H); 2.14 (s, 3H); 1.03 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 158.8; 155.0; 154.7; 150.0; 149.5; 148.4; 147.2; 136.3; 136.2; 134.7; 131.3; 124.9; 124.3; 122.8; 122.2; 102.2; 64.2; 54.7 (2CH); 46.2 (2CH); 43.9; 34.3; 24.6; 15.9. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>30</sub>N<sub>6</sub>O<sub>3</sub> 462.2379, found 463.2458 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.51 min.</div></div><div id="sec4_16_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> (3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl 4-(Cyclopropylmethyl)piperazine-1-carboxylate hydrochloride (<b>71</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 9 from <b>44</b> (25 mg, 0.075 mmol) and 1-(cyclopropylmethyl)piperazine (16 mg, 0.113 mmol). Purification by prep-HPLC (basic conditions) followed by HCl treatment gave <b>71</b> as a white solid (20 mg, 52% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 10.90 (br, 1H); 9.34 (s, 1H); 9.25 (s, 1H); 8.91 (d, <i>J</i> = 5.9 Hz, 1H); 8.17 (s, 1H); 8.03 (s, 1H), 7.98–7.90 (m, 1H); 7.74 (d, <i>J</i> = 7.3 Hz, 1H); 7.60 (d, <i>J</i> = 7.4 Hz, 1H); 7.19–7.06 (m, 1H); 5.71 (s, 2H); 4.15–4.04 (m, 2H); 3.73–3.21 (m, 4H); 3.17–3.07 (m, 2H); 3.07–2.93 (m, 4H); 2.80 (s, 3H); 1.14–1.05 (m, 1H); 1.06 (t, <i>J</i> = 7.2 Hz, 3H); 0.68–0.58 (m, 2H); 0.42–0.34 (m, 2H). LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>28</sub>H<sub>34</sub>N<sub>6</sub>O<sub>3</sub> 502.2692, found 503.2769 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.54 min.</div></div><div id="sec4_16_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> <i>tert</i>-Butyl 4-((((3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methoxy)carbonyl)amino)piperidine-1-carboxylate (<b>72a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 9 from <b>44</b> (50 mg, 0.149 mmol) and 1-<i>N</i>-Boc-4-aminopiperidine (46 mg, 0.223 mmol). Et<sub>2</sub>O (3 mL) was added to the reaction mixture, and the precipitate was filtered off, washed, and dried in vacuo to give <b>72a</b> as a white solid (55 mg, 66% yield). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.23 (s, 1H); 9.07 (s, 1H); 8.57 (d, <i>J</i> = 5.0 Hz, 1H); 8.06 (s, 1H); 7.57 (d, <i>J</i> = 7.3 Hz, 1H); 7.47 (d, <i>J</i> = 7.3 Hz, 1H); 7.37–7.32 (m, 2H); 7.30–7.26 (d, <i>J</i> = 5.0 Hz, 1H); 7.13–7.05 (m, 1H); 5.57 (s, 2H); 3.86–3.77 (m, 2H); 3.57–3.43 (m, 1H); 3.17–3.07 (m, 2H); 2.88–2.71 (m, 2H); 2.55 (s, 3H); 1.77–1.66 (m, 2H); 1.37 (s, 9H); 1.31–1.15 (m, 2H); 1.04 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI, <i>m</i>/<i>z</i>): 563.4 [M + H<sup>+</sup>].</div></div><div id="sec4_16_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> (3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl Piperidin-4-ylcarbamate (<b>72</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 13 from <b>72a</b> (55 mg, 0.098 mmol). Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>72</b> as a white solid (36 mg, 80% yield). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.24 (s, 1H); 9.12 (s, 1H); 8.59 (d, <i>J</i> = 5.1 Hz, 1H); 8.08 (s, 1H); 7.59 (d, <i>J</i> = 7.3 Hz, 1H); 7.49 (d, <i>J</i> = 7.3 Hz, 1H); 7.41–7.31 (m, 2H); 7.30 (d, <i>J</i> = 4.6 Hz, 1H); 7.15–7.05 (m, 1H); 5.58 (s, 2H); 3.48–3.22 (m, 3H); 3.17–3.05 (m, 2H); 3.00–2.78 (m, 2H); 2.57 (s, 3H); 1.78–1.64 (m, 2H); 1.43–1.19 (m, 2H); 1.06 (t, <i>J</i> = 7.2 Hz, 3H); piperidine NH missing. <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 158.8; 155.5; 155.0; 150.0; 149.5; 148.5; 147.2; 136.2 (2CH); 135.1; 131.2; 124.9; 124.3; 122.8; 122.2; 102.1; 62.9; 48.6; 45.0 (2CH); 34.3; 32.9 (2CH); 24.6; 15.9. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>30</sub>N<sub>6</sub>O<sub>3</sub> 462.2379, found 463.2462 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.52 min.</div></div><div id="sec4_16_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> <i>tert</i>-Butyl (<i>cis</i>)-4-((((3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methoxy)carbonyl)amino)-3-fluoropiperidine-1-carboxylate (<b>73a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 9 from <b>44</b> (50 mg, 0.149 mmol) and <i>cis</i>-4-amino-1-Boc-3-fluoropiperidine (49 mg, 0.223 mmol). However, after overnight at rt, the reaction mixture was further stirred at 40 °C for 70 h. Et<sub>2</sub>O (3 mL) was added to the reaction mixture, and the precipitate was filtered off, washed, and dried in vacuo to give <b>73a</b> as a white solid (53 mg) which was used without further purification.</div></div><div id="sec4_16_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> (3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl ((<i>cis</i>)-3-Fluoropiperidin-4-yl)carbamate (<b>73</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 13 from <b>73a</b> (50 mg, 0.085 mmol). Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>73</b> as a beige solid (26 mg, 39% yield over 2 steps). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.24 (s, 1H); 9.08 (s, 1H); 8.57 (d, <i>J</i> = 5.0 Hz, 1H); 8.06 (s, 1H); 7.60–7.55 (m, 1H); 7.54–7.46 (m, 2H); 7.36 (s, 1H); 7.31–7.26 (m, 1H); 7.13–7.06 (m, 1H); 5.59 (s, 2H); 4.66–4.44 (m, 1H); 3.71–3.48 (m, 1H); 3.18–3.06 (m, 2H); 3.06–2.97 (m, 1H); 2.91–2.81 (m, 1H); 2.77–2.54 (m, 1H); 2.55 (s, 3H); 2.05–1.90 (m, 1H); 1.64–1.41 (m, 2H); 1.04 (t, <i>J</i> = 7.1 Hz, 3H); piperidine NH missing. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>6</sub>O<sub>3</sub>F 480.2285, found 481.2357 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.51 min.</div></div><div id="sec4_16_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> <i>tert</i>-Butyl (<i>trans</i>)-4-((((3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methoxy)carbonyl)amino)-3-fluoropiperidine-1-carboxylate (<b>74a</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 9 from <b>44</b> (50 mg, 0.149 mmol) and <i>trans</i>-4-amino-1-Boc-3-fluoropiperidine (49 mg, 0.223 mmol). However, after overnight at rt, <i>trans</i>-4-amino-1-Boc-3-fluoropiperidine (49 mg, 0.223 mmol) and DIPEA (0.039 mL, 0.223 mmol) were added again, and the reaction mixture was further stirred at 40 °C for 70 h. Et<sub>2</sub>O (3 mL) was added to the reaction mixture, and the precipitate was filtered off, washed, and dried in vacuo to give <b>74a</b> as a white solid (42 mg) which was used without further purification.</div></div><div id="sec4_16_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> (3-(3-Ethylureido)-5-(2-methylpyridin-4-yl)isoquinolin-8-yl)methyl ((<i>trans</i>)-3-Fluoropiperidin-4-yl)carbamate (<b>74</b>)</h4><div class="NLM_p last">Prepared according to General Procedure 12 from <b>74a</b> (42 mg, 0.073 mmol). However, Et<sub>2</sub>O (3 mL) was added to the reaction mixture at the end of the reaction, and the precipitate was triturated, filtered, collected, and dried. Purification by CC (DCM/MeOH + 1% NH<sub>4</sub>OH 100:0 to 90:10) gave <b>74</b> as a beige solid (20 mg, 27% yield over 2 steps). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ: 9.25 (s, 1H); 9.13 (s, 1H); 8.64–8.56 (m, 1H); 8.08 (s, 1H); 7.65–7.54 (m, 2H); 7.53–7.46 (m, 1H); 7.38 (s, 1H); 7.34–7.26 (m, 1H); 7.15–7.06 (m, 1H); 5.60 (s, 2H); 4.33–4.08 (m, 1H); 3.61–3.46 (m, 1H); 3.23–3.06 (m, 3H); 2.86–2.72 (m, 1H); 2.57 (s, 3H); 2.54–2.30 (m, 1H); 1.82–1.73 (m, 1H); 1.39–1.21 (m, 2H); 1.07–1.04 (m, 3H); piperidine NH missing. LC-HRMS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>6</sub>O<sub>3</sub>F 480.2285, found 481.2370 [M + H<sup>+</sup>]; <sup><i>t</i></sup><i>R</i> = 0.52 min.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i124"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01834">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01834" class="ext-link">10.1021/acs.jmedchem.6b01834</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental details on cloning of DNA gyrase and topo IV genes, protein production and purification, expressed sequence for the GyrB24 (<i>E. coli</i>) crystallography construct, crystallization conditions, data collection and refinement statistics, gyrase and topo IV supercoiling and relaxation inhibition assay, ATPase inhibition assay, MIC testing, hK<sub>V</sub>11.1 (“hERG”) assay, logD and p<i>K</i><sub>a</sub> determination, neutropenic murine thigh infection model, pharmacokinetics in the mouse and in the rat, conversion of <b>68</b> in vitro in blood, and procedures for synthesis of <b>5</b>–<b>16</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01834/suppl_file/jm6b01834_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01834/suppl_file/jm6b01834_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01834/suppl_file/jm6b01834_si_001.pdf">jm6b01834_si_001.pdf (593.36 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01834/suppl_file/jm6b01834_si_002.csv">jm6b01834_si_002.csv (5.8 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">We will release the atomic coordinates and experimental data upon article publication. PDB code for <i>E. coli</i> GyrB with bound <b>27</b> is 5MMN; for <i>E. coli</i> GyrB with bound <b>36</b> is 5MMP; and for <i>E. coli</i> GyrB with bound <b>58</b> is 5MMO.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01834" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Panchaud</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7823-7639" title="Orcid link">http://orcid.org/0000-0001-7823-7639</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8dfde5e4e1e4fdfde8a3fdece3eee5ecf8e9cdeceef9e8e1e4e2e3a3eee2e0"><span class="__cf_email__" data-cfemail="cdbda5a4a1a4bdbda8e3bdaca3aea5acb8a98dacaeb9a8a1a4a2a3e3aea2a0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Bruyère</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne-Catherine Blumstein</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Bur</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alain Chambovey</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric A. Ertel</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Gude</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Hubschwerlen</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loïc Jacob</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Kimmerlin</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Pfeifer</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lars Prade</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Seiler</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Ritz</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georg Rueedi</span> - <span class="hlFld-Affiliation affiliation">Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e8134-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i129">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Aengus Mac Sweeney and Dr. Naomi Tidten-Luksch for preparation and submission of files to the PDB, Dr. Carmela Gnerre for helpful discussions, Eser Ihlan and Viktor Ribic for syntheses of libraries, Dr. Hans Locher, Jonathan Delers, and Daniela Sabato from the microbiology team, Marina Dos Santos, Marta Gerber, Stéphanie Kraemer, and Stefan Weiser for IC<sub>50</sub> measurements, Michel Enderlin-Paput and Maria Weiss for efficacy experiments, Alexander Hasler and Romain Sube for hERG measurements, the DMPK as well as the preformulation and preclinical galenics groups for their continuous support with routine in vitro and in vivo measurements, and Dr. Roman Fisera, Dr. Attila Latika, Dr. Henrich Brath, and Dr. Juraj Rehak from SYNKOLA Ltd. for building block synthesis.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i130" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i130"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i131" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i131"> Abbreviations Used</h2><tr><td class="NLM_term">BrettPhos</td><td class="NLM_def"><p class="first last">2-(dicyclohexylphosphino)-3,6-dimethoxy-2′,4′,6′-triisopropyl-1,1′-biphenyl</p></td></tr><tr><td class="NLM_term">CC</td><td class="NLM_def"><p class="first last">column chromatography</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">1,1′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony forming unit</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenyl phosphoryl azide</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-ferrocenediyl-bis(diphenylphosphine)</p></td></tr><tr><td class="NLM_term">ELSD</td><td class="NLM_def"><p class="first last">evaporative light scattering detector</p></td></tr><tr><td class="NLM_term">MRSA</td><td class="NLM_def"><p class="first last">methicillin-resistant <i>Staphylococcus aureus</i></p></td></tr><tr><td class="NLM_term">RIA</td><td class="NLM_def"><p class="first last">relaxation inhibition assay</p></td></tr><tr><td class="NLM_term">RTI</td><td class="NLM_def"><p class="first last">respiratory tract infection</p></td></tr><tr><td class="NLM_term">SCIA</td><td class="NLM_def"><p class="first last">supercoiling inhibition assay</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride solution</p></td></tr><tr><td class="NLM_term">VRE</td><td class="NLM_def"><p class="first last">vancomycin-resistant enterococci</p></td></tr><tr><td class="NLM_term">XPhos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i132">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">CDC</span><span class="NLM_x">. </span> <span class="citation_source-book">Antibiotic Resistance Threats in the United States</span>; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>. <a href="https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf" class="extLink">https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf</a> (accessed Dec 5,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=CDC&title=Antibiotic+Resistance+Threats+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DAntibiotic%2520Resistance%2520Threats%2520in%2520the%2520United%2520States%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hooper, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacoby, G. A.</span><span> </span><span class="NLM_article-title">Topoisomerase inhibitors: Fluoroquinolone mechanisms of action and resistance</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">a025320</span><span class="refDoi"> DOI: 10.1101/cshperspect.a025320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1101%2Fcshperspect.a025320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=27449972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1ylsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=a025320&author=D.+C.+Hooperauthor=G.+A.+Jacoby&title=Topoisomerase+inhibitors%3A+Fluoroquinolone+mechanisms+of+action+and+resistance&doi=10.1101%2Fcshperspect.a025320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance</span></div><div class="casAuthors">Hooper, David C.; Jacoby, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">a025320/1-a025320/22</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Quinolone antimicrobials are widely used in clin. medicine and are the only current class of agents that directly inhibit bacterial DNA synthesis.  Quinolones dually target DNA gyrase and topoisomerase IV binding to specific domains and conformations so as to block DNA strand passage catalysis and stabilize DNA -enzyme complexes that block the DNA replication app. and generate double breaks in DNA that underlie their bactericidal activity.  Resistance has emerged with clin. use of these agents and is common in some bacterial pathogens.  Mechanisms of resistance include mutational alterations in drug target affinity and efflux pump expression and acquisition of resistance-conferring genes.  Resistance mutations in one or both of the two drug target enzymes are commonly in a localized domain of the GyrA and ParC subunits of gyrase and topoisomerase IV, resp., and reduce drug binding to the enzyme-DNA complex.  Other resistance mutations occur in regulatory genes that control the expression of native efflux pumps localized in the bacterial membrane(s).  These pumps have broad substrate profiles that include other antimicrobials as well as quinolones.  Mutations of both types can accumulate with selection pressure and produce highly resistant strains.  Resistance genes acquired on plasmids confer low-level resistance that promotes the selection of mutational high-level resistance.  Plasmid-encoded resistance is because of Qnr proteins that protect the target enzymes from quinolone action, a mutant aminoglycoside-modifying enzyme that also modifies certain quinolones, and mobile efflux pumps.  Plasmids with these mechanisms often encode addnl. antimicrobial resistances and can transfer multidrug resistance that includes quinolones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJX0P7_nTppbVg90H21EOLACvtfcHk0li_jLnVM1LaiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1ylsLo%253D&md5=2dfb6502bdbdbb004e33668cd4641e2b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025320%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DD.%2BC.%26aulast%3DJacoby%26aufirst%3DG.%2BA.%26atitle%3DTopoisomerase%2520inhibitors%253A%2520Fluoroquinolone%2520mechanisms%2520of%2520action%2520and%2520resistance%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2016%26volume%3D6%26spage%3Da025320%26doi%3D10.1101%2Fcshperspect.a025320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Liu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, B. M.</span><span> </span><span class="NLM_article-title">Type II DNA topoisomerases: Enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span><span class="refDoi"> DOI: 10.1016/S0092-8674(80)80046-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2FS0092-8674%2880%2980046-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=6244895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADyaL3cXhslKntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1980&pages=697-707&author=L.+F.+Liuauthor=C.-C.+Liuauthor=B.+M.+Alberts&title=Type+II+DNA+topoisomerases%3A+Enzymes+that+can+unknot+a+topologically+knotted+DNA+molecule+via+a+reversible+double-strand+break&doi=10.1016%2FS0092-8674%2880%2980046-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Type II DNA topoisomerases. enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break</span></div><div class="casAuthors">Liu, Leroy F.; Liu, Chung-Cheng; Alberts, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">697-707</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Phage T4 DNA topoisomerase (I) is a multisubunit protein that appears to have an essential role in the initiation of T4 bacteriophage DNA replication.  Treatment of double-stranded (ds) circular DNA with large amts. of I in the absence of ATP yielded new DNA species which were knotted topol. isomers of the ds DNA circle.  These knotted DNA circles, whether covalently closed or nicked, were converted to unknotted circles by treatment with trace amts. of I in the presence of ATP.  Very similar ATP-dependent enzyme activities capable of unknotting DNA were present in exts. of Drosophila and Xenopus laevis eggs and in CHO cultures.  The prokaryotic enzyzme, DNA gyrase, was also capable of unknotting DNA.  These unknotting enzymes are proposed to constitute a new general class of I (type II I).  These enzymes must act via mechanisms that involve the concerted cleavage and rejoining of 2 opposite DNA strands, such that the DNA double helix is transiently broken.  The passage of a second ds DNA segment through this reversible ds break results in a variety of DNA topoisomerization reactions, including relaxation:supercoiling; knotting:unknotting, and catenation:decatenation.  In support of this type of mechanism, T4 I was shown to change the linking no. of a covalently closed ds circular DNA mol. only by multiples of 2.  Possible roles of such enzymes in a variety of biol. functions, along with their probable mol. mechanisms, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruCiIrcBArerVg90H21EOLACvtfcHk0lhGfS6QvMmxmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhslKntb0%253D&md5=7cc5d068e9a4fa02fb2204bc266b68a2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2880%2980046-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252880%252980046-8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DLiu%26aufirst%3DC.-C.%26aulast%3DAlberts%26aufirst%3DB.%2BM.%26atitle%3DType%2520II%2520DNA%2520topoisomerases%253A%2520Enzymes%2520that%2520can%2520unknot%2520a%2520topologically%2520knotted%2520DNA%2520molecule%2520via%2520a%2520reversible%2520double-strand%2520break%26jtitle%3DCell%26date%3D1980%26volume%3D19%26spage%3D697%26epage%3D707%26doi%3D10.1016%2FS0092-8674%2880%2980046-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Sissi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, M.</span><span> </span><span class="NLM_article-title">In front of and behind the replication fork: Bacterial type IIa topoisomerases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2001</span><span class="NLM_x">–</span> <span class="NLM_lpage">2024</span><span class="refDoi"> DOI: 10.1007/s00018-010-0299-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1007%2Fs00018-010-0299-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=20165898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFyrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=2001-2024&author=C.+Sissiauthor=M.+Palumbo&title=In+front+of+and+behind+the+replication+fork%3A+Bacterial+type+IIa+topoisomerases&doi=10.1007%2Fs00018-010-0299-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In front of and behind the replication fork: bacterial type IIA topoisomerases</span></div><div class="casAuthors">Sissi, Claudia; Palumbo, Manlio</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2001-2024</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Topoisomerases are vital enzymes specialized in controlling DNA topol., in particular supercoiling and decatenation, to properly handle nucleic acid packing and cell dynamics.  The type IIA enzymes act by cleaving both strands of a double helix and having another strand from the same or another mol. cross the DNA gate before a re-sealing event completes the catalytic cycle.  Here, we will consider the two types of IIA prokaryotic topoisomerases, DNA Gyrase and Topoisomerase IV, as crucial regulators of bacterial cell cycle progression.  Their synergistic action allows control of chromosome packing and grants occurrence of functional transcription and replication processes.  In addn. to displaying a fascinating mol. mechanism of action, which transduces chem. energy into mech. energy by means of large conformational changes, these enzymes represent attractive pharmacol. targets for antibacterial chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ESOZ27csO7Vg90H21EOLACvtfcHk0lhGfS6QvMmxmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFyrurg%253D&md5=beddf7151ca953f43ced56b17baa9f7c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00018-010-0299-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-010-0299-5%26sid%3Dliteratum%253Aachs%26aulast%3DSissi%26aufirst%3DC.%26aulast%3DPalumbo%26aufirst%3DM.%26atitle%3DIn%2520front%2520of%2520and%2520behind%2520the%2520replication%2520fork%253A%2520Bacterial%2520type%2520IIa%2520topoisomerases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2010%26volume%3D67%26spage%3D2001%26epage%3D2024%26doi%3D10.1007%2Fs00018-010-0299-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bush, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans-Roberts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, A.</span><span> </span><span class="NLM_article-title">DNA topoisomerases</span> <span class="citation_source-journal">EcoSal Plus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="refDoi"> DOI: 10.1128/ecosalplus.ESP-0010-2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2Fecosalplus.ESP-0010-2014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6&author=N.+G.+Bushauthor=K.+Evans-Robertsauthor=A.+Maxwell&title=DNA+topoisomerases&doi=10.1128%2Fecosalplus.ESP-0010-2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2Fecosalplus.ESP-0010-2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fecosalplus.ESP-0010-2014%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DN.%2BG.%26aulast%3DEvans-Roberts%26aufirst%3DK.%26aulast%3DMaxwell%26aufirst%3DA.%26atitle%3DDNA%2520topoisomerases%26jtitle%3DEcoSal%2520Plus%26date%3D2015%26volume%3D6%26spage%3D6%26doi%3D10.1128%2Fecosalplus.ESP-0010-2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span> </span><span class="NLM_article-title">DNA topoisomerases and their poisoning by anticancer and antibacterial drugs</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2010.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2Fj.chembiol.2010.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=20534341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=421-433&author=Y.+Pommierauthor=E.+Leoauthor=H.+Zhangauthor=C.+Marchand&title=DNA+topoisomerases+and+their+poisoning+by+anticancer+and+antibacterial+drugs&doi=10.1016%2Fj.chembiol.2010.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs</span></div><div class="casAuthors">Pommier, Yves; Leo, Elisabetta; Zhang, Hong-Liang; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-433</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  DNA topoisomerases are the targets of important anticancer and antibacterial drugs.  Camptothecins and novel noncamptothecins in clin. development (indenoisoquinolines and ARC-111) target eukaryotic type IB topoisomerases (Top1), whereas human type IIA topoisomerases (Top2α and Top2β) are the targets of the widely used anticancer agents etoposide, anthracyclines (doxorubicin, daunorubicin), and mitoxantrone.  Bacterial type II topoisomerases (gyrase and Topo IV) are the targets of quinolones and aminocoumarin antibiotics.  This review focuses on the mol. and biochem. characteristics of topoisomerases and their inhibitors.  We also discuss the common mechanism of action of topoisomerase poisons by interfacial inhibition and trapping of topoisomerase cleavage complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr6m1st3bchbVg90H21EOLACvtfcHk0lgwO1NA9PAiwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslCjsLY%253D&md5=ab00ffa6d0e8bf0c433b154e2a4b484a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DLeo%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DDNA%2520topoisomerases%2520and%2520their%2520poisoning%2520by%2520anticancer%2520and%2520antibacterial%2520drugs%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D421%26epage%3D433%26doi%3D10.1016%2Fj.chembiol.2010.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Collin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karkare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, A.</span><span> </span><span class="NLM_article-title">Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives</span> <span class="citation_source-journal">Appl. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1007/s00253-011-3557-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1007%2Fs00253-011-3557-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=21904817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yhurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2011&pages=479-497&author=F.+Collinauthor=S.+Karkareauthor=A.+Maxwell&title=Exploiting+bacterial+DNA+gyrase+as+a+drug+target%3A+Current+state+and+perspectives&doi=10.1007%2Fs00253-011-3557-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting bacterial DNA gyrase as a drug target: current state and perspectives</span></div><div class="casAuthors">Collin, Frederic; Karkare, Shantanu; Maxwell, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Applied Microbiology and Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">479-497</span>CODEN:
                <span class="NLM_cas:coden">AMBIDG</span>;
        ISSN:<span class="NLM_cas:issn">0175-7598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  DNA gyrase is a type II topoisomerase that can introduce neg. supercoils into DNA at the expense of ATP hydrolysis.  It is essential in all bacteria but absent from higher eukaryotes, making it an attractive target for antibacterials.  The fluoroquinolones are examples of very successful gyrase-targeted drugs, but the rise in bacterial resistance to these agents means that the authors not only need to seek new compds., but also new modes of inhibition of this enzyme.  The authors review known gyrase-specific drugs and toxins and assess the prospects for developing new antibacterials targeted to this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFeiVFp1eOYrVg90H21EOLACvtfcHk0lgujZXGzkroOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yhurrF&md5=9bd1603bbe55c389ca99eb8c14e26c63</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00253-011-3557-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00253-011-3557-z%26sid%3Dliteratum%253Aachs%26aulast%3DCollin%26aufirst%3DF.%26aulast%3DKarkare%26aufirst%3DS.%26aulast%3DMaxwell%26aufirst%3DA.%26atitle%3DExploiting%2520bacterial%2520DNA%2520gyrase%2520as%2520a%2520drug%2520target%253A%2520Current%2520state%2520and%2520perspectives%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2011%26volume%3D92%26spage%3D479%26epage%3D497%26doi%3D10.1007%2Fs00253-011-3557-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">East, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, L. L.</span><span> </span><span class="NLM_article-title">Multitarget ligands in antibacterial research: Progress and opportunities</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1517/17460441.2013.743991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1517%2F17460441.2013.743991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=23252414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=143-156&author=S.+P.+Eastauthor=L.+L.+Silver&title=Multitarget+ligands+in+antibacterial+research%3A+Progress+and+opportunities&doi=10.1517%2F17460441.2013.743991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget ligands in antibacterial research: progress and opportunities</span></div><div class="casAuthors">East, Stephen P.; Silver, Lynn L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-156</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Resistance to current antibacterial therapies is an inevitability that represents a significant global health concern.  Bacteria have the capacity to render all current drug treatments ineffective, which places a demand on the drug discovery community to constantly develop new antibacterial agents.  Compds. that inhibit multiple biol. targets, often referred to as multitarget ligands, are an inviting prospect in antibacterial research because, although they will not solve the issue of resistance, they might help to delay the onset. Areas covered: This review covers some of the recent progress in identifying new ligands that deliberately interact with more than one essential biol. target in bacteria.  The two principal areas covered are inhibitors of DNA replication and cell wall biosynthesis. Expert opinion: Antibacterial programs for the design of multitarget ligands present an important opportunity for prodn. of antibacterial agents.  Their longevity, due to slow development of resistance, is comparable to that seen with other successful agents - but is much improved over single-targeted agents for which resistance can appear in vitro overnight.  The preclin. development of these agents will have to overcome the std. problems of antibacterial discovery.  Such problems include optimization of characteristics favoring cell entry and particularly the demonstration of selectivity of inhibition of the desired multiple targets without inhibition of other bacterial or any mammalian functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbhpbYgIA8HrVg90H21EOLACvtfcHk0ljoEN-fP2c7mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cku74%253D&md5=2b335d54e579d210ab9a1220ea2d6a57</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.743991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.743991%26sid%3Dliteratum%253Aachs%26aulast%3DEast%26aufirst%3DS.%2BP.%26aulast%3DSilver%26aufirst%3DL.%2BL.%26atitle%3DMultitarget%2520ligands%2520in%2520antibacterial%2520research%253A%2520Progress%2520and%2520opportunities%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D143%26epage%3D156%26doi%3D10.1517%2F17460441.2013.743991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sugino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peebles, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzarelli, N. R.</span><span> </span><span class="NLM_article-title">Energy coupling in DNA gyrase and the mechanism of action of novobiocin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">4838</span><span class="NLM_x">–</span> <span class="NLM_lpage">4842</span><span class="refDoi"> DOI: 10.1073/pnas.75.10.4838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1073%2Fpnas.75.10.4838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=368801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADyaE1MXjsFSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1978&pages=4838-4842&author=A.+Suginoauthor=N.+P.+Higginsauthor=P.+O.+Brownauthor=C.+L.+Peeblesauthor=N.+R.+Cozzarelli&title=Energy+coupling+in+DNA+gyrase+and+the+mechanism+of+action+of+novobiocin&doi=10.1073%2Fpnas.75.10.4838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Energy coupling in DNA gyrase and the mechanism of action of novobiocin</span></div><div class="casAuthors">Sugino, Akio; Higgins, N. Patrick; Brown, Patrick O.; Peebles, Craig L.; Cozzarelli, Nicholas R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4838-42</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Escherichia coli DNA gyrase (I) catalyzes neg. supercoiling of closed duplex DNA at the expense of ATP.  Two addnl. activities of the enzyme that have illuminated the energy coupling component of the supercoiling reaction are the DNA-dependent hydrolysis of ATP to ADP and inorg. phosphate and the alteration by ATP of the DNA site specificity of the I cleavage reaction.  This cleavage of both DNA strands results from treatment with Na dodecyl sulfate of the stable I-DNA complex that is trapped by the inhibitor, oxolinic acid.  Either ATP or a nonhydrolyzable analog, adenyl-5'-yl-imidodiphosphate (II), shifts the primary cleavage site on ColE1 DNA.  The prevention by novobiocin and coumermycin A1 of this cleavage rearrangement places the site of action of the antibiotics at a reaction step prior to ATP hydrolysis.  The step blocked is the binding of ATP because coumermycin A1 and novobiocin interact competitively with ATP in the ATPase and supercoiling assays; the Ki values are >4 orders of magnitude less than the Km for ATP.  This simple mechanism accounts for all effects of the drugs on I.  Studies with II, another potent competitive inhibitor of reactions catalyzed by I show that cleavage of a high-energy bond is not required for driving DNA into the higher-energy supercoiled form.  With substrate levels of I, II induces supercoiling that is proportional to the amt. of enzyme; a -0.3 superhelical turn was introduced per gyrase promoter A.  Apparently, ATP and II are allosteric effectors of a conformational change of I that leads to 1 round of supercoiling.  Nucleotide dissocn. favored by hydrolysis of ATP returns I to its original conformation and thereby permits enzyme turnover.  Such cyclic conformational changes accompanying alteration in nucleotide affinity also seem to be a common feature of energy transduction in other diverse processes including muscle contraction, protein synthesis, and oxidative phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2xXSnmkXv-LVg90H21EOLACvtfcHk0liuGJQnpzAyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXjsFSrtQ%253D%253D&md5=9b2e96025197d93bddc51c55e79cf496</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.75.10.4838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.75.10.4838%26sid%3Dliteratum%253Aachs%26aulast%3DSugino%26aufirst%3DA.%26aulast%3DHiggins%26aufirst%3DN.%2BP.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DPeebles%26aufirst%3DC.%2BL.%26aulast%3DCozzarelli%26aufirst%3DN.%2BR.%26atitle%3DEnergy%2520coupling%2520in%2520DNA%2520gyrase%2520and%2520the%2520mechanism%2520of%2520action%2520of%2520novobiocin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1978%26volume%3D75%26spage%3D4838%26epage%3D4842%26doi%3D10.1073%2Fpnas.75.10.4838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Holdgate, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tunnicliffe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, W. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weston, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbrock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I. W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, D.</span><span> </span><span class="NLM_article-title">The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: A thermodynamic and crystallographic study</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">9663</span><span class="NLM_x">–</span> <span class="NLM_lpage">9673</span><span class="refDoi"> DOI: 10.1021/bi970294+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi970294%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=9663-9673&author=G.+A.+Holdgateauthor=A.+Tunnicliffeauthor=W.+H.+J.+Wardauthor=S.+A.+Westonauthor=G.+Rosenbrockauthor=P.+T.+Barthauthor=I.+W.+F.+Taylorauthor=R.+A.+Pauptitauthor=D.+Timms&title=The+entropic+penalty+of+ordered+water+accounts+for+weaker+binding+of+the+antibiotic+novobiocin+to+a+resistant+mutant+of+DNA+gyrase%3A+A+thermodynamic+and+crystallographic+study&doi=10.1021%2Fbi970294%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Entropic Penalty of Ordered Water Accounts for Weaker Binding of the Antibiotic Novobiocin to a Resistant Mutant of DNA Gyrase: A Thermodynamic and Crystallographic Study</span></div><div class="casAuthors">Holdgate, Geoffrey A.; Tunnicliffe, Alan; Ward, Walter H. J.; Weston, Simon A.; Rosenbrock, Gina; Barth, Peter T.; Taylor, Ian W. F.; Pauptit, Richard A.; Timms, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">9663-9673</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novobiocin is an antibiotic which binds to a 24 kDa fragment from the B subunit of DNA gyrase.  Naturally occurring resistance arises from mutation of Arg-136 which hydrogen bonds to the coumarin ring of novobiocin.  We have applied calorimetry to characterize the binding of novobiocin to wild-type and R136H mutant 24 kDa fragments.  Upon mutation, the Kd increases from 32 to 1200 nM at 300 K.  The enthalpy of binding is more favorable for the mutant (ΔH° shifts from -12.1 to -17.5 kcal/mol), and the entropy of binding is much less favorable (TΔS° changes from -1.8 to -9.4 kcal/mol).  Both of these changes are in the direction opposite to that expected if the loss of the Arg residue reduces hydrogen bonding.  The change in heat capacity at const. pressure upon binding (ΔCp) shifts from -295 to -454 cal mol-1 K-1.  We also report the crystal structure, at 2.3 Å resoln., of a complex between the R136H 24 kDa fragment and novobiocin.  Although the change in ΔCp often would be interpreted as reflecting increased burial of the hydrophobic surface on binding, this structure reveals a small decrease.  Furthermore, an ordered water mol. is sequestered into the vol. vacated by removal of the guanidinium group.  There are large discrepancies when the measured thermodn. parameters are compared to those estd. from the structural data using empirical relationships.  These differences seem to arise from the effects of sequestering ordered water mols. upon complexation.  The water-mediated hydrogen bonds linking novobiocin to the mutant protein make a favorable enthalpic contribution, whereas the immobilization of the water leads to an entropic cost and a redn. in the heat capacity of the system.  Such a neg. contribution to ΔCp, ΔH°, and TΔS° appears to be a general property of water mols. that are sequestered when ligands bind to proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQavsSOGjoibVg90H21EOLACvtfcHk0liuGJQnpzAyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFWgsr8%253D&md5=560c913d4a9cbf6a5ccca550345d7ef4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbi970294%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi970294%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DTunnicliffe%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DW.%2BH.%2BJ.%26aulast%3DWeston%26aufirst%3DS.%2BA.%26aulast%3DRosenbrock%26aufirst%3DG.%26aulast%3DBarth%26aufirst%3DP.%2BT.%26aulast%3DTaylor%26aufirst%3DI.%2BW.%2BF.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DTimms%26aufirst%3DD.%26atitle%3DThe%2520entropic%2520penalty%2520of%2520ordered%2520water%2520accounts%2520for%2520weaker%2520binding%2520of%2520the%2520antibiotic%2520novobiocin%2520to%2520a%2520resistant%2520mutant%2520of%2520DNA%2520gyrase%253A%2520A%2520thermodynamic%2520and%2520crystallographic%2520study%26jtitle%3DBiochemistry%26date%3D1997%26volume%3D36%26spage%3D9663%26epage%3D9673%26doi%3D10.1021%2Fbi970294%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippke, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span> </span><span class="NLM_article-title">Crystal structures of <i>Escherichia coli</i> topoisomerase IV ParE subunit (24 and 43 kilodaltons): A single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1864</span><span class="refDoi"> DOI: 10.1128/AAC.48.5.1856-1864.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2FAAC.48.5.1856-1864.2004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1856-1864&author=S.+Bellonauthor=J.+D.+Parsonsauthor=Y.+Weiauthor=K.+Hayakawaauthor=L.+L.+Swensonauthor=P.+S.+Charifsonauthor=J.+A.+Lippkeauthor=R.+Aldapeauthor=C.+H.+Gross&title=Crystal+structures+of+Escherichia+coli+topoisomerase+IV+ParE+subunit+%2824+and+43+kilodaltons%29%3A+A+single+residue+dictates+differences+in+novobiocin+potency+against+topoisomerase+IV+and+DNA+gyrase&doi=10.1128%2FAAC.48.5.1856-1864.2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1856-1864.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1856-1864.2004%26sid%3Dliteratum%253Aachs%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DLippke%26aufirst%3DJ.%2BA.%26aulast%3DAldape%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DC.%2BH.%26atitle%3DCrystal%2520structures%2520of%2520Escherichia%2520coli%2520topoisomerase%2520IV%2520ParE%2520subunit%2520%252824%2520and%252043%2520kilodaltons%2529%253A%2520A%2520single%2520residue%2520dictates%2520differences%2520in%2520novobiocin%2520potency%2520against%2520topoisomerase%2520IV%2520and%2520DNA%2520gyrase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1856%26epage%3D1864%26doi%3D10.1128%2FAAC.48.5.1856-1864.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bisacchi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchester, J. I.</span><span> </span><span class="NLM_article-title">A new-class antibacterial - almost. Lessons in drug discovery and development: A critical analysis of more than 50 years of effort toward ATPase inhibitors of DNA gyrase and topoisomerase IV</span> <span class="citation_source-journal">ACS Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1021/id500013t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/id500013t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGmsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=4-41&author=G.+S.+Bisacchiauthor=J.+I.+Manchester&title=A+new-class+antibacterial+-+almost.+Lessons+in+drug+discovery+and+development%3A+A+critical+analysis+of+more+than+50+years+of+effort+toward+ATPase+inhibitors+of+DNA+gyrase+and+topoisomerase+IV&doi=10.1021%2Fid500013t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV</span></div><div class="casAuthors">Bisacchi, Gregory S.; Manchester, John I.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-41</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The introduction into clin. practice of an ATPase inhibitor of bacterial DNA gyrase and topoisomerase IV (topo IV) would represent a new-class agent for the treatment of resistant bacterial infections.  Novobiocin, the only historical member of this class, established the clin. proof of concept for this novel mechanism during the late 1950s, but its use declined rapidly and it was eventually withdrawn from the market.  Despite significant and prolonged effort across the biopharmaceutical industry to develop other agents of this class, novobiocin remains the only ATPase inhibitor of gyrase and topo IV ever to progress beyond Phase I.  In this review, we analyze the historical attempts to discover and develop agents within this class and highlight factors that might have hindered those efforts.  Within the last 15 years, however, our tech. understanding of the mol. details of the inhibition of the gyrase and topo IV ATPases, the factors governing resistance development to such inhibitors, and our knowledge of the phys. properties required for robust clin. drug candidates have all matured to the point wherein the industry may now address this mechanism of action with greater confidence.  The antibacterial spectrum within this class has recently been extended to begin to include serious Gram neg. pathogens such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae.  In spite of this recent tech. progress, adverse economics assocd. with antibacterial R&D over the last 20 years has diminished industry's ability to commit the resources and perseverance needed to bring new-class agents to launch.  Consequently, a no. of recent efforts in the ATPase class have been derailed by organizational rather than scientific factors.  Nevertheless, within this context we discuss the unique opportunity for the development of ATPase inhibitors of gyrase and topo IV as new-class antibacterial agents with broad spectrum potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXubyDLdrSrrVg90H21EOLACvtfcHk0lj10eauq2pGLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGmsbnL&md5=95ce2833dab37f68a3a4a018e381e198</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fid500013t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fid500013t%26sid%3Dliteratum%253Aachs%26aulast%3DBisacchi%26aufirst%3DG.%2BS.%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26atitle%3DA%2520new-class%2520antibacterial%2520-%2520almost.%2520Lessons%2520in%2520drug%2520discovery%2520and%2520development%253A%2520A%2520critical%2520analysis%2520of%2520more%2520than%252050%2520years%2520of%2520effort%2520toward%2520ATPase%2520inhibitors%2520of%2520DNA%2520gyrase%2520and%2520topoisomerase%2520IV%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D4%26epage%3D41%26doi%3D10.1021%2Fid500013t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Maxwell, A.</span><span> </span><span class="NLM_article-title">DNA gyrase as a drug target</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span><span class="refDoi"> DOI: 10.1016/S0966-842X(96)10085-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2FS0966-842X%2896%2910085-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=102-109&author=A.+Maxwell&title=DNA+gyrase+as+a+drug+target&doi=10.1016%2FS0966-842X%2896%2910085-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0966-842X%2896%2910085-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0966-842X%252896%252910085-8%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DA.%26atitle%3DDNA%2520gyrase%2520as%2520a%2520drug%2520target%26jtitle%3DTrends%2520Microbiol.%26date%3D1997%26volume%3D5%26spage%3D102%26epage%3D109%26doi%3D10.1016%2FS0966-842X%2896%2910085-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Drlica, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, M.</span><span> </span><span class="NLM_article-title">Fluoroquinolones: Action and resistance</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.2174/1568026033452537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.2174%2F1568026033452537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=12570763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=249-282&author=K.+Drlicaauthor=M.+Malik&title=Fluoroquinolones%3A+Action+and+resistance&doi=10.2174%2F1568026033452537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fluoroquinolones: action and resistance</span></div><div class="casAuthors">Drlica, Karl; Malik, Muhammad</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-282</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Fluoroquinolones trap gyrase and topoisomerase IV on DNA as ternary complexes that block the movement of replication forks and transcription complexes.  Studies with resistant mutants indicate that during complex formation quinolones bind to a surface α-helix of the GyrA and ParC proteins.  Lethal action is a distinct event that is proposed to arise from release of DNA breaks from the ternary complexes.  Many bacterial pathogens are exhibiting resistance due to alterations in drug permeability, drug efflux, gyrase-protecting proteins, and target topoisomerases.  When selection of resistant mutants is described in terms of fluoroquinolone concn., a threshold (mutant prevention concn., MPC) can be defined for restricting the development of resistance.  MPC varies among fluoroquinolones and pathogens; when combined with pharmacokinetics, MPC can be used to identify compds. least likely to enrich mutant subpopulations.  Use of suboptimal doses and compds. erodes the efficacy of the class as a whole because resistance to one quinolone reduces susceptibility to others and/or increases the frequency at which resistance develops.  When using fluoroquinolones in combination therapy, the development of resistance may be minimized by optimizing regimens for pharmacokinetic overlap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3WUy9qQC8PLVg90H21EOLACvtfcHk0liAKDJj00ROVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Clug%253D%253D&md5=840aae442481ffb4f91a60f4b688cc4c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1568026033452537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452537%26sid%3Dliteratum%253Aachs%26aulast%3DDrlica%26aufirst%3DK.%26aulast%3DMalik%26aufirst%3DM.%26atitle%3DFluoroquinolones%253A%2520Action%2520and%2520resistance%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D249%26epage%3D282%26doi%3D10.2174%2F1568026033452537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Oblak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solmajer, T.</span><span> </span><span class="NLM_article-title">Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2047</span><span class="refDoi"> DOI: 10.2174/092986707781368414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.2174%2F092986707781368414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=17691945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFequ7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=2033-2047&author=M.+Oblakauthor=M.+Kotnikauthor=T.+Solmajer&title=Discovery+and+development+of+ATPase+inhibitors+of+DNA+gyrase+as+antibacterial+agents&doi=10.2174%2F092986707781368414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents</span></div><div class="casAuthors">Oblak, Marko; Kotnik, Miha; Solmajer, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2033-2047</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  DNA gyrase is an attractive and well established target for the development of antibacterial agents.  This bacterial enzyme, whose biol. function is to control the topol. state of DNA mols., consists of two catalytic subunits; GyrA is responsible for DNA breakage and reunion, while the subunit GyrB contains the ATP-binding site.  Coumarins and cyclothialidines are natural products that inhibit the ATPase activity of DNA gyrase by blocking the binding of ATP to subunit GyrB.  The mechanism of action of these compds. was exhaustively characterized by biochem. methods and supported by protein crystallog.  The abundance of crystallog. data on the N-terminal domain of GyrB in its complexes with various ligands had enabled the structure-based design of novel efficient chemotypes as inhibitors of the ATPase domain.  This review summarizes the discovery of ATPase inhibitors of DNA gyrase B in the last decade and their development as potential antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl-Tm7LdvTcrVg90H21EOLACvtfcHk0liAKDJj00ROVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFequ7o%253D&md5=b3cc136ff918251727972a686f1a0b02</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F092986707781368414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707781368414%26sid%3Dliteratum%253Aachs%26aulast%3DOblak%26aufirst%3DM.%26aulast%3DKotnik%26aufirst%3DM.%26aulast%3DSolmajer%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520development%2520of%2520ATPase%2520inhibitors%2520of%2520DNA%2520gyrase%2520as%2520antibacterial%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D2033%26epage%3D2047%26doi%3D10.2174%2F092986707781368414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Škedelj, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomašić, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mašič, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zega, A.</span><span> </span><span class="NLM_article-title">ATP-binding site of bacterial enzymes as a target for antibacterial drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span><span class="refDoi"> DOI: 10.1021/jm101121s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101121s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=915-929&author=V.+%C5%A0kedeljauthor=T.+Toma%C5%A1i%C4%87author=L.+P.+Ma%C5%A1i%C4%8Dauthor=A.+Zega&title=ATP-binding+site+of+bacterial+enzymes+as+a+target+for+antibacterial+drug+design&doi=10.1021%2Fjm101121s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm101121s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101121s%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0kedelj%26aufirst%3DV.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3DMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%2BP.%26aulast%3DZega%26aufirst%3DA.%26atitle%3DATP-binding%2520site%2520of%2520bacterial%2520enzymes%2520as%2520a%2520target%2520for%2520antibacterial%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D915%26epage%3D929%26doi%3D10.1021%2Fjm101121s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mayer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">Non-quinolone inhibitors of bacterial type IIa topoisomerases: A feat of bioisosterism</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">2313</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span><span class="refDoi"> DOI: 10.1021/cr4003984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4003984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2313-2342&author=C.+Mayerauthor=Y.+L.+Janin&title=Non-quinolone+inhibitors+of+bacterial+type+IIa+topoisomerases%3A+A+feat+of+bioisosterism&doi=10.1021%2Fcr4003984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism</span></div><div class="casAuthors">Mayer, Claudine; Janin, Yves L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2313-2342</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  DNA gyrase and topoisomerase IV are the bacterial type IIA topoisomerases.  These are ubiquitous nucleic acid-dependent nanomachines, essential to cell life, that solve DNA topol. problems resulting from the replication, transcription, and recombination of DNA.  From the discovery that novobiocin and fluoroquinolone antibiotics were selectively acting on bacterial type IIA topoisomerases, a remarkable no. of series of inhibitors of these enzymes has been reported.  The design of biochem. or cellular assays, amenable to high-throughput screenings, along with X-ray-derived structures of the early inhibitors bound to DNA gyrase, were instrumental in this.  From these structures, an array of strategies, which are today called fragment-based approaches, provided quite a no. of addnl. starting points for medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-y7YT9Lg6rVg90H21EOLACvtfcHk0lgNDcgFnDWbIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO&md5=8559c27866d96e85cc08763e0cae1c01</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fcr4003984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4003984%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DC.%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DNon-quinolone%2520inhibitors%2520of%2520bacterial%2520type%2520IIa%2520topoisomerases%253A%2520A%2520feat%2520of%2520bioisosterism%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2313%26epage%3D2342%26doi%3D10.1021%2Fcr4003984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Tomašić, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mašič, L.</span><span> </span><span class="NLM_article-title">Prospects for developing new antibacterials targeting bacterial type IIa topoisomerases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.2174/1568026613666131113153251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.2174%2F1568026613666131113153251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=24236722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlyrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=130-151&author=T.+Toma%C5%A1i%C4%87author=L.+Ma%C5%A1i%C4%8D&title=Prospects+for+developing+new+antibacterials+targeting+bacterial+type+IIa+topoisomerases&doi=10.2174%2F1568026613666131113153251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Prospects for Developing New Antibacterials Targeting Bacterial Type IIA Topoisomerases</span></div><div class="casAuthors">Tomasic, Tihomir; Masic, Lucija Peterlin</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130-151</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The modulation of DNA topol. by DNA gyrase and topoisomerase IV, both of which are type IIA topoisomerases and found in most bacteria, is a function vital to DNA replication, repair and decatenation.  Despite the potential for resistance development, DNA gyrase and/or topoisomerase IV have been proven to be and remain highly attractive targets in antibacterial drug discovery due to their potential for dual targeting.  The search for new GyrA and/or ParC inhibitors that can overcome the increasing spread of multidrug-resistant bacteria has been successfully focused in the last decades on the modification of the known fluoroquinolone scaffold as primarily guided by ligand-based design via classical structure-activity relationship studies and the optimization of physicochem. properties.  This focus has resulted in several novel fluoroquinolones that have been introduced into clin. practice since 2000, and several of these new compds. are currently in different phases of clin. trials.  Due to increasing resistance to fluoroquinolones, a significant part of DNA gyrase research has shifted to the discovery of new GyrB and/or ParE inhibitors, which are commonly identified through fragment-based design as well as virtual screening techniques and structure-based hit optimization programs.  This research often results in lead compds. with potent inhibitory activity and promising antibacterial activity profiles.  Nevertheless, it is important to understand how different physicochem. properties (e.g., logD and total polar surface area) and different structural motifs influence the compds.' permeability to ensure the efficient discovery of potent, small-mol. antibacterials particularly against Gram-neg. strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqli6ENt9H6UrVg90H21EOLACvtfcHk0lgUjP6REoFJ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlyrt78%253D&md5=5de1f9a0b3d72cbf42792c91d6d98bb6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568026613666131113153251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026613666131113153251%26sid%3Dliteratum%253Aachs%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3DMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%26atitle%3DProspects%2520for%2520developing%2520new%2520antibacterials%2520targeting%2520bacterial%2520type%2520IIa%2520topoisomerases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D130%26epage%3D151%26doi%3D10.2174%2F1568026613666131113153251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzelka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span> </span><span class="NLM_article-title">In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span><span class="refDoi"> DOI: 10.1128/AAC.50.4.1228-1237.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2FAAC.50.4.1228-1237.2006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1228-1237&author=N.+Maniauthor=C.+H.+Grossauthor=J.+D.+Parsonsauthor=B.+Hanzelkaauthor=U.+Muhauthor=S.+Mullinauthor=Y.+Liaoauthor=A.+L.+Grillotauthor=D.+Stamosauthor=P.+S.+Charifsonauthor=T.+H.+Grossman&title=In+vitro+characterization+of+the+antibacterial+spectrum+of+novel+bacterial+type+II+topoisomerase+inhibitors+of+the+aminobenzimidazole+class&doi=10.1128%2FAAC.50.4.1228-1237.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.4.1228-1237.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.4.1228-1237.2006%26sid%3Dliteratum%253Aachs%26aulast%3DMani%26aufirst%3DN.%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DMuh%26aufirst%3DU.%26aulast%3DMullin%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DGrillot%26aufirst%3DA.%2BL.%26aulast%3DStamos%26aufirst%3DD.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520the%2520antibacterial%2520spectrum%2520of%2520novel%2520bacterial%2520type%2520II%2520topoisomerase%2520inhibitors%2520of%2520the%2520aminobenzimidazole%2520class%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1228%26epage%3D1237%26doi%3D10.1128%2FAAC.50.4.1228-1237.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">East, S. P.; Czaplewski, L. G.; Haydon, D. J.</span><span> </span><span class="NLM_article-title">Ethyl Urea Inhibitors of the Bacterial Type II Topoisomerases DNA Gyrase (GyrB) and Topoisomerase IV (ParE)</span>. In  <span class="citation_source-book">Designing Multi-Target Drugs</span>; <span class="NLM_publisher-name">RSC Publishing</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">21</span>, pp  <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1039%2F9781849734912-00335" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=335-352&author=S.+P.+East&author=L.+G.+Czaplewski&author=D.+J.+Haydon&title=Designing+Multi-Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2F9781849734912-00335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849734912-00335%26sid%3Dliteratum%253Aachs%26aulast%3DEast%26aufirst%3DS.%2BP.%26atitle%3DEthyl%2520Urea%2520Inhibitors%2520of%2520the%2520Bacterial%2520Type%2520II%2520Topoisomerases%2520DNA%2520Gyrase%2520%2528GyrB%2529%2520and%2520Topoisomerase%2520IV%2520%2528ParE%2529%26btitle%3DDesigning%2520Multi-Target%2520Drugs%26pub%3DRSC%2520Publishing%26date%3D2012%26volume%3D21%26spage%3D335%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Axford, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrau, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gannon, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunniss, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offermann, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narasinga Rao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomaides-Brears, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyndall, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydon, D. J.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6598</span><span class="NLM_x">–</span> <span class="NLM_lpage">6603</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2Fj.bmcl.2013.10.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=24239017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWnsL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6598-6603&author=L.+C.+Axfordauthor=P.+K.+Agarwalauthor=K.+H.+Andersonauthor=L.+N.+Andrauauthor=J.+Atherallauthor=S.+Barkerauthor=J.+M.+Bennettauthor=M.+Blairauthor=I.+Collinsauthor=L.+G.+Czaplewskiauthor=D.+T.+Daviesauthor=C.+T.+Gannonauthor=D.+Kumarauthor=P.+Lancettauthor=A.+Loganauthor=C.+J.+Lunnissauthor=D.+R.+Mitchellauthor=D.+A.+Offermannauthor=J.+T.+Palmerauthor=N.+Palmerauthor=G.+R.+Pittauthor=S.+Pommierauthor=D.+Priceauthor=B.+Narasinga+Raoauthor=R.+Saxenaauthor=T.+Shuklaauthor=A.+K.+Singhauthor=M.+Singhauthor=A.+Srivastavaauthor=C.+Steeleauthor=N.+R.+Stokesauthor=H.+B.+Thomaides-Brearsauthor=E.+M.+Tyndallauthor=D.+Watsonauthor=D.+J.+Haydon&title=Design%2C+synthesis+and+biological+evaluation+of+%CE%B1-substituted+isonipecotic+acid+benzothiazole+analogues+as+potent+bacterial+type+II+topoisomerase+inhibitors&doi=10.1016%2Fj.bmcl.2013.10.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors</span></div><div class="casAuthors">Axford, Lorraine C.; Agarwal, Piyush K.; Anderson, Kelly H.; Andrau, Laura N.; Atherall, John; Barker, Stephanie; Bennett, James M.; Blair, Michael; Collins, Ian; Czaplewski, Lloyd G.; Davies, David T.; Gannon, Carlie T.; Kumar, Dushyant; Lancett, Paul; Logan, Alastair; Lunniss, Christopher J.; Mitchell, Dale R.; Offermann, Daniel A.; Palmer, James T.; Palmer, Nicholas; Pitt, Gary R. W.; Pommier, Stephanie; Price, Daniel; Narasinga Rao, B.; Saxena, Rashmi; Shukla, Tarun; Singh, Amit K.; Singh, Mahipal; Srivastava, Anil; Steele, Christopher; Stokes, Neil R.; Thomaides-Brears, Helena B.; Tyndall, Edward M.; Watson, David; Haydon, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6598-6603</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a new class of benzothiazole small mols. (e.g. I) that inhibit bacterial DNA gyrase and topoisomerase IV are described.  Antibacterial properties have been demonstrated by activity against DNA gyrase ATPase and potent activity against Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, and Haemophilus influenzae.  Further refinements to the scaffold designed to enhance drug-likeness included analogs bearing an α-substituent to the carboxylic acid group, resulting in excellent soly. and favorable pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDcM3TGLzV17Vg90H21EOLACvtfcHk0lhNUbmeI2UrfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWnsL3J&md5=c65277685571a1e7a0689d33785e0926</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.058%26sid%3Dliteratum%253Aachs%26aulast%3DAxford%26aufirst%3DL.%2BC.%26aulast%3DAgarwal%26aufirst%3DP.%2BK.%26aulast%3DAnderson%26aufirst%3DK.%2BH.%26aulast%3DAndrau%26aufirst%3DL.%2BN.%26aulast%3DAtherall%26aufirst%3DJ.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBlair%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DDavies%26aufirst%3DD.%2BT.%26aulast%3DGannon%26aufirst%3DC.%2BT.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DLancett%26aufirst%3DP.%26aulast%3DLogan%26aufirst%3DA.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DMitchell%26aufirst%3DD.%2BR.%26aulast%3DOffermann%26aufirst%3DD.%2BA.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPalmer%26aufirst%3DN.%26aulast%3DPitt%26aufirst%3DG.%2BR.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DNarasinga%2BRao%26aufirst%3DB.%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DShukla%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DSteele%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DN.%2BR.%26aulast%3DThomaides-Brears%26aufirst%3DH.%2BB.%26aulast%3DTyndall%26aufirst%3DE.%2BM.%26aulast%3DWatson%26aufirst%3DD.%26aulast%3DHaydon%26aufirst%3DD.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520%25CE%25B1-substituted%2520isonipecotic%2520acid%2520benzothiazole%2520analogues%2520as%2520potent%2520bacterial%2520type%2520II%2520topoisomerase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6598%26epage%3D6603%26doi%3D10.1016%2Fj.bmcl.2013.10.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Stokes, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomaides-Brears, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamble, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunniss, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peasley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydon, D. J.</span><span> </span><span class="NLM_article-title">Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5977</span><span class="NLM_x">–</span> <span class="NLM_lpage">5986</span><span class="refDoi"> DOI: 10.1128/AAC.00719-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2FAAC.00719-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=24041906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A280%3ADC%252BC3sbosl2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=5977-5986&author=N.+R.+Stokesauthor=H.+B.+Thomaides-Brearsauthor=S.+Barkerauthor=J.+M.+Bennettauthor=J.+Berryauthor=I.+Collinsauthor=L.+G.+Czaplewskiauthor=V.+Gambleauthor=P.+Lancettauthor=A.+Loganauthor=C.+J.+Lunnissauthor=H.+Peasleyauthor=S.+Pommierauthor=D.+Priceauthor=C.+Smeeauthor=D.+J.+Haydon&title=Biological+evaluation+of+benzothiazole+ethyl+urea+inhibitors+of+bacterial+type+II+topoisomerases&doi=10.1128%2FAAC.00719-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases</span></div><div class="casAuthors">Stokes Neil R; Thomaides-Brears Helena B; Barker Stephanie; Bennett James M; Berry Joanne; Collins Ian; Czaplewski Lloyd G; Gamble Vicki; Lancett Paul; Logan Alastair; Lunniss Christopher J; Peasley Hilary; Pommier Stephanie; Price Daniel; Smee Carol; Haydon David J</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5977-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The type II topoisomerases DNA gyrase (GyrA/GyrB) and topoisomerase IV (ParC/ParE) are well-validated targets for antibacterial drug discovery.  Because of their structural and functional homology, these enzymes are amenable to dual targeting by a single ligand.  In this study, two novel benzothiazole ethyl urea-based small molecules, designated compound A and compound B, were evaluated for their biochemical, antibacterial, and pharmacokinetic properties.  The two compounds inhibited the ATPase activity of GyrB and ParE with 50% inhibitory concentrations of <0.1 μg/ml.  Prevention of DNA supercoiling by DNA gyrase was also observed.  Both compounds potently inhibited the growth of a range of bacterial organisms, including staphylococci, streptococci, enterococci, Clostridium difficile, and selected Gram-negative respiratory pathogens.  MIC90s against clinical isolates ranged from 0.015 μg/ml for Streptococcus pneumoniae to 0.25 μg/ml for Staphylococcus aureus.  No cross-resistance with common drug resistance phenotypes was observed.  In addition, no synergistic or antagonistic interactions between compound A or compound B and other antibiotics, including the topoisomerase inhibitors novobiocin and levofloxacin, were detected in checkerboard experiments.  The frequencies of spontaneous resistance for S. aureus were <2.3 × 10(-10) with compound A and <5.8 × 10(-11) with compound B at concentrations equivalent to 8× the MICs.  These values indicate a multitargeting mechanism of action.  The pharmacokinetic properties of both compounds were profiled in rats.  Following intravenous administration, compound B showed approximately 3-fold improvement over compound A in terms of both clearance and the area under the concentration-time curve.  The measured oral bioavailability of compound B was 47.7%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTB7u8-ATVsmBFwe7cAcrfPfW6udTcc2ebmY5ce152va7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbosl2ruw%253D%253D&md5=6ede7459b1d20c528f016a29446253c4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FAAC.00719-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00719-13%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DN.%2BR.%26aulast%3DThomaides-Brears%26aufirst%3DH.%2BB.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBerry%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DGamble%26aufirst%3DV.%26aulast%3DLancett%26aufirst%3DP.%26aulast%3DLogan%26aufirst%3DA.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DPeasley%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DSmee%26aufirst%3DC.%26aulast%3DHaydon%26aufirst%3DD.%2BJ.%26atitle%3DBiological%2520evaluation%2520of%2520benzothiazole%2520ethyl%2520urea%2520inhibitors%2520of%2520bacterial%2520type%2520II%2520topoisomerases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D5977%26epage%3D5986%26doi%3D10.1128%2FAAC.00719-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchester, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boriack-Sjodin, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dangel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Illingworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uria-Nickelsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eakin, A. E.</span><span> </span><span class="NLM_article-title">Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8712</span><span class="NLM_x">–</span> <span class="NLM_lpage">8735</span><span class="refDoi"> DOI: 10.1021/jm401208b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401208b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8712-8735&author=G.+S.+Basarabauthor=J.+I.+Manchesterauthor=S.+Bistauthor=P.+A.+Boriack-Sjodinauthor=B.+Dangelauthor=R.+Illingworthauthor=B.+A.+Shererauthor=S.+Sriramauthor=M.+Uria-Nickelsenauthor=A.+E.+Eakin&title=Fragment-to-hit-to-lead+discovery+of+a+novel+pyridylurea+scaffold+of+ATP+competitive+dual+targeting+type+II+topoisomerase+inhibiting+antibacterial+agents&doi=10.1021%2Fjm401208b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401208b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401208b%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26aulast%3DBist%26aufirst%3DS.%26aulast%3DBoriack-Sjodin%26aufirst%3DP.%2BA.%26aulast%3DDangel%26aufirst%3DB.%26aulast%3DIllingworth%26aufirst%3DR.%26aulast%3DSherer%26aufirst%3DB.%2BA.%26aulast%3DSriram%26aufirst%3DS.%26aulast%3DUria-Nickelsen%26aufirst%3DM.%26aulast%3DEakin%26aufirst%3DA.%2BE.%26atitle%3DFragment-to-hit-to-lead%2520discovery%2520of%2520a%2520novel%2520pyridylurea%2520scaffold%2520of%2520ATP%2520competitive%2520dual%2520targeting%2520type%2520II%2520topoisomerase%2520inhibiting%2520antibacterial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8712%26epage%3D8735%26doi%3D10.1021%2Fjm401208b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yule, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narramore, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishwick, C. W.</span><span> </span><span class="NLM_article-title">Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2Fj.ejmech.2014.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=25137573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleiur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=31-38&author=I.+A.+Yuleauthor=L.+G.+Czaplewskiauthor=S.+Pommierauthor=D.+T.+Daviesauthor=S.+K.+Narramoreauthor=C.+W.+Fishwick&title=Pyridine-3-carboxamide-6-yl-ureas+as+novel+inhibitors+of+bacterial+DNA+gyrase%3A+Structure+based+design%2C+synthesis%2C+SAR+and+antimicrobial+activity&doi=10.1016%2Fj.ejmech.2014.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity</span></div><div class="casAuthors">Yule, Ian A.; Czaplewski, Lloyd G.; Pommier, Stephanie; Davies, David T.; Narramore, Sarah K.; Fishwick, Colin W. G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of antibacterial drugs based on novel chemotypes is essential to the future management of serious drug resistant infections.  We herein report the design, synthesis and SAR of a novel series of N-ethylurea inhibitors based on a pyridine-3-carboxamide scaffold targeting the ATPase sub-unit of DNA gyrase.  Consideration of structural aspects of the GyrB ATPase site has aided the development of this series resulting in derivs. that demonstrate excellent enzyme inhibitory activity coupled to potent Gram pos. antibacterial efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa7ay8GaYorVg90H21EOLACvtfcHk0lhP9jhNAwSGSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleiur%252FL&md5=0b6959bec14a8d28d3321db46b33b4fa</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DYule%26aufirst%3DI.%2BA.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DD.%2BT.%26aulast%3DNarramore%26aufirst%3DS.%2BK.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26atitle%3DPyridine-3-carboxamide-6-yl-ureas%2520as%2520novel%2520inhibitors%2520of%2520bacterial%2520DNA%2520gyrase%253A%2520Structure%2520based%2520design%252C%2520synthesis%252C%2520SAR%2520and%2520antimicrobial%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D31%26epage%3D38%26doi%3D10.1016%2Fj.ejmech.2014.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Huang, L.; Liu, S.; Lunney, E. A.; Planken, S. P.</span><span> </span><span class="NLM_article-title">Substituted 2-Amino-fused Heterocyclic Compounds as JNK Modulators and Their Preparation, Pharmaceutical Compositions, and Use in the Treatment of Diabetes and Related Diseases</span>. PCT International Patent WO 2007125405A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=L.+Huang&author=S.+Liu&author=E.+A.+Lunney&author=S.+P.+Planken&title=Substituted+2-Amino-fused+Heterocyclic+Compounds+as+JNK+Modulators+and+Their+Preparation%2C+Pharmaceutical+Compositions%2C+and+Use+in+the+Treatment+of+Diabetes+and+Related+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26atitle%3DSubstituted%25202-Amino-fused%2520Heterocyclic%2520Compounds%2520as%2520JNK%2520Modulators%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diabetes%2520and%2520Related%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wang, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J. M.</span><span> </span><span class="NLM_article-title">N-heterocyclic carbene-palladium(II)-1-methylimidazole complex-catalyzed Suzuki-Miyaura coupling of benzyl carbamates with arylboronic acids</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">11438</span><span class="NLM_x">–</span> <span class="NLM_lpage">11444</span><span class="refDoi"> DOI: 10.1039/C5OB01782C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1039%2FC5OB01782C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=26446833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2hurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=11438-11444&author=X.+X.+Wangauthor=M.+J.+Luoauthor=J.+M.+Lu&title=N-heterocyclic+carbene-palladium%28II%29-1-methylimidazole+complex-catalyzed+Suzuki-Miyaura+coupling+of+benzyl+carbamates+with+arylboronic+acids&doi=10.1039%2FC5OB01782C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">N-Heterocyclic carbene-palladium(II)-1-methylimidazole complex-catalyzed Suzuki-Miyaura coupling of benzyl carbamates with arylboronic acids</span></div><div class="casAuthors">Wang, Xiao-Xia; Luo, Mao-Jun; Lu, Jian-Mei</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">11438-11444</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The Suzuki-Miyaura coupling of benzyl carbamates with arylboronic acids was achieved in an environmentally benign medium.  Using water as the sole solvent, such transformation took place very well to give the desired diarylmethane derivs. in good to almost quant. yields in the presence of a well-defined NHC-Pd(II)-Im complex under mild conditions.  It is worth noting here that this is the first example of benzyl carbamates used in the coupling reaction, thus affording a new method for the formation of diarylmethanes by palladium-catalyzed C-O bond activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqboah4eCZxF7Vg90H21EOLACvtfcHk0lhP9jhNAwSGSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2hurfF&md5=b13dccfb187bab48e10b7e55152eea23</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC5OB01782C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB01782C%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BX.%26aulast%3DLuo%26aufirst%3DM.%2BJ.%26aulast%3DLu%26aufirst%3DJ.%2BM.%26atitle%3DN-heterocyclic%2520carbene-palladium%2528II%2529-1-methylimidazole%2520complex-catalyzed%2520Suzuki-Miyaura%2520coupling%2520of%2520benzyl%2520carbamates%2520with%2520arylboronic%2520acids%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D11438%26epage%3D11444%26doi%3D10.1039%2FC5OB01782C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Matsukura, M.</span><span> </span><span class="NLM_article-title">Preparation of Pyridine Derivatives Having [(Phosphonooxy)methyl]pyridinium Group as Antifungal Agents</span>. PCT International Patent WO 2010150761A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Matsukura&title=Preparation+of+Pyridine+Derivatives+Having+%5B%28Phosphonooxy%29methyl%5Dpyridinium+Group+as+Antifungal+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMatsukura%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Pyridine%2520Derivatives%2520Having%2520%255B%2528Phosphonooxy%2529methyl%255Dpyridinium%2520Group%2520as%2520Antifungal%2520Agents%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hata, K.; Yamamoto, E.; Okubo, M.</span><span> </span><span class="NLM_article-title">Physicochemical Properties and Nonclinical Pharmacokinetics of E1211: A Water-Soluble Prodrug of E1210</span>. In  <span class="citation_source-book">51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)</span>; Poster F1-1376, Chicago, IL,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Hata&author=E.+Yamamoto&author=M.+Okubo&title=51st+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy+%28ICAAC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHata%26aufirst%3DK.%26atitle%3DPhysicochemical%2520Properties%2520and%2520Nonclinical%2520Pharmacokinetics%2520of%2520E1211%253A%2520A%2520Water-Soluble%2520Prodrug%2520of%2520E1210%26btitle%3D51st%2520Interscience%2520Conference%2520on%2520Antimicrobial%2520Agents%2520and%2520Chemotherapy%2520%2528ICAAC%2529%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergquist, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becherer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashim, M. A.</span><span> </span><span class="NLM_article-title">Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1446</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span><span class="refDoi"> DOI: 10.1038/bjp.2008.267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1038%2Fbjp.2008.267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=18587422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVajsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1446-1456&author=X.+Yaoauthor=D.+L.+Andersonauthor=S.+A.+Rossauthor=D.+G.+Langauthor=B.+Z.+Desaiauthor=D.+C.+Cooperauthor=P.+Wheelanauthor=M.+S.+McIntyreauthor=M.+L.+Bergquistauthor=K.+I.+MacKenzieauthor=J.+D.+Bechererauthor=M.+A.+Hashim&title=Predicting+QT+prolongation+in+humans+during+early+drug+development+using+hERG+inhibition+and+an+anaesthetized+guinea-pig+model&doi=10.1038%2Fbjp.2008.267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model</span></div><div class="casAuthors">Yao, X.; Anderson, D. L.; Ross, S. A.; Lang, D. G.; Desai, B. Z.; Cooper, D. C.; Wheelan, P.; McIntyre, M. S.; Bergquist, M. L.; MacKenzie, K. I.; Becherer, J. D.; Hashim, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1446-1456</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug-induced prolongation of the QT interval can lead to torsade de pointes, a life-threatening ventricular arrhythmia.  Finding appropriate assays from among the plethora of options available to predict reliably this serious adverse effect in humans remains a challenging issue for the discovery and development of drugs.  The purpose of the present study was to develop and verify a reliable and relatively simple approach for assessing, during preclin. development, the propensity of drugs to prolong the QT interval in humans.  Sixteen marketed drugs from various pharmacol. classes with a known incidence-or lack thereof-of QT prolongation in humans were examd. in hERG (human ether a-go-go-related gene) patch-clamp assay and an anesthetized guinea-pig assay for QT prolongation using specific protocols.  Drug concns. in perfusates from hERG assays and plasma samples from guinea-pigs were detd. using liq. chromatog.-mass spectrometry.  Various pharmacol. agents that inhibit hERG currents prolong the QT interval in anesthetized guinea-pigs in a manner similar to that seen in humans and at comparable drug exposures.  Several compds. not assocd. with QT prolongation in humans failed to prolong the QT interval in this model.  Anal. of hERG inhibitory potency in conjunction with drug exposures and QT interval measurements in anesthetized guinea-pigs can reliably predict, during preclin. drug development, the risk of human QT prolongation.  A strategy is proposed for mitigating the risk of QT prolongation of new chem. entities during early lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRuiQ1CyjedrVg90H21EOLACvtfcHk0li2vjdURDfqfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVajsLw%253D&md5=1dbf4f50957b26496c4efa213e3f7e5c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.267%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DX.%26aulast%3DAnderson%26aufirst%3DD.%2BL.%26aulast%3DRoss%26aufirst%3DS.%2BA.%26aulast%3DLang%26aufirst%3DD.%2BG.%26aulast%3DDesai%26aufirst%3DB.%2BZ.%26aulast%3DCooper%26aufirst%3DD.%2BC.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DMcIntyre%26aufirst%3DM.%2BS.%26aulast%3DBergquist%26aufirst%3DM.%2BL.%26aulast%3DMacKenzie%26aufirst%3DK.%2BI.%26aulast%3DBecherer%26aufirst%3DJ.%2BD.%26aulast%3DHashim%26aufirst%3DM.%2BA.%26atitle%3DPredicting%2520QT%2520prolongation%2520in%2520humans%2520during%2520early%2520drug%2520development%2520using%2520hERG%2520inhibition%2520and%2520an%2520anaesthetized%2520guinea-pig%2520model%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1446%26epage%3D1456%26doi%3D10.1038%2Fbjp.2008.267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sander, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Korff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rufener, C.</span><span> </span><span class="NLM_article-title">DataWarrior: An open-source program for chemistry aware data visualization and analysis</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1021/ci500588j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500588j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=460-473&author=T.+Sanderauthor=J.+Freyssauthor=M.+von+Korffauthor=C.+Rufener&title=DataWarrior%3A+An+open-source+program+for+chemistry+aware+data+visualization+and+analysis&doi=10.1021%2Fci500588j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis</span></div><div class="casAuthors">Sander, Thomas; Freyss, Joel; von Korff, Modest; Rufener, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">460-473</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug discovery projects in the pharmaceutical industry accumulate thousands of chem. structures and ten-thousands of data points from a dozen or more biol. and pharmacol. assays.  A sufficient interpretation of the data requires understanding which mol. families are present, which structural motifs correlate with measured properties, and which tiny structural changes cause large property changes.  Data visualization and anal. software with sufficient chem. intelligence to support chemists in this task is rare.  In an attempt to contribute to filling the gap, we released our inhouse developed chem. aware data anal. program DataWarrior for free public use.  This paper gives an overview of DataWarrior's functionality and architecture.  Exemplarily, a new unsupervised, 2-dimensional scaling algorithm is presented, which employs vector-based or nonvector-based descriptors to visualize the chem. or pharmacophore space of even large data sets.  DataWarrior uses this method to interactively explore chem. space, activity landscapes, and activity cliffs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_PNPlIkf72LVg90H21EOLACvtfcHk0li2vjdURDfqfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFWnuw%253D%253D&md5=5c849901b5cb4549d870d81f5eeaca0a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fci500588j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500588j%26sid%3Dliteratum%253Aachs%26aulast%3DSander%26aufirst%3DT.%26aulast%3DFreyss%26aufirst%3DJ.%26aulast%3Dvon%2BKorff%26aufirst%3DM.%26aulast%3DRufener%26aufirst%3DC.%26atitle%3DDataWarrior%253A%2520An%2520open-source%2520program%2520for%2520chemistry%2520aware%2520data%2520visualization%2520and%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D460%26epage%3D473%26doi%3D10.1021%2Fci500588j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Andes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ogtrop, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, W. A.</span><span> </span><span class="NLM_article-title">In vivo pharmacodynamics of a new oxazolidinone (linezolid)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3484</span><span class="NLM_x">–</span> <span class="NLM_lpage">3489</span><span class="refDoi"> DOI: 10.1128/AAC.46.11.3484-3489.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2FAAC.46.11.3484-3489.2002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3484-3489&author=D.+Andesauthor=M.+L.+van+Ogtropauthor=J.+Pengauthor=W.+A.+Craig&title=In+vivo+pharmacodynamics+of+a+new+oxazolidinone+%28linezolid%29&doi=10.1128%2FAAC.46.11.3484-3489.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.11.3484-3489.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.11.3484-3489.2002%26sid%3Dliteratum%253Aachs%26aulast%3DAndes%26aufirst%3DD.%26aulast%3Dvan%2BOgtrop%26aufirst%3DM.%2BL.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DCraig%26aufirst%3DW.%2BA.%26atitle%3DIn%2520vivo%2520pharmacodynamics%2520of%2520a%2520new%2520oxazolidinone%2520%2528linezolid%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3484%26epage%3D3489%26doi%3D10.1128%2FAAC.46.11.3484-3489.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bur, D.; Gude, M.; Hubschwerlen, C.; Panchaud, P.</span><span> </span><span class="NLM_article-title">Preparation of Antibacterial (Isoquinolin-3-yl)urea Derivatives</span>. PCT International Patent WO 2011121555A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+Bur&author=M.+Gude&author=C.+Hubschwerlen&author=P.+Panchaud&title=Preparation+of+Antibacterial+%28Isoquinolin-3-yl%29urea+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBur%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520Antibacterial%2520%2528Isoquinolin-3-yl%2529urea%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 37 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Suzanne S. Stokes, Rajender Vemula, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Pucci</span>. </span><span class="cited-content_cbyCitation_article-title">Advancement of GyrB Inhibitors for Treatment of Infections Caused by Mycobacterium tuberculosis and Non-tuberculous Mycobacteria. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (6)
                                     , 1323-1331. <a href="https://doi.org/10.1021/acsinfecdis.0c00025" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00025%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DAdvancement%252Bof%252BGyrB%252BInhibitors%252Bfor%252BTreatment%252Bof%252BInfections%252BCaused%252Bby%252BMycobacterium%252Btuberculosis%252Band%252BNon-tuberculous%252BMycobacteria%26aulast%3DStokes%26aufirst%3DSuzanne%2BS.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15012020%26date%3D25032020%26date%3D17032020%26volume%3D6%26issue%3D6%26spage%3D1323%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinming Fan, Wei Zhang, Wangxi Gao, Tao Wang, Wei-Liang Duan, Yong Liang, <span class="NLM_string-name hlFld-ContribAuthor">Zunting Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses of Benzofuranoquinolines and Analogues via Photoinduced Acceptorless Dehydrogenative Annulation of o-Phenylfuranylpyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (22)
                                     , 9183-9187. <a href="https://doi.org/10.1021/acs.orglett.9b03556" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03556%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSyntheses%252Bof%252BBenzofuranoquinolines%252Band%252BAnalogues%252Bvia%252BPhotoinduced%252BAcceptorless%252BDehydrogenative%252BAnnulation%252Bof%252Bo-Phenylfuranylpyridines%26aulast%3DFan%26aufirst%3DJinming%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08102019%26date%3D05112019%26volume%3D21%26issue%3D22%26spage%3D9183%26epage%3D9187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul N. Mortenson, Daniel A. Erlanson, Iwan J. P. de Esch, Wolfgang Jahnke, <span class="NLM_string-name hlFld-ContribAuthor">Christopher N. Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2017. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 3857-3872. <a href="https://doi.org/10.1021/acs.jmedchem.8b01472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2017%26aulast%3DMortenson%26aufirst%3DPaul%2BN.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D21092018%26date%3D21112018%26volume%3D62%26issue%3D8%26spage%3D3857%26epage%3D3872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Long-Yong Xie, Sha Peng, Fang Liu, Yan-Fang Liu, Meng Sun, Zi-Long Tang, Si Jiang, Zhong Cao, <span class="NLM_string-name hlFld-ContribAuthor">Wei-Min He</span>. </span><span class="cited-content_cbyCitation_article-title">Clean Preparation of Quinolin-2-yl Substituted Ureas in Water. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2019,</strong> <em>7 </em>
                                    (7)
                                     , 7193-7199. <a href="https://doi.org/10.1021/acssuschemeng.9b00200" title="DOI URL">https://doi.org/10.1021/acssuschemeng.9b00200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.9b00200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.9b00200%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DClean%252BPreparation%252Bof%252BQuinolin-2-yl%252BSubstituted%252BUreas%252Bin%252BWater%26aulast%3DXie%26aufirst%3DLong-Yong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11012019%26date%3D04032019%26date%3D19032019%26date%3D08032019%26volume%3D7%26issue%3D7%26spage%3D7193%26epage%3D7199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Long-Yong Xie, Sha Peng, Ling-Hui Lu, Jue Hu, Wen-Hu Bao, Fei Zeng, Zilong Tang, Xinhua Xu, <span class="NLM_string-name hlFld-ContribAuthor">Wei-Min He</span>. </span><span class="cited-content_cbyCitation_article-title">Brønsted Acidic Ionic Liquid-Promoted Amidation of Quinoline N-Oxides with Nitriles. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2018,</strong> <em>6 </em>
                                    (6)
                                     , 7989-7994. <a href="https://doi.org/10.1021/acssuschemeng.8b01358" title="DOI URL">https://doi.org/10.1021/acssuschemeng.8b01358</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.8b01358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.8b01358%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DBr%2525C3%2525B8nsted%252BAcidic%252BIonic%252BLiquid-Promoted%252BAmidation%252Bof%252BQuinoline%252BN-Oxides%252Bwith%252BNitriles%26aulast%3DXie%26aufirst%3DLong-Yong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26032018%26date%3D30042018%26volume%3D6%26issue%3D6%26spage%3D7989%26epage%3D7994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zengbao  Yang</span>, <span class="hlFld-ContribAuthor ">Hui  Zhou</span>, <span class="hlFld-ContribAuthor ">Maoyao  He</span>, <span class="hlFld-ContribAuthor ">Jianglian  Li</span>, <span class="hlFld-ContribAuthor ">Zhongzhen  Yang</span>, <span class="hlFld-ContribAuthor ">Yong  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">One‐pot Synthesis of 3‐Acylsilane‐Substituted Isoquinolines via Rhodium (III)‐Catalyzed C−H Activation/Annulation of
              O
              ‐pivaloyl Oximes With Acryloylsilanes. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (7)
                                     , 1683-1686. <a href="https://doi.org/10.1002/ajoc.202100254" title="DOI URL">https://doi.org/10.1002/ajoc.202100254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100254%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne%2525E2%252580%252590pot%252BSynthesis%252Bof%252B3%2525E2%252580%252590Acylsilane%2525E2%252580%252590Substituted%252BIsoquinolines%252Bvia%252BRhodium%252B%252528III%252529%2525E2%252580%252590Catalyzed%252BC%2525E2%252588%252592H%252BActivation%25252FAnnulation%252Bof%252BO%252B%2525E2%252580%252590pivaloyl%252BOximes%252BWith%252BAcryloylsilanes%26aulast%3DYang%26aufirst%3DZengbao%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D7%26spage%3D1683%26epage%3D1686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Ning</span>, <span class="hlFld-ContribAuthor ">Simin  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Du</span>, <span class="hlFld-ContribAuthor ">Bingyi  Guo</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Huizhe  Lu</span>, <span class="hlFld-ContribAuthor ">Yanhong  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, bioactivity and 3D-QSAR of azamacrolide compounds with a carbamate or urea moiety as potential fungicides and inhibitors of quorum sensing. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (6)
                                     , 3048-3058. <a href="https://doi.org/10.1039/D0NJ05727D" title="DOI URL">https://doi.org/10.1039/D0NJ05727D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ05727D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ05727D%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbioactivity%252Band%252B3D-QSAR%252Bof%252Bazamacrolide%252Bcompounds%252Bwith%252Ba%252Bcarbamate%252Bor%252Burea%252Bmoiety%252Bas%252Bpotential%252Bfungicides%252Band%252Binhibitors%252Bof%252Bquorum%252Bsensing%26aulast%3DNing%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D6%26spage%3D3048%26epage%3D3058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gangadhar Rao  Mathi</span>, <span class="hlFld-ContribAuthor ">Byeongseok  Kweon</span>, <span class="hlFld-ContribAuthor ">Yonghoon  Moon</span>, <span class="hlFld-ContribAuthor ">Yujin  Jeong</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective C−H Functionalization of Heteroarene
              N
              ‐Oxides Enabled by a Traceless Nucleophile. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (50)
                                     , 22864-22872. <a href="https://doi.org/10.1002/ange.202010597" title="DOI URL">https://doi.org/10.1002/ange.202010597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202010597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202010597%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRegioselective%252BC%2525E2%252588%252592H%252BFunctionalization%252Bof%252BHeteroarene%252BN%252B%2525E2%252580%252590Oxides%252BEnabled%252Bby%252Ba%252BTraceless%252BNucleophile%26aulast%3DMathi%26aufirst%3DGangadhar%2BRao%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D50%26spage%3D22864%26epage%3D22872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gangadhar Rao  Mathi</span>, <span class="hlFld-ContribAuthor ">Byeongseok  Kweon</span>, <span class="hlFld-ContribAuthor ">Yonghoon  Moon</span>, <span class="hlFld-ContribAuthor ">Yujin  Jeong</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective C−H Functionalization of Heteroarene
              N
              ‐Oxides Enabled by a Traceless Nucleophile. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (50)
                                     , 22675-22683. <a href="https://doi.org/10.1002/anie.202010597" title="DOI URL">https://doi.org/10.1002/anie.202010597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202010597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202010597%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRegioselective%252BC%2525E2%252588%252592H%252BFunctionalization%252Bof%252BHeteroarene%252BN%252B%2525E2%252580%252590Oxides%252BEnabled%252Bby%252Ba%252BTraceless%252BNucleophile%26aulast%3DMathi%26aufirst%3DGangadhar%2BRao%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D50%26spage%3D22675%26epage%3D22683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Ezugwu</span>, <span class="hlFld-ContribAuthor ">Uchechukwu C.  Okoro</span>, <span class="hlFld-ContribAuthor ">Mercy A.  Ezeokonkwo</span>, <span class="hlFld-ContribAuthor ">China R.  Bhimapaka</span>, <span class="hlFld-ContribAuthor ">Sunday N.  Okafor</span>, <span class="hlFld-ContribAuthor ">David I.  Ugwu</span>, <span class="hlFld-ContribAuthor ">Ogechi C.  Ekoh</span>, <span class="hlFld-ContribAuthor ">Solomon I.  Attah</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Leu-Val Based Dipeptide as Antimicrobial and Antimalarial Agents: Synthesis and Molecular Docking. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.583926" title="DOI URL">https://doi.org/10.3389/fchem.2020.583926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.583926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.583926%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DNovel%252BLeu-Val%252BBased%252BDipeptide%252Bas%252BAntimicrobial%252Band%252BAntimalarial%252BAgents%25253A%252BSynthesis%252Band%252BMolecular%252BDocking%26aulast%3DEzugwu%26aufirst%3DJames%2BA.%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuimu  Lin</span>, <span class="hlFld-ContribAuthor ">Chunjie  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongxia  Li</span>, <span class="hlFld-ContribAuthor ">Yongzhi  Chen</span>, <span class="hlFld-ContribAuthor ">Shouping  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Potent in vitro and in vivo antimicrobial activity of semisynthetic amphiphilic γ-mangostin derivative LS02 against Gram-positive bacteria with destructive effect on bacterial membrane. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Biomembranes</span><span> <strong>2020,</strong> <em>1862 </em>
                                    (9)
                                     , 183353. <a href="https://doi.org/10.1016/j.bbamem.2020.183353" title="DOI URL">https://doi.org/10.1016/j.bbamem.2020.183353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamem.2020.183353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamem.2020.183353%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Biomembranes%26atitle%3DPotent%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bantimicrobial%252Bactivity%252Bof%252Bsemisynthetic%252Bamphiphilic%252B%2525CE%2525B3-mangostin%252Bderivative%252BLS02%252Bagainst%252BGram-positive%252Bbacteria%252Bwith%252Bdestructive%252Beffect%252Bon%252Bbacterial%252Bmembrane%26aulast%3DLin%26aufirst%3DShuimu%26date%3D2020%26volume%3D1862%26issue%3D9%26spage%3D183353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Žiga  Skok</span>, <span class="hlFld-ContribAuthor ">Martina  Durcik</span>, <span class="hlFld-ContribAuthor ">Darja  Gramec Skledar</span>, <span class="hlFld-ContribAuthor ">Michaela  Barančoková</span>, <span class="hlFld-ContribAuthor ">Lucija  Peterlin Mašič</span>, <span class="hlFld-ContribAuthor ">Tihomir  Tomašič</span>, <span class="hlFld-ContribAuthor ">Anamarija  Zega</span>, <span class="hlFld-ContribAuthor ">Danijel  Kikelj</span>, <span class="hlFld-ContribAuthor ">Nace  Zidar</span>, <span class="hlFld-ContribAuthor ">Janez  Ilaš</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new ATP-competitive inhibitors of human DNA topoisomerase IIα through screening of bacterial topoisomerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>102 </em>, 104049. <a href="https://doi.org/10.1016/j.bioorg.2020.104049" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252BATP-competitive%252Binhibitors%252Bof%252Bhuman%252BDNA%252Btopoisomerase%252BII%2525CE%2525B1%252Bthrough%252Bscreening%252Bof%252Bbacterial%252Btopoisomerase%252Binhibitors%26aulast%3DSkok%26aufirst%3D%25C5%25BDiga%26date%3D2020%26volume%3D102%26spage%3D104049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhamad  Mustafa</span>, <span class="hlFld-ContribAuthor ">Yaser A.  Mostafa</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial Pyridazines: Synthesis, Characterization, Cytotoxicity, Substrate Promiscuity, and Molecular Docking. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2020,</strong> <em>17 </em>
                                    (6)
                                     <a href="https://doi.org/10.1002/cbdv.202000100" title="DOI URL">https://doi.org/10.1002/cbdv.202000100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.202000100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.202000100%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DAntimicrobial%252BPyridazines%25253A%252BSynthesis%25252C%252BCharacterization%25252C%252BCytotoxicity%25252C%252BSubstrate%252BPromiscuity%25252C%252Band%252BMolecular%252BDocking%26aulast%3DMustafa%26aufirst%3DMuhamad%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Nie</span>, <span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Zeng</span>, <span class="hlFld-ContribAuthor ">Qingyun  Ren</span>, <span class="hlFld-ContribAuthor ">Ji  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Isoquinoline Derivatives via Palladium‐Catalyzed C−H/C−N Bond Activation of
              N
              ‐Acyl Hydrazones with
              α
              ‐Substituted Vinyl Azides. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (6)
                                     , 1362-1369. <a href="https://doi.org/10.1002/adsc.201901394" title="DOI URL">https://doi.org/10.1002/adsc.201901394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901394%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSynthesis%252Bof%252BIsoquinoline%252BDerivatives%252Bvia%252BPalladium%2525E2%252580%252590Catalyzed%252BC%2525E2%252588%252592H%25252FC%2525E2%252588%252592N%252BBond%252BActivation%252Bof%252BN%252B%2525E2%252580%252590Acyl%252BHydrazones%252Bwith%252B%2525CE%2525B1%252B%2525E2%252580%252590Substituted%252BVinyl%252BAzides%26aulast%3DNie%26aufirst%3DBiao%26date%3D2020%26volume%3D362%26issue%3D6%26spage%3D1362%26epage%3D1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-min  Kong</span>, <span class="hlFld-ContribAuthor ">Jia-wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bing-zhi  Liu</span>, <span class="hlFld-ContribAuthor ">Guang-rong  Meng</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126901. <a href="https://doi.org/10.1016/j.bmcl.2019.126901" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126901%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B5-%252528pyridin-3-yl%252529-1H-indole-4%25252C7-diones%252Bas%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%26aulast%3DKong%26aufirst%3DKai-min%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srikanth  Gatadi</span>, <span class="hlFld-ContribAuthor ">Y.V.  Madhavi</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>. </span><span class="cited-content_cbyCitation_article-title">Promising antibacterial agents against multidrug resistant Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103252. <a href="https://doi.org/10.1016/j.bioorg.2019.103252" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103252%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPromising%252Bantibacterial%252Bagents%252Bagainst%252Bmultidrug%252Bresistant%252BStaphylococcus%252Baureus%26aulast%3DGatadi%26aufirst%3DSrikanth%26date%3D2019%26volume%3D92%26spage%3D103252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan A.  Ivanenkov</span>, <span class="hlFld-ContribAuthor ">Renat S.  Yamidanov</span>, <span class="hlFld-ContribAuthor ">Ilya A.  Osterman</span>, <span class="hlFld-ContribAuthor ">Petr V.  Sergiev</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Aladinskiy</span>, <span class="hlFld-ContribAuthor ">Anastasia V.  Aladinskaya</span>, <span class="hlFld-ContribAuthor ">Victor A.  Terentiev</span>, <span class="hlFld-ContribAuthor ">Mark S.  Veselov</span>, <span class="hlFld-ContribAuthor ">Andrey A.  Ayginin</span>, <span class="hlFld-ContribAuthor ">Dmitry A.  Skvortsov</span>, <span class="hlFld-ContribAuthor ">Katerina S.  Komarova</span>, <span class="hlFld-ContribAuthor ">Sergey V.  Sadovnikov</span>, <span class="hlFld-ContribAuthor ">Rustam  Matniyazov</span>, <span class="hlFld-ContribAuthor ">Alina A.  Sofronova</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Malyshev</span>, <span class="hlFld-ContribAuthor ">Alexey E.  Machulkin</span>, <span class="hlFld-ContribAuthor ">Rostislav A.  Petrov</span>, <span class="hlFld-ContribAuthor ">Dmitrii  Lukianov</span>, <span class="hlFld-ContribAuthor ">Svetlana  Iarovenko</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Bezrukov</span>, <span class="hlFld-ContribAuthor ">Andrey Kh.  Baymiev</span>, <span class="hlFld-ContribAuthor ">Olga A.  Dontsova</span>. </span><span class="cited-content_cbyCitation_article-title">2-Pyrazol-1-yl-thiazole derivatives as novel highly potent antibacterials. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Antibiotics</span><span> <strong>2019,</strong> <em>72 </em>
                                    (11)
                                     , 827-833. <a href="https://doi.org/10.1038/s41429-019-0211-y" title="DOI URL">https://doi.org/10.1038/s41429-019-0211-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41429-019-0211-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41429-019-0211-y%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Antibiotics%26atitle%3D2-Pyrazol-1-yl-thiazole%252Bderivatives%252Bas%252Bnovel%252Bhighly%252Bpotent%252Bantibacterials%26aulast%3DIvanenkov%26aufirst%3DYan%2BA.%26date%3D2019%26date%3D2019%26volume%3D72%26issue%3D11%26spage%3D827%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iman Dindarloo  Inaloo</span>, <span class="hlFld-ContribAuthor ">Sahar  Majnooni</span>. </span><span class="cited-content_cbyCitation_article-title">A Fe
              3
              O
              4
              @SiO
              2
              /Schiff Base/Pd Complex as an Efficient Heterogeneous and Recyclable Nanocatalyst for One-Pot Domino Synthesis of Carbamates and Unsymmetrical Ureas. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (37)
                                     , 6359-6368. <a href="https://doi.org/10.1002/ejoc.201901140" title="DOI URL">https://doi.org/10.1002/ejoc.201901140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901140%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BFe%252B3%252BO%252B4%252B%252540SiO%252B2%252B%25252FSchiff%252BBase%25252FPd%252BComplex%252Bas%252Ban%252BEfficient%252BHeterogeneous%252Band%252BRecyclable%252BNanocatalyst%252Bfor%252BOne-Pot%252BDomino%252BSynthesis%252Bof%252BCarbamates%252Band%252BUnsymmetrical%252BUreas%26aulast%3DInaloo%26aufirst%3DIman%2BDindarloo%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D37%26spage%3D6359%26epage%3D6368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Insuasty</span>, <span class="hlFld-ContribAuthor ">Serena  Carrara</span>, <span class="hlFld-ContribAuthor ">Linjing  Tang</span>, <span class="hlFld-ContribAuthor ">Craig  Forsyth</span>, <span class="hlFld-ContribAuthor ">Conor F.  Hogan</span>, <span class="hlFld-ContribAuthor ">Christopher R.  McNeill</span>, <span class="hlFld-ContribAuthor ">Steven J.  Langford</span>. </span><span class="cited-content_cbyCitation_article-title">A Family of Heterocyclic Naphthalene Diimide (NDI) Analogues: Comparing Parent Isoquinoline Diimides and Phthalazine Diimides with NDI. </span><span class="cited-content_cbyCitation_journal-name">ChemPlusChem</span><span> <strong>2019,</strong> <em>84 </em>
                                    (10)
                                     , 1638-1642. <a href="https://doi.org/10.1002/cplu.201900596" title="DOI URL">https://doi.org/10.1002/cplu.201900596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cplu.201900596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcplu.201900596%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPlusChem%26atitle%3DA%252BFamily%252Bof%252BHeterocyclic%252BNaphthalene%252BDiimide%252B%252528NDI%252529%252BAnalogues%25253A%252BComparing%252BParent%252BIsoquinoline%252BDiimides%252Band%252BPhthalazine%252BDiimides%252Bwith%252BNDI%26aulast%3DInsuasty%26aufirst%3DAlberto%26date%3D2019%26date%3D2019%26volume%3D84%26issue%3D10%26spage%3D1638%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengbo  Xu</span>, <span class="hlFld-ContribAuthor ">Shanshan  Qiao</span>, <span class="hlFld-ContribAuthor ">Song  Sun</span>, <span class="hlFld-ContribAuthor ">Jin-Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Jiang  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium-catalyzed C–H activation/annulation of amidines with 4-diazoisochroman-3-imines toward isochromeno[3,4-
              c
              ]isoquinolines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (36)
                                     , 8417-8424. <a href="https://doi.org/10.1039/C9OB01612K" title="DOI URL">https://doi.org/10.1039/C9OB01612K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01612K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01612K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRhodium-catalyzed%252BC%2525E2%252580%252593H%252Bactivation%25252Fannulation%252Bof%252Bamidines%252Bwith%252B4-diazoisochroman-3-imines%252Btoward%252Bisochromeno%25255B3%25252C4-%252Bc%252B%25255Disoquinolines%26aulast%3DXu%26aufirst%3DShengbo%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D36%26spage%3D8417%26epage%3D8424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan A.  Ivanenkov</span>, <span class="hlFld-ContribAuthor ">Renat S.  Yamidanov</span>, <span class="hlFld-ContribAuthor ">Ilya A.  Osterman</span>, <span class="hlFld-ContribAuthor ">Petr V.  Sergiev</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Aladinskiy</span>, <span class="hlFld-ContribAuthor ">Anastasia V.  Aladinskaya</span>, <span class="hlFld-ContribAuthor ">Victor A.  Terentiev</span>, <span class="hlFld-ContribAuthor ">Mark S.  Veselov</span>, <span class="hlFld-ContribAuthor ">Andrey A.  Ayginin</span>, <span class="hlFld-ContribAuthor ">Dmitry A.  Skvortsov</span>, <span class="hlFld-ContribAuthor ">Katerina S.  Komarova</span>, <span class="hlFld-ContribAuthor ">Alexey V.  Chemeris</span>, <span class="hlFld-ContribAuthor ">Alexey Kh.  Baimiev</span>, <span class="hlFld-ContribAuthor ">Alina A.  Sofronova</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Malyshev</span>, <span class="hlFld-ContribAuthor ">Alexey E.  Machulkin</span>, <span class="hlFld-ContribAuthor ">Rostislav A.  Petrov</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Bezrukov</span>, <span class="hlFld-ContribAuthor ">Gleb I.  Filkov</span>, <span class="hlFld-ContribAuthor ">Maria M.  Puchinina</span>, <span class="hlFld-ContribAuthor ">Liana F.  Zainullina</span>, <span class="hlFld-ContribAuthor ">Marina A.  Maximova</span>, <span class="hlFld-ContribAuthor ">Zulfiya R.  Zileeva</span>, <span class="hlFld-ContribAuthor ">Yulia V.  Vakhitova</span>, <span class="hlFld-ContribAuthor ">Olga A.  Dontsova</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of N-Substituted Triazolo-azetidines as Novel Antibacterials using pDualrep2 HTS Platform. </span><span class="cited-content_cbyCitation_journal-name">Combinatorial Chemistry & High Throughput Screening</span><span> <strong>2019,</strong> <em>22 </em>
                                    (5)
                                     , 346-354. <a href="https://doi.org/10.2174/1386207322666190412165316" title="DOI URL">https://doi.org/10.2174/1386207322666190412165316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1386207322666190412165316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1386207322666190412165316%26sid%3Dliteratum%253Aachs%26jtitle%3DCombinatorial%2520Chemistry%2520%2526%2520High%2520Throughput%2520Screening%26atitle%3DIdentification%252Bof%252BN-Substituted%252BTriazolo-azetidines%252Bas%252BNovel%252BAntibacterials%252Busing%252BpDualrep2%252BHTS%252BPlatform%26aulast%3DIvanenkov%26aufirst%3DYan%2BA.%26date%3D2019%26volume%3D22%26issue%3D5%26spage%3D346%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah  Narramore</span>, <span class="hlFld-ContribAuthor ">Clare E.M.  Stevenson</span>, <span class="hlFld-ContribAuthor ">Anthony  Maxwell</span>, <span class="hlFld-ContribAuthor ">David M.  Lawson</span>, <span class="hlFld-ContribAuthor ">Colin W.G.  Fishwick</span>. </span><span class="cited-content_cbyCitation_article-title">New insights into the binding mode of pyridine-3-carboxamide inhibitors of E. coli DNA gyrase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3546-3550. <a href="https://doi.org/10.1016/j.bmc.2019.06.015" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNew%252Binsights%252Binto%252Bthe%252Bbinding%252Bmode%252Bof%252Bpyridine-3-carboxamide%252Binhibitors%252Bof%252BE.%252Bcoli%252BDNA%252Bgyrase%26aulast%3DNarramore%26aufirst%3DSarah%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3546%26epage%3D3550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Panyuan  Cai</span>, <span class="hlFld-ContribAuthor ">Yimiao  He</span>, <span class="hlFld-ContribAuthor ">Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Ling  Zhong</span>, <span class="hlFld-ContribAuthor ">Shumin  Ding</span>, <span class="hlFld-ContribAuthor ">Yongjia  Shang</span>. </span><span class="cited-content_cbyCitation_article-title">Tuneable access to isoquinolines
              via
              a transition-metal-free C(sp
              3
              )–C(sp
              3
              ) bond cleavage rearrangement reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (14)
                                     , 2430-2434. <a href="https://doi.org/10.1039/C9QO00427K" title="DOI URL">https://doi.org/10.1039/C9QO00427K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO00427K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO00427K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DTuneable%252Baccess%252Bto%252Bisoquinolines%252Bvia%252Ba%252Btransition-metal-free%252BC%252528sp%252B3%252B%252529%2525E2%252580%252593C%252528sp%252B3%252B%252529%252Bbond%252Bcleavage%252Brearrangement%252Breaction%26aulast%3DWang%26aufirst%3DJian%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D14%26spage%3D2430%26epage%3D2434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ehab M.  Zayed</span>, <span class="hlFld-ContribAuthor ">Fatma A.  El-Samahy</span>, <span class="hlFld-ContribAuthor ">Gehad G.  Mohamed</span>. </span><span class="cited-content_cbyCitation_article-title">Structural, spectroscopic, molecular docking, thermal and DFT studies on metal complexes of bidentate orthoquinone ligand. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2019,</strong> <em>13 </em>, e5065. <a href="https://doi.org/10.1002/aoc.5065" title="DOI URL">https://doi.org/10.1002/aoc.5065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.5065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.5065%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DStructural%25252C%252Bspectroscopic%25252C%252Bmolecular%252Bdocking%25252C%252Bthermal%252Band%252BDFT%252Bstudies%252Bon%252Bmetal%252Bcomplexes%252Bof%252Bbidentate%252Borthoquinone%252Bligand%26aulast%3DZayed%26aufirst%3DEhab%2BM.%26date%3D2019%26date%3D2019%26volume%3D13%26spage%3De5065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. A.  Aghekyan</span>, <span class="hlFld-ContribAuthor ">G. G.  Mkryan</span>, <span class="hlFld-ContribAuthor ">H. A.  Panosyan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of New 2′-(2- and 3-Aminopropanoyl)-6′,7′-dimethoxy-2′,3′-dihydro-1′H-spiro[cyclopentane-1,4′-isoquinoline]-1′-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>55 </em>
                                    (3)
                                     , 302-307. <a href="https://doi.org/10.1134/S1070428019030047" title="DOI URL">https://doi.org/10.1134/S1070428019030047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428019030047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428019030047%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNew%252B2%2525E2%252580%2525B2-%2525282-%252Band%252B3-Aminopropanoyl%252529-6%2525E2%252580%2525B2%25252C7%2525E2%252580%2525B2-dimethoxy-2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2-dihydro-1%2525E2%252580%2525B2H-spiro%25255Bcyclopentane-1%25252C4%2525E2%252580%2525B2-isoquinoline%25255D-1%2525E2%252580%2525B2-carboxamides%26aulast%3DAghekyan%26aufirst%3DA.%2BA.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D3%26spage%3D302%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long‐Yong  Xie</span>, <span class="hlFld-ContribAuthor ">Sha  Peng</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Jin‐Yu  Yi</span>, <span class="hlFld-ContribAuthor ">Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Zilong  Tang</span>, <span class="hlFld-ContribAuthor ">Xinhua  Xu</span>, <span class="hlFld-ContribAuthor ">Wei‐Min  He</span>. </span><span class="cited-content_cbyCitation_article-title">Metal‐free Deoxygenative 2‐Amidation of Quinoline
              N
              ‐oxides with Nitriles via a Radical Activation Pathway. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (21)
                                     , 4259-4264. <a href="https://doi.org/10.1002/adsc.201800918" title="DOI URL">https://doi.org/10.1002/adsc.201800918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800918%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DMetal%2525E2%252580%252590free%252BDeoxygenative%252B2%2525E2%252580%252590Amidation%252Bof%252BQuinoline%252BN%252B%2525E2%252580%252590oxides%252Bwith%252BNitriles%252Bvia%252Ba%252BRadical%252BActivation%252BPathway%26aulast%3DXie%26aufirst%3DLong%25E2%2580%2590Yong%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D21%26spage%3D4259%26epage%3D4264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soo Yei  Ho</span>, <span class="hlFld-ContribAuthor ">Weiling  Wang</span>, <span class="hlFld-ContribAuthor ">Fui Mee  Ng</span>, <span class="hlFld-ContribAuthor ">Yun Xuan  Wong</span>, <span class="hlFld-ContribAuthor ">Zhi Ying  Poh</span>, <span class="hlFld-ContribAuthor ">Sum Wai Eldwin  Tan</span>, <span class="hlFld-ContribAuthor ">Shi Hua  Ang</span>, <span class="hlFld-ContribAuthor ">Si Si  Liew</span>, <span class="hlFld-ContribAuthor ">Yin Sze  Joyner Wong</span>, <span class="hlFld-ContribAuthor ">Yvonne  Tan</span>, <span class="hlFld-ContribAuthor ">Anders  Poulsen</span>, <span class="hlFld-ContribAuthor ">Vishal  Pendharkar</span>, <span class="hlFld-ContribAuthor ">Kanda  Sangthongpitag</span>, <span class="hlFld-ContribAuthor ">John  Manchester</span>, <span class="hlFld-ContribAuthor ">Gregory  Basarab</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hill</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Keller</span>, <span class="hlFld-ContribAuthor ">Joseph  Cherian</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 610-621. <a href="https://doi.org/10.1016/j.ejmech.2018.08.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bdual%252BGyrB%25252FParE%252Binhibitors%252Bactive%252Bagainst%252BGram-negative%252Bbacteria%26aulast%3DHo%26aufirst%3DSoo%2BYei%26date%3D2018%26volume%3D157%26spage%3D610%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clement  Opoku-Temeng</span>, <span class="hlFld-ContribAuthor ">George A.  Naclerio</span>, <span class="hlFld-ContribAuthor ">Haroon  Mohammad</span>, <span class="hlFld-ContribAuthor ">Neetu  Dayal</span>, <span class="hlFld-ContribAuthor ">Nader S.  Abutaleb</span>, <span class="hlFld-ContribAuthor ">Mohamed N.  Seleem</span>, <span class="hlFld-ContribAuthor ">Herman O.  Sintim</span>. </span><span class="cited-content_cbyCitation_article-title">N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 797-805. <a href="https://doi.org/10.1016/j.ejmech.2018.06.023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.06.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.06.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-%2525281%25252C3%25252C4-oxadiazol-2-yl%252529benzamide%252Banalogs%25252C%252Bbacteriostatic%252Bagents%252Bagainst%252Bmethicillin-%252Band%252Bvancomycin-resistant%252Bbacteria%26aulast%3DOpoku-Temeng%26aufirst%3DClement%26date%3D2018%26volume%3D155%26spage%3D797%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiong  Jin</span>, <span class="hlFld-ContribAuthor ">Dong  Yang</span>, <span class="hlFld-ContribAuthor ">Zhi  Dai</span>, <span class="hlFld-ContribAuthor ">Afsar  Khan</span>, <span class="hlFld-ContribAuthor ">Bei  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Ying  Sun</span>, <span class="hlFld-ContribAuthor ">Yun-Li  Zhao</span>, <span class="hlFld-ContribAuthor ">Yi-Fen  Wang</span>, <span class="hlFld-ContribAuthor ">Ya-Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Xu-Dong  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiao-Dong  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor aporphine alkaloids from Thalictrum wangii. </span><span class="cited-content_cbyCitation_journal-name">Fitoterapia</span><span> <strong>2018,</strong> <em>128 </em>, 204-212. <a href="https://doi.org/10.1016/j.fitote.2018.05.012" title="DOI URL">https://doi.org/10.1016/j.fitote.2018.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fitote.2018.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fitote.2018.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DFitoterapia%26atitle%3DAntitumor%252Baporphine%252Balkaloids%252Bfrom%252BThalictrum%252Bwangii%26aulast%3DJin%26aufirst%3DQiong%26date%3D2018%26volume%3D128%26spage%3D204%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michaela  Barančoková</span>, <span class="hlFld-ContribAuthor ">Danijel  Kikelj</span>, <span class="hlFld-ContribAuthor ">Janez  Ilaš</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in the discovery and development of DNA gyrase B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (10)
                                     , 1207-1227. <a href="https://doi.org/10.4155/fmc-2017-0257" title="DOI URL">https://doi.org/10.4155/fmc-2017-0257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0257%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bthe%252Bdiscovery%252Band%252Bdevelopment%252Bof%252BDNA%252Bgyrase%252BB%252Binhibitors%26aulast%3DBaran%25C4%258Dokov%25C3%25A1%26aufirst%3DMichaela%26date%3D2018%26volume%3D10%26issue%3D10%26spage%3D1207%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh  Kumar</span>, <span class="hlFld-ContribAuthor ">Gaurav  Kumar</span>, <span class="hlFld-ContribAuthor ">Amit Kumar  Tripathi</span>, <span class="hlFld-ContribAuthor ">Sahadevan  Seena</span>, <span class="hlFld-ContribAuthor ">Joonseok  Koh</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced fluorescence norfloxacin substituted naphthalimide derivatives: Molecular docking and antibacterial activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2018,</strong> <em>1157 </em>, 292-299. <a href="https://doi.org/10.1016/j.molstruc.2017.12.067" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.12.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.12.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.12.067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DEnhanced%252Bfluorescence%252Bnorfloxacin%252Bsubstituted%252Bnaphthalimide%252Bderivatives%25253A%252BMolecular%252Bdocking%252Band%252Bantibacterial%252Bactivity%26aulast%3DKumar%26aufirst%3DSantosh%26date%3D2018%26volume%3D1157%26spage%3D292%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan-Chen  Pan</span>, <span class="hlFld-ContribAuthor ">Jian-Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Study on the iodine-catalyzed reaction of 3-aminopyrazine-2-carbohydrazide and 2-(arylethynyl)benzaldehydes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (13)
                                     , 1468-1475. <a href="https://doi.org/10.1016/j.tet.2018.02.007" title="DOI URL">https://doi.org/10.1016/j.tet.2018.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DStudy%252Bon%252Bthe%252Biodine-catalyzed%252Breaction%252Bof%252B3-aminopyrazine-2-carbohydrazide%252Band%252B2-%252528arylethynyl%252529benzaldehydes%26aulast%3DPan%26aufirst%3DWan-Chen%26date%3D2018%26volume%3D74%26issue%3D13%26spage%3D1468%26epage%3D1475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinghua  Chen</span>, <span class="hlFld-ContribAuthor ">Mei  Peng</span>, <span class="hlFld-ContribAuthor ">Hao  Huang</span>, <span class="hlFld-ContribAuthor ">Yangfan  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Tao</span>, <span class="hlFld-ContribAuthor ">Chunlian  He</span>, <span class="hlFld-ContribAuthor ">Yi  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">TsOH·H
              2
              O-mediated
              N
              -amidation of quinoline
              N
              -oxides: facile and regioselective synthesis of
              N
              -(quinolin-2-yl)amides. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (34)
                                     , 6202-6205. <a href="https://doi.org/10.1039/C8OB00862K" title="DOI URL">https://doi.org/10.1039/C8OB00862K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB00862K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB00862K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DTsOH%2525C2%2525B7H%252B2%252BO-mediated%252BN%252B-amidation%252Bof%252Bquinoline%252BN%252B-oxides%25253A%252Bfacile%252Band%252Bregioselective%252Bsynthesis%252Bof%252BN%252B-%252528quinolin-2-yl%252529amides%26aulast%3DChen%26aufirst%3DXinghua%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D34%26spage%3D6202%26epage%3D6205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian-Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Dong</span>, <span class="hlFld-ContribAuthor ">Wen-Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of quinazoline or pyrrolo[1,2-a]quinazolin-5(1H)-one derivatives in ionic liquids catalyzed by iodine. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (12)
                                     , 6787-6801. <a href="https://doi.org/10.1007/s11164-017-3020-6" title="DOI URL">https://doi.org/10.1007/s11164-017-3020-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-017-3020-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-017-3020-6%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252Bquinazoline%252Bor%252Bpyrrolo%25255B1%25252C2-a%25255Dquinazolin-5%2525281H%252529-one%252Bderivatives%252Bin%252Bionic%252Bliquids%252Bcatalyzed%252Bby%252Biodine%26aulast%3DLiu%26aufirst%3DJian-Quan%26date%3D2017%26date%3D2017%26volume%3D43%26issue%3D12%26spage%3D6787%26epage%3D6801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.L.  Obasi</span>, <span class="hlFld-ContribAuthor ">G.U.  Kaior</span>, <span class="hlFld-ContribAuthor ">A.  Ibezim</span>, <span class="hlFld-ContribAuthor ">Alfred E.  Ochonogor</span>, <span class="hlFld-ContribAuthor ">Lydia  Rhyman</span>, <span class="hlFld-ContribAuthor ">Veikko  Uahengo</span>, <span class="hlFld-ContribAuthor ">Michael  Lutter</span>, <span class="hlFld-ContribAuthor ">Klaus  Jurkschat</span>, <span class="hlFld-ContribAuthor ">Ponnadurai  Ramasami</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, antimicrobial screening and in silico studies of Schiff bases derived from trans- para -methoxycinnamaldehyde. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1149 </em>, 8-16. <a href="https://doi.org/10.1016/j.molstruc.2017.07.097" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.07.097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.07.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.07.097%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Bantimicrobial%252Bscreening%252Band%252Bin%252Bsilico%252Bstudies%252Bof%252BSchiff%252Bbases%252Bderived%252Bfrom%252Btrans-%252Bpara%252B-methoxycinnamaldehyde%26aulast%3DObasi%26aufirst%3DN.L.%26date%3D2017%26volume%3D1149%26spage%3D8%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenke  Qi</span>, <span class="hlFld-ContribAuthor ">Yimei  Wu</span>, <span class="hlFld-ContribAuthor ">Yongxu  Han</span>, <span class="hlFld-ContribAuthor ">Yi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Isoquinolinones via Regioselective Palladium-Catalyzed C–H Activation/Annulation. </span><span class="cited-content_cbyCitation_journal-name">Catalysts</span><span> <strong>2017,</strong> <em>7 </em>
                                    (11)
                                     , 320. <a href="https://doi.org/10.3390/catal7110320" title="DOI URL">https://doi.org/10.3390/catal7110320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/catal7110320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcatal7110320%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysts%26atitle%3DSynthesis%252Bof%252BIsoquinolinones%252Bvia%252BRegioselective%252BPalladium-Catalyzed%252BC%2525E2%252580%252593H%252BActivation%25252FAnnulation%26aulast%3DQi%26aufirst%3DWenke%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D11%26spage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Jin  Zhou</span>, <span class="hlFld-ContribAuthor ">Xue  Tang</span>, <span class="hlFld-ContribAuthor ">Yang  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Bo  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Drug design based on pentaerythritol tetranitrate reductase: synthesis and antibacterial activity of Pogostone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (31)
                                     , 6548-6556. <a href="https://doi.org/10.1039/C7OB01429E" title="DOI URL">https://doi.org/10.1039/C7OB01429E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01429E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01429E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDrug%252Bdesign%252Bbased%252Bon%252Bpentaerythritol%252Btetranitrate%252Breductase%25253A%252Bsynthesis%252Band%252Bantibacterial%252Bactivity%252Bof%252BPogostone%252Bderivatives%26aulast%3DWang%26aufirst%3DBiao%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D31%26spage%3D6548%26epage%3D6556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of novobiocin <b>1</b>, benzimidazole urea <b>2</b>, and schematic representation of the H-bond network involving the conserved Asp73 residue and water molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reaction scheme for producing ethyl ureas <b>3</b> from respective amines <b>4</b>. Estimated IC<sub>50</sub>s and LEs for <i>E. coli</i> gyrase ATPase inhibition are shown for selected derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-Ethyl Urea Isoquinoline Intermediates <b>21a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>17</b>, MeOH, rt–70 °C, 2–23 h. (b) H<sub>2</sub>SO<sub>4</sub>, rt–80 °C, 3–22 h. (c) EtNCO, dioxane, 50 °C, 1–6 days; or EtNCO, pyridine, 65 °C, 42 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Derivatives <b>22</b>–<b>28</b>, <b>30</b>, and <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Me<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>·DCM, THF, 80 °C, 22 h. (b) py-3-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 4 h. (c) R<sup>5</sup>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90–110 °C, 2–4 h. (d) bis(neopentyl glycolato)diboron, KOAc, Pd(dppf)Cl<sub>2</sub>·DCM, DMSO, 90 °C, 2 h. (e) R<sup>5</sup>Br, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90–110 °C, 2–4 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of R<sup>8</sup>-Heteroaryl Derivatives <b>33</b>, <b>36</b>, <b>37</b>, <b>39</b>, and <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) py-4-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, 2 h. (b) py-3-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, 3 h. (c) ArNH<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, NaO<i>t</i>Bu, dioxane, 90 °C, 2–4 h. (d) 2-R-py-4-B(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 2–3 h. (e) TFA, rt, 2 h. (f) py-3-OH, CuI, <i>N</i>,<i>N</i>-dimethylGly, K<sub>3</sub>PO<sub>4</sub>, DMSO, 90 °C, 23 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of R<sup>8</sup>-Heteroaryl Derivatives <b>46</b>–<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CO (5 atm), Pd(dppf)Cl<sub>2</sub>·DCM, NaOAc, MeOH, 60 °C, 7 h. (b) LAH, THF, −40 °C, 5 h. (c) 2-Me-py-4-B(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 90 °C, 3 h. (d) (1) CDI, DIPEA, DMF, 40 °C, 4 h; (2) morpholine, DIPEA, DCM, rt, 18 h. (e) ArB(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 90 °C, 5–10 h. (f) 1<i>H</i>-1,2,3-triazole, PPh<sub>3</sub>, DIAD, THF, 0 °C to rt, 3 h.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of R<sup>8</sup>-Carbamate and Amide Derivatives <b>50</b>–<b>54</b> and <b>57</b>–<b>67</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) DPPA, DBU, THF, rt, 3 h; (2) PPh<sub>3</sub>, water, rt, 2 h. (b) R<sup>8</sup>OCOCl, Et<sub>3</sub>N, DCM, rt, 18 h. (c) (1) R<sup>8</sup>OH, CDI, DIPEA, DCM, rt, 3 h; (2) <b>49</b>, DIPEA, DMF, rt, 18 h. (d) 2-Me-py-4-B(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 90 °C, 2–3 h. (e) HCl, dioxane, rt, 2 h. (f) py-4-B(OH)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 1 h. (g) TFA, DCM, rt, 1 h. (h) (1) pivaldehyde, 1:1 DCE/MeOH, rt, 16 h; (2) NaBH<sub>4</sub>, rt, 4 h. (i) (1) R<sup>8</sup>OH, CDI, DIPEA, DCM, rt, 3 h; (2) <b>55</b> or <b>56</b>, DIPEA, NMP, rt, 18 h. (j) TFA, 10:1 THF/water, rt, 1 h. (k) R<sup>8</sup>COOH, T3P, DIPEA, DMF, rt, 18 h.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Phosphoryloxymethyl Prodrug <b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) NaI, DCM, rt, 72 h; (2) TFA, 0 °C, 3 h.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of R<sup>8</sup>-Carbamate Derivatives <b>69</b>–<b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) CDI, DIPEA, DMF, 40 °C, 4 h; (2) R<sup>8</sup>NH<sub>2</sub>, DIPEA, DCM, rt–40 °C, 18–70 h. (b) TFA, DCM, rt, 1 h. (c) HCl, dioxane, rt, 2 h.</p></p></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of <b>27</b> (yellow) bound to <i>E. coli</i> GyrB 24 kDa (gray). Residues 77–98 have been omitted for clarity. Residues engaged in key interactions (Asp73 and Val120) are represented in stick format. Hydrogen bonds are displayed as black dotted lines, and water molecules appear as red balls. PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMN">5MMN</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Crystal structure of <b>36</b> (yellow) in <i>E. coli</i> GyrB 24 kDa (gray). Residues 77–98 have been omitted for clarity. Residues engaged in key interactions (Val120, Asp73, Glu50, and Arg76) are represented in stick format. Hydrogen bonds are displayed as black dotted lines, and water molecules appear as red balls. PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMP">5MMP</a>. (B) Side view of <b>36</b>. (C) Crystal structure of <b>58</b> (yellow) in <i>E. coli</i> GyrB 24 kDa (gray). PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMO">5MMO</a>. (D) Side view of <b>58</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structure of prodrug <b>68</b> at physiological pH and half-lives upon incubation in blood in vitro.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/medium/jm-2016-01834g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Oral efficacy in a 24 h neutropenic murine thigh infection model with <i>S. aureus</i> A-1178. Mice were treated orally at 40 and 120 mg/kg (1q22h for linezolid and 4q5.5h for <b>50</b>) starting at 2 h post-infection and sacrificed at 24 h post-infection. Bars and error bars represent median and interquartile ranges.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.6b01834/20170505/images/large/jm-2016-01834g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01834&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i132">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">CDC</span><span class="NLM_x">. </span> <span class="citation_source-book">Antibiotic Resistance Threats in the United States</span>; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>. <a href="https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf" class="extLink">https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf</a> (accessed Dec 5,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=CDC&title=Antibiotic+Resistance+Threats+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DAntibiotic%2520Resistance%2520Threats%2520in%2520the%2520United%2520States%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hooper, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacoby, G. A.</span><span> </span><span class="NLM_article-title">Topoisomerase inhibitors: Fluoroquinolone mechanisms of action and resistance</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">a025320</span><span class="refDoi"> DOI: 10.1101/cshperspect.a025320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1101%2Fcshperspect.a025320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=27449972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1ylsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=a025320&author=D.+C.+Hooperauthor=G.+A.+Jacoby&title=Topoisomerase+inhibitors%3A+Fluoroquinolone+mechanisms+of+action+and+resistance&doi=10.1101%2Fcshperspect.a025320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance</span></div><div class="casAuthors">Hooper, David C.; Jacoby, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">a025320/1-a025320/22</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Quinolone antimicrobials are widely used in clin. medicine and are the only current class of agents that directly inhibit bacterial DNA synthesis.  Quinolones dually target DNA gyrase and topoisomerase IV binding to specific domains and conformations so as to block DNA strand passage catalysis and stabilize DNA -enzyme complexes that block the DNA replication app. and generate double breaks in DNA that underlie their bactericidal activity.  Resistance has emerged with clin. use of these agents and is common in some bacterial pathogens.  Mechanisms of resistance include mutational alterations in drug target affinity and efflux pump expression and acquisition of resistance-conferring genes.  Resistance mutations in one or both of the two drug target enzymes are commonly in a localized domain of the GyrA and ParC subunits of gyrase and topoisomerase IV, resp., and reduce drug binding to the enzyme-DNA complex.  Other resistance mutations occur in regulatory genes that control the expression of native efflux pumps localized in the bacterial membrane(s).  These pumps have broad substrate profiles that include other antimicrobials as well as quinolones.  Mutations of both types can accumulate with selection pressure and produce highly resistant strains.  Resistance genes acquired on plasmids confer low-level resistance that promotes the selection of mutational high-level resistance.  Plasmid-encoded resistance is because of Qnr proteins that protect the target enzymes from quinolone action, a mutant aminoglycoside-modifying enzyme that also modifies certain quinolones, and mobile efflux pumps.  Plasmids with these mechanisms often encode addnl. antimicrobial resistances and can transfer multidrug resistance that includes quinolones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJX0P7_nTppbVg90H21EOLACvtfcHk0lizen1_IwNy6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1ylsLo%253D&md5=2dfb6502bdbdbb004e33668cd4641e2b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025320%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DD.%2BC.%26aulast%3DJacoby%26aufirst%3DG.%2BA.%26atitle%3DTopoisomerase%2520inhibitors%253A%2520Fluoroquinolone%2520mechanisms%2520of%2520action%2520and%2520resistance%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2016%26volume%3D6%26spage%3Da025320%26doi%3D10.1101%2Fcshperspect.a025320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Liu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, B. M.</span><span> </span><span class="NLM_article-title">Type II DNA topoisomerases: Enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span><span class="refDoi"> DOI: 10.1016/S0092-8674(80)80046-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2FS0092-8674%2880%2980046-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=6244895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADyaL3cXhslKntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1980&pages=697-707&author=L.+F.+Liuauthor=C.-C.+Liuauthor=B.+M.+Alberts&title=Type+II+DNA+topoisomerases%3A+Enzymes+that+can+unknot+a+topologically+knotted+DNA+molecule+via+a+reversible+double-strand+break&doi=10.1016%2FS0092-8674%2880%2980046-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Type II DNA topoisomerases. enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break</span></div><div class="casAuthors">Liu, Leroy F.; Liu, Chung-Cheng; Alberts, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">697-707</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Phage T4 DNA topoisomerase (I) is a multisubunit protein that appears to have an essential role in the initiation of T4 bacteriophage DNA replication.  Treatment of double-stranded (ds) circular DNA with large amts. of I in the absence of ATP yielded new DNA species which were knotted topol. isomers of the ds DNA circle.  These knotted DNA circles, whether covalently closed or nicked, were converted to unknotted circles by treatment with trace amts. of I in the presence of ATP.  Very similar ATP-dependent enzyme activities capable of unknotting DNA were present in exts. of Drosophila and Xenopus laevis eggs and in CHO cultures.  The prokaryotic enzyzme, DNA gyrase, was also capable of unknotting DNA.  These unknotting enzymes are proposed to constitute a new general class of I (type II I).  These enzymes must act via mechanisms that involve the concerted cleavage and rejoining of 2 opposite DNA strands, such that the DNA double helix is transiently broken.  The passage of a second ds DNA segment through this reversible ds break results in a variety of DNA topoisomerization reactions, including relaxation:supercoiling; knotting:unknotting, and catenation:decatenation.  In support of this type of mechanism, T4 I was shown to change the linking no. of a covalently closed ds circular DNA mol. only by multiples of 2.  Possible roles of such enzymes in a variety of biol. functions, along with their probable mol. mechanisms, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruCiIrcBArerVg90H21EOLACvtfcHk0lizen1_IwNy6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhslKntb0%253D&md5=7cc5d068e9a4fa02fb2204bc266b68a2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2880%2980046-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252880%252980046-8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DLiu%26aufirst%3DC.-C.%26aulast%3DAlberts%26aufirst%3DB.%2BM.%26atitle%3DType%2520II%2520DNA%2520topoisomerases%253A%2520Enzymes%2520that%2520can%2520unknot%2520a%2520topologically%2520knotted%2520DNA%2520molecule%2520via%2520a%2520reversible%2520double-strand%2520break%26jtitle%3DCell%26date%3D1980%26volume%3D19%26spage%3D697%26epage%3D707%26doi%3D10.1016%2FS0092-8674%2880%2980046-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Sissi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, M.</span><span> </span><span class="NLM_article-title">In front of and behind the replication fork: Bacterial type IIa topoisomerases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2001</span><span class="NLM_x">–</span> <span class="NLM_lpage">2024</span><span class="refDoi"> DOI: 10.1007/s00018-010-0299-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1007%2Fs00018-010-0299-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=20165898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFyrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=2001-2024&author=C.+Sissiauthor=M.+Palumbo&title=In+front+of+and+behind+the+replication+fork%3A+Bacterial+type+IIa+topoisomerases&doi=10.1007%2Fs00018-010-0299-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In front of and behind the replication fork: bacterial type IIA topoisomerases</span></div><div class="casAuthors">Sissi, Claudia; Palumbo, Manlio</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2001-2024</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Topoisomerases are vital enzymes specialized in controlling DNA topol., in particular supercoiling and decatenation, to properly handle nucleic acid packing and cell dynamics.  The type IIA enzymes act by cleaving both strands of a double helix and having another strand from the same or another mol. cross the DNA gate before a re-sealing event completes the catalytic cycle.  Here, we will consider the two types of IIA prokaryotic topoisomerases, DNA Gyrase and Topoisomerase IV, as crucial regulators of bacterial cell cycle progression.  Their synergistic action allows control of chromosome packing and grants occurrence of functional transcription and replication processes.  In addn. to displaying a fascinating mol. mechanism of action, which transduces chem. energy into mech. energy by means of large conformational changes, these enzymes represent attractive pharmacol. targets for antibacterial chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ESOZ27csO7Vg90H21EOLACvtfcHk0lizen1_IwNy6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFyrurg%253D&md5=beddf7151ca953f43ced56b17baa9f7c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00018-010-0299-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-010-0299-5%26sid%3Dliteratum%253Aachs%26aulast%3DSissi%26aufirst%3DC.%26aulast%3DPalumbo%26aufirst%3DM.%26atitle%3DIn%2520front%2520of%2520and%2520behind%2520the%2520replication%2520fork%253A%2520Bacterial%2520type%2520IIa%2520topoisomerases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2010%26volume%3D67%26spage%3D2001%26epage%3D2024%26doi%3D10.1007%2Fs00018-010-0299-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bush, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans-Roberts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, A.</span><span> </span><span class="NLM_article-title">DNA topoisomerases</span> <span class="citation_source-journal">EcoSal Plus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="refDoi"> DOI: 10.1128/ecosalplus.ESP-0010-2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2Fecosalplus.ESP-0010-2014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6&author=N.+G.+Bushauthor=K.+Evans-Robertsauthor=A.+Maxwell&title=DNA+topoisomerases&doi=10.1128%2Fecosalplus.ESP-0010-2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2Fecosalplus.ESP-0010-2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fecosalplus.ESP-0010-2014%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DN.%2BG.%26aulast%3DEvans-Roberts%26aufirst%3DK.%26aulast%3DMaxwell%26aufirst%3DA.%26atitle%3DDNA%2520topoisomerases%26jtitle%3DEcoSal%2520Plus%26date%3D2015%26volume%3D6%26spage%3D6%26doi%3D10.1128%2Fecosalplus.ESP-0010-2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span> </span><span class="NLM_article-title">DNA topoisomerases and their poisoning by anticancer and antibacterial drugs</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2010.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2Fj.chembiol.2010.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=20534341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=421-433&author=Y.+Pommierauthor=E.+Leoauthor=H.+Zhangauthor=C.+Marchand&title=DNA+topoisomerases+and+their+poisoning+by+anticancer+and+antibacterial+drugs&doi=10.1016%2Fj.chembiol.2010.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs</span></div><div class="casAuthors">Pommier, Yves; Leo, Elisabetta; Zhang, Hong-Liang; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-433</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  DNA topoisomerases are the targets of important anticancer and antibacterial drugs.  Camptothecins and novel noncamptothecins in clin. development (indenoisoquinolines and ARC-111) target eukaryotic type IB topoisomerases (Top1), whereas human type IIA topoisomerases (Top2α and Top2β) are the targets of the widely used anticancer agents etoposide, anthracyclines (doxorubicin, daunorubicin), and mitoxantrone.  Bacterial type II topoisomerases (gyrase and Topo IV) are the targets of quinolones and aminocoumarin antibiotics.  This review focuses on the mol. and biochem. characteristics of topoisomerases and their inhibitors.  We also discuss the common mechanism of action of topoisomerase poisons by interfacial inhibition and trapping of topoisomerase cleavage complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr6m1st3bchbVg90H21EOLACvtfcHk0ljQk2bJ3-C64Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslCjsLY%253D&md5=ab00ffa6d0e8bf0c433b154e2a4b484a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DLeo%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DDNA%2520topoisomerases%2520and%2520their%2520poisoning%2520by%2520anticancer%2520and%2520antibacterial%2520drugs%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D421%26epage%3D433%26doi%3D10.1016%2Fj.chembiol.2010.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Collin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karkare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, A.</span><span> </span><span class="NLM_article-title">Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives</span> <span class="citation_source-journal">Appl. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1007/s00253-011-3557-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1007%2Fs00253-011-3557-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=21904817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yhurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2011&pages=479-497&author=F.+Collinauthor=S.+Karkareauthor=A.+Maxwell&title=Exploiting+bacterial+DNA+gyrase+as+a+drug+target%3A+Current+state+and+perspectives&doi=10.1007%2Fs00253-011-3557-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting bacterial DNA gyrase as a drug target: current state and perspectives</span></div><div class="casAuthors">Collin, Frederic; Karkare, Shantanu; Maxwell, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Applied Microbiology and Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">479-497</span>CODEN:
                <span class="NLM_cas:coden">AMBIDG</span>;
        ISSN:<span class="NLM_cas:issn">0175-7598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  DNA gyrase is a type II topoisomerase that can introduce neg. supercoils into DNA at the expense of ATP hydrolysis.  It is essential in all bacteria but absent from higher eukaryotes, making it an attractive target for antibacterials.  The fluoroquinolones are examples of very successful gyrase-targeted drugs, but the rise in bacterial resistance to these agents means that the authors not only need to seek new compds., but also new modes of inhibition of this enzyme.  The authors review known gyrase-specific drugs and toxins and assess the prospects for developing new antibacterials targeted to this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFeiVFp1eOYrVg90H21EOLACvtfcHk0ljQk2bJ3-C64Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yhurrF&md5=9bd1603bbe55c389ca99eb8c14e26c63</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00253-011-3557-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00253-011-3557-z%26sid%3Dliteratum%253Aachs%26aulast%3DCollin%26aufirst%3DF.%26aulast%3DKarkare%26aufirst%3DS.%26aulast%3DMaxwell%26aufirst%3DA.%26atitle%3DExploiting%2520bacterial%2520DNA%2520gyrase%2520as%2520a%2520drug%2520target%253A%2520Current%2520state%2520and%2520perspectives%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2011%26volume%3D92%26spage%3D479%26epage%3D497%26doi%3D10.1007%2Fs00253-011-3557-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">East, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, L. L.</span><span> </span><span class="NLM_article-title">Multitarget ligands in antibacterial research: Progress and opportunities</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1517/17460441.2013.743991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1517%2F17460441.2013.743991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=23252414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=143-156&author=S.+P.+Eastauthor=L.+L.+Silver&title=Multitarget+ligands+in+antibacterial+research%3A+Progress+and+opportunities&doi=10.1517%2F17460441.2013.743991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget ligands in antibacterial research: progress and opportunities</span></div><div class="casAuthors">East, Stephen P.; Silver, Lynn L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-156</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Resistance to current antibacterial therapies is an inevitability that represents a significant global health concern.  Bacteria have the capacity to render all current drug treatments ineffective, which places a demand on the drug discovery community to constantly develop new antibacterial agents.  Compds. that inhibit multiple biol. targets, often referred to as multitarget ligands, are an inviting prospect in antibacterial research because, although they will not solve the issue of resistance, they might help to delay the onset. Areas covered: This review covers some of the recent progress in identifying new ligands that deliberately interact with more than one essential biol. target in bacteria.  The two principal areas covered are inhibitors of DNA replication and cell wall biosynthesis. Expert opinion: Antibacterial programs for the design of multitarget ligands present an important opportunity for prodn. of antibacterial agents.  Their longevity, due to slow development of resistance, is comparable to that seen with other successful agents - but is much improved over single-targeted agents for which resistance can appear in vitro overnight.  The preclin. development of these agents will have to overcome the std. problems of antibacterial discovery.  Such problems include optimization of characteristics favoring cell entry and particularly the demonstration of selectivity of inhibition of the desired multiple targets without inhibition of other bacterial or any mammalian functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbhpbYgIA8HrVg90H21EOLACvtfcHk0li4mLy7a5NteQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cku74%253D&md5=2b335d54e579d210ab9a1220ea2d6a57</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.743991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.743991%26sid%3Dliteratum%253Aachs%26aulast%3DEast%26aufirst%3DS.%2BP.%26aulast%3DSilver%26aufirst%3DL.%2BL.%26atitle%3DMultitarget%2520ligands%2520in%2520antibacterial%2520research%253A%2520Progress%2520and%2520opportunities%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D143%26epage%3D156%26doi%3D10.1517%2F17460441.2013.743991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sugino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peebles, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzarelli, N. R.</span><span> </span><span class="NLM_article-title">Energy coupling in DNA gyrase and the mechanism of action of novobiocin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">4838</span><span class="NLM_x">–</span> <span class="NLM_lpage">4842</span><span class="refDoi"> DOI: 10.1073/pnas.75.10.4838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1073%2Fpnas.75.10.4838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=368801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADyaE1MXjsFSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1978&pages=4838-4842&author=A.+Suginoauthor=N.+P.+Higginsauthor=P.+O.+Brownauthor=C.+L.+Peeblesauthor=N.+R.+Cozzarelli&title=Energy+coupling+in+DNA+gyrase+and+the+mechanism+of+action+of+novobiocin&doi=10.1073%2Fpnas.75.10.4838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Energy coupling in DNA gyrase and the mechanism of action of novobiocin</span></div><div class="casAuthors">Sugino, Akio; Higgins, N. Patrick; Brown, Patrick O.; Peebles, Craig L.; Cozzarelli, Nicholas R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4838-42</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Escherichia coli DNA gyrase (I) catalyzes neg. supercoiling of closed duplex DNA at the expense of ATP.  Two addnl. activities of the enzyme that have illuminated the energy coupling component of the supercoiling reaction are the DNA-dependent hydrolysis of ATP to ADP and inorg. phosphate and the alteration by ATP of the DNA site specificity of the I cleavage reaction.  This cleavage of both DNA strands results from treatment with Na dodecyl sulfate of the stable I-DNA complex that is trapped by the inhibitor, oxolinic acid.  Either ATP or a nonhydrolyzable analog, adenyl-5'-yl-imidodiphosphate (II), shifts the primary cleavage site on ColE1 DNA.  The prevention by novobiocin and coumermycin A1 of this cleavage rearrangement places the site of action of the antibiotics at a reaction step prior to ATP hydrolysis.  The step blocked is the binding of ATP because coumermycin A1 and novobiocin interact competitively with ATP in the ATPase and supercoiling assays; the Ki values are >4 orders of magnitude less than the Km for ATP.  This simple mechanism accounts for all effects of the drugs on I.  Studies with II, another potent competitive inhibitor of reactions catalyzed by I show that cleavage of a high-energy bond is not required for driving DNA into the higher-energy supercoiled form.  With substrate levels of I, II induces supercoiling that is proportional to the amt. of enzyme; a -0.3 superhelical turn was introduced per gyrase promoter A.  Apparently, ATP and II are allosteric effectors of a conformational change of I that leads to 1 round of supercoiling.  Nucleotide dissocn. favored by hydrolysis of ATP returns I to its original conformation and thereby permits enzyme turnover.  Such cyclic conformational changes accompanying alteration in nucleotide affinity also seem to be a common feature of energy transduction in other diverse processes including muscle contraction, protein synthesis, and oxidative phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2xXSnmkXv-LVg90H21EOLACvtfcHk0li4mLy7a5NteQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXjsFSrtQ%253D%253D&md5=9b2e96025197d93bddc51c55e79cf496</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.75.10.4838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.75.10.4838%26sid%3Dliteratum%253Aachs%26aulast%3DSugino%26aufirst%3DA.%26aulast%3DHiggins%26aufirst%3DN.%2BP.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DPeebles%26aufirst%3DC.%2BL.%26aulast%3DCozzarelli%26aufirst%3DN.%2BR.%26atitle%3DEnergy%2520coupling%2520in%2520DNA%2520gyrase%2520and%2520the%2520mechanism%2520of%2520action%2520of%2520novobiocin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1978%26volume%3D75%26spage%3D4838%26epage%3D4842%26doi%3D10.1073%2Fpnas.75.10.4838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Holdgate, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tunnicliffe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, W. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weston, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbrock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I. W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, D.</span><span> </span><span class="NLM_article-title">The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: A thermodynamic and crystallographic study</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">9663</span><span class="NLM_x">–</span> <span class="NLM_lpage">9673</span><span class="refDoi"> DOI: 10.1021/bi970294+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi970294%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=9663-9673&author=G.+A.+Holdgateauthor=A.+Tunnicliffeauthor=W.+H.+J.+Wardauthor=S.+A.+Westonauthor=G.+Rosenbrockauthor=P.+T.+Barthauthor=I.+W.+F.+Taylorauthor=R.+A.+Pauptitauthor=D.+Timms&title=The+entropic+penalty+of+ordered+water+accounts+for+weaker+binding+of+the+antibiotic+novobiocin+to+a+resistant+mutant+of+DNA+gyrase%3A+A+thermodynamic+and+crystallographic+study&doi=10.1021%2Fbi970294%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Entropic Penalty of Ordered Water Accounts for Weaker Binding of the Antibiotic Novobiocin to a Resistant Mutant of DNA Gyrase: A Thermodynamic and Crystallographic Study</span></div><div class="casAuthors">Holdgate, Geoffrey A.; Tunnicliffe, Alan; Ward, Walter H. J.; Weston, Simon A.; Rosenbrock, Gina; Barth, Peter T.; Taylor, Ian W. F.; Pauptit, Richard A.; Timms, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">9663-9673</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novobiocin is an antibiotic which binds to a 24 kDa fragment from the B subunit of DNA gyrase.  Naturally occurring resistance arises from mutation of Arg-136 which hydrogen bonds to the coumarin ring of novobiocin.  We have applied calorimetry to characterize the binding of novobiocin to wild-type and R136H mutant 24 kDa fragments.  Upon mutation, the Kd increases from 32 to 1200 nM at 300 K.  The enthalpy of binding is more favorable for the mutant (ΔH° shifts from -12.1 to -17.5 kcal/mol), and the entropy of binding is much less favorable (TΔS° changes from -1.8 to -9.4 kcal/mol).  Both of these changes are in the direction opposite to that expected if the loss of the Arg residue reduces hydrogen bonding.  The change in heat capacity at const. pressure upon binding (ΔCp) shifts from -295 to -454 cal mol-1 K-1.  We also report the crystal structure, at 2.3 Å resoln., of a complex between the R136H 24 kDa fragment and novobiocin.  Although the change in ΔCp often would be interpreted as reflecting increased burial of the hydrophobic surface on binding, this structure reveals a small decrease.  Furthermore, an ordered water mol. is sequestered into the vol. vacated by removal of the guanidinium group.  There are large discrepancies when the measured thermodn. parameters are compared to those estd. from the structural data using empirical relationships.  These differences seem to arise from the effects of sequestering ordered water mols. upon complexation.  The water-mediated hydrogen bonds linking novobiocin to the mutant protein make a favorable enthalpic contribution, whereas the immobilization of the water leads to an entropic cost and a redn. in the heat capacity of the system.  Such a neg. contribution to ΔCp, ΔH°, and TΔS° appears to be a general property of water mols. that are sequestered when ligands bind to proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQavsSOGjoibVg90H21EOLACvtfcHk0li4mLy7a5NteQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFWgsr8%253D&md5=560c913d4a9cbf6a5ccca550345d7ef4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbi970294%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi970294%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DTunnicliffe%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DW.%2BH.%2BJ.%26aulast%3DWeston%26aufirst%3DS.%2BA.%26aulast%3DRosenbrock%26aufirst%3DG.%26aulast%3DBarth%26aufirst%3DP.%2BT.%26aulast%3DTaylor%26aufirst%3DI.%2BW.%2BF.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DTimms%26aufirst%3DD.%26atitle%3DThe%2520entropic%2520penalty%2520of%2520ordered%2520water%2520accounts%2520for%2520weaker%2520binding%2520of%2520the%2520antibiotic%2520novobiocin%2520to%2520a%2520resistant%2520mutant%2520of%2520DNA%2520gyrase%253A%2520A%2520thermodynamic%2520and%2520crystallographic%2520study%26jtitle%3DBiochemistry%26date%3D1997%26volume%3D36%26spage%3D9663%26epage%3D9673%26doi%3D10.1021%2Fbi970294%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippke, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span> </span><span class="NLM_article-title">Crystal structures of <i>Escherichia coli</i> topoisomerase IV ParE subunit (24 and 43 kilodaltons): A single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1864</span><span class="refDoi"> DOI: 10.1128/AAC.48.5.1856-1864.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2FAAC.48.5.1856-1864.2004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1856-1864&author=S.+Bellonauthor=J.+D.+Parsonsauthor=Y.+Weiauthor=K.+Hayakawaauthor=L.+L.+Swensonauthor=P.+S.+Charifsonauthor=J.+A.+Lippkeauthor=R.+Aldapeauthor=C.+H.+Gross&title=Crystal+structures+of+Escherichia+coli+topoisomerase+IV+ParE+subunit+%2824+and+43+kilodaltons%29%3A+A+single+residue+dictates+differences+in+novobiocin+potency+against+topoisomerase+IV+and+DNA+gyrase&doi=10.1128%2FAAC.48.5.1856-1864.2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1856-1864.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1856-1864.2004%26sid%3Dliteratum%253Aachs%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DLippke%26aufirst%3DJ.%2BA.%26aulast%3DAldape%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DC.%2BH.%26atitle%3DCrystal%2520structures%2520of%2520Escherichia%2520coli%2520topoisomerase%2520IV%2520ParE%2520subunit%2520%252824%2520and%252043%2520kilodaltons%2529%253A%2520A%2520single%2520residue%2520dictates%2520differences%2520in%2520novobiocin%2520potency%2520against%2520topoisomerase%2520IV%2520and%2520DNA%2520gyrase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1856%26epage%3D1864%26doi%3D10.1128%2FAAC.48.5.1856-1864.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bisacchi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchester, J. I.</span><span> </span><span class="NLM_article-title">A new-class antibacterial - almost. Lessons in drug discovery and development: A critical analysis of more than 50 years of effort toward ATPase inhibitors of DNA gyrase and topoisomerase IV</span> <span class="citation_source-journal">ACS Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1021/id500013t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/id500013t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGmsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=4-41&author=G.+S.+Bisacchiauthor=J.+I.+Manchester&title=A+new-class+antibacterial+-+almost.+Lessons+in+drug+discovery+and+development%3A+A+critical+analysis+of+more+than+50+years+of+effort+toward+ATPase+inhibitors+of+DNA+gyrase+and+topoisomerase+IV&doi=10.1021%2Fid500013t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV</span></div><div class="casAuthors">Bisacchi, Gregory S.; Manchester, John I.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-41</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The introduction into clin. practice of an ATPase inhibitor of bacterial DNA gyrase and topoisomerase IV (topo IV) would represent a new-class agent for the treatment of resistant bacterial infections.  Novobiocin, the only historical member of this class, established the clin. proof of concept for this novel mechanism during the late 1950s, but its use declined rapidly and it was eventually withdrawn from the market.  Despite significant and prolonged effort across the biopharmaceutical industry to develop other agents of this class, novobiocin remains the only ATPase inhibitor of gyrase and topo IV ever to progress beyond Phase I.  In this review, we analyze the historical attempts to discover and develop agents within this class and highlight factors that might have hindered those efforts.  Within the last 15 years, however, our tech. understanding of the mol. details of the inhibition of the gyrase and topo IV ATPases, the factors governing resistance development to such inhibitors, and our knowledge of the phys. properties required for robust clin. drug candidates have all matured to the point wherein the industry may now address this mechanism of action with greater confidence.  The antibacterial spectrum within this class has recently been extended to begin to include serious Gram neg. pathogens such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae.  In spite of this recent tech. progress, adverse economics assocd. with antibacterial R&D over the last 20 years has diminished industry's ability to commit the resources and perseverance needed to bring new-class agents to launch.  Consequently, a no. of recent efforts in the ATPase class have been derailed by organizational rather than scientific factors.  Nevertheless, within this context we discuss the unique opportunity for the development of ATPase inhibitors of gyrase and topo IV as new-class antibacterial agents with broad spectrum potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXubyDLdrSrrVg90H21EOLACvtfcHk0lh-bRBd2XFirw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGmsbnL&md5=95ce2833dab37f68a3a4a018e381e198</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fid500013t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fid500013t%26sid%3Dliteratum%253Aachs%26aulast%3DBisacchi%26aufirst%3DG.%2BS.%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26atitle%3DA%2520new-class%2520antibacterial%2520-%2520almost.%2520Lessons%2520in%2520drug%2520discovery%2520and%2520development%253A%2520A%2520critical%2520analysis%2520of%2520more%2520than%252050%2520years%2520of%2520effort%2520toward%2520ATPase%2520inhibitors%2520of%2520DNA%2520gyrase%2520and%2520topoisomerase%2520IV%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D4%26epage%3D41%26doi%3D10.1021%2Fid500013t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Maxwell, A.</span><span> </span><span class="NLM_article-title">DNA gyrase as a drug target</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span><span class="refDoi"> DOI: 10.1016/S0966-842X(96)10085-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2FS0966-842X%2896%2910085-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=102-109&author=A.+Maxwell&title=DNA+gyrase+as+a+drug+target&doi=10.1016%2FS0966-842X%2896%2910085-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0966-842X%2896%2910085-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0966-842X%252896%252910085-8%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DA.%26atitle%3DDNA%2520gyrase%2520as%2520a%2520drug%2520target%26jtitle%3DTrends%2520Microbiol.%26date%3D1997%26volume%3D5%26spage%3D102%26epage%3D109%26doi%3D10.1016%2FS0966-842X%2896%2910085-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Drlica, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, M.</span><span> </span><span class="NLM_article-title">Fluoroquinolones: Action and resistance</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.2174/1568026033452537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.2174%2F1568026033452537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=12570763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=249-282&author=K.+Drlicaauthor=M.+Malik&title=Fluoroquinolones%3A+Action+and+resistance&doi=10.2174%2F1568026033452537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fluoroquinolones: action and resistance</span></div><div class="casAuthors">Drlica, Karl; Malik, Muhammad</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-282</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Fluoroquinolones trap gyrase and topoisomerase IV on DNA as ternary complexes that block the movement of replication forks and transcription complexes.  Studies with resistant mutants indicate that during complex formation quinolones bind to a surface α-helix of the GyrA and ParC proteins.  Lethal action is a distinct event that is proposed to arise from release of DNA breaks from the ternary complexes.  Many bacterial pathogens are exhibiting resistance due to alterations in drug permeability, drug efflux, gyrase-protecting proteins, and target topoisomerases.  When selection of resistant mutants is described in terms of fluoroquinolone concn., a threshold (mutant prevention concn., MPC) can be defined for restricting the development of resistance.  MPC varies among fluoroquinolones and pathogens; when combined with pharmacokinetics, MPC can be used to identify compds. least likely to enrich mutant subpopulations.  Use of suboptimal doses and compds. erodes the efficacy of the class as a whole because resistance to one quinolone reduces susceptibility to others and/or increases the frequency at which resistance develops.  When using fluoroquinolones in combination therapy, the development of resistance may be minimized by optimizing regimens for pharmacokinetic overlap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3WUy9qQC8PLVg90H21EOLACvtfcHk0lh-bRBd2XFirw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Clug%253D%253D&md5=840aae442481ffb4f91a60f4b688cc4c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1568026033452537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452537%26sid%3Dliteratum%253Aachs%26aulast%3DDrlica%26aufirst%3DK.%26aulast%3DMalik%26aufirst%3DM.%26atitle%3DFluoroquinolones%253A%2520Action%2520and%2520resistance%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D249%26epage%3D282%26doi%3D10.2174%2F1568026033452537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Oblak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solmajer, T.</span><span> </span><span class="NLM_article-title">Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2047</span><span class="refDoi"> DOI: 10.2174/092986707781368414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.2174%2F092986707781368414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=17691945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFequ7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=2033-2047&author=M.+Oblakauthor=M.+Kotnikauthor=T.+Solmajer&title=Discovery+and+development+of+ATPase+inhibitors+of+DNA+gyrase+as+antibacterial+agents&doi=10.2174%2F092986707781368414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents</span></div><div class="casAuthors">Oblak, Marko; Kotnik, Miha; Solmajer, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2033-2047</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  DNA gyrase is an attractive and well established target for the development of antibacterial agents.  This bacterial enzyme, whose biol. function is to control the topol. state of DNA mols., consists of two catalytic subunits; GyrA is responsible for DNA breakage and reunion, while the subunit GyrB contains the ATP-binding site.  Coumarins and cyclothialidines are natural products that inhibit the ATPase activity of DNA gyrase by blocking the binding of ATP to subunit GyrB.  The mechanism of action of these compds. was exhaustively characterized by biochem. methods and supported by protein crystallog.  The abundance of crystallog. data on the N-terminal domain of GyrB in its complexes with various ligands had enabled the structure-based design of novel efficient chemotypes as inhibitors of the ATPase domain.  This review summarizes the discovery of ATPase inhibitors of DNA gyrase B in the last decade and their development as potential antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl-Tm7LdvTcrVg90H21EOLACvtfcHk0li446pShd92JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFequ7o%253D&md5=b3cc136ff918251727972a686f1a0b02</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F092986707781368414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707781368414%26sid%3Dliteratum%253Aachs%26aulast%3DOblak%26aufirst%3DM.%26aulast%3DKotnik%26aufirst%3DM.%26aulast%3DSolmajer%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520development%2520of%2520ATPase%2520inhibitors%2520of%2520DNA%2520gyrase%2520as%2520antibacterial%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D2033%26epage%3D2047%26doi%3D10.2174%2F092986707781368414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Škedelj, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomašić, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mašič, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zega, A.</span><span> </span><span class="NLM_article-title">ATP-binding site of bacterial enzymes as a target for antibacterial drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span><span class="refDoi"> DOI: 10.1021/jm101121s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101121s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=915-929&author=V.+%C5%A0kedeljauthor=T.+Toma%C5%A1i%C4%87author=L.+P.+Ma%C5%A1i%C4%8Dauthor=A.+Zega&title=ATP-binding+site+of+bacterial+enzymes+as+a+target+for+antibacterial+drug+design&doi=10.1021%2Fjm101121s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm101121s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101121s%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0kedelj%26aufirst%3DV.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3DMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%2BP.%26aulast%3DZega%26aufirst%3DA.%26atitle%3DATP-binding%2520site%2520of%2520bacterial%2520enzymes%2520as%2520a%2520target%2520for%2520antibacterial%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D915%26epage%3D929%26doi%3D10.1021%2Fjm101121s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mayer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">Non-quinolone inhibitors of bacterial type IIa topoisomerases: A feat of bioisosterism</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">2313</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span><span class="refDoi"> DOI: 10.1021/cr4003984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4003984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2313-2342&author=C.+Mayerauthor=Y.+L.+Janin&title=Non-quinolone+inhibitors+of+bacterial+type+IIa+topoisomerases%3A+A+feat+of+bioisosterism&doi=10.1021%2Fcr4003984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism</span></div><div class="casAuthors">Mayer, Claudine; Janin, Yves L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2313-2342</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  DNA gyrase and topoisomerase IV are the bacterial type IIA topoisomerases.  These are ubiquitous nucleic acid-dependent nanomachines, essential to cell life, that solve DNA topol. problems resulting from the replication, transcription, and recombination of DNA.  From the discovery that novobiocin and fluoroquinolone antibiotics were selectively acting on bacterial type IIA topoisomerases, a remarkable no. of series of inhibitors of these enzymes has been reported.  The design of biochem. or cellular assays, amenable to high-throughput screenings, along with X-ray-derived structures of the early inhibitors bound to DNA gyrase, were instrumental in this.  From these structures, an array of strategies, which are today called fragment-based approaches, provided quite a no. of addnl. starting points for medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-y7YT9Lg6rVg90H21EOLACvtfcHk0ljB5hxJrb_hpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO&md5=8559c27866d96e85cc08763e0cae1c01</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fcr4003984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4003984%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DC.%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DNon-quinolone%2520inhibitors%2520of%2520bacterial%2520type%2520IIa%2520topoisomerases%253A%2520A%2520feat%2520of%2520bioisosterism%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2313%26epage%3D2342%26doi%3D10.1021%2Fcr4003984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Tomašić, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mašič, L.</span><span> </span><span class="NLM_article-title">Prospects for developing new antibacterials targeting bacterial type IIa topoisomerases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.2174/1568026613666131113153251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.2174%2F1568026613666131113153251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=24236722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlyrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=130-151&author=T.+Toma%C5%A1i%C4%87author=L.+Ma%C5%A1i%C4%8D&title=Prospects+for+developing+new+antibacterials+targeting+bacterial+type+IIa+topoisomerases&doi=10.2174%2F1568026613666131113153251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Prospects for Developing New Antibacterials Targeting Bacterial Type IIA Topoisomerases</span></div><div class="casAuthors">Tomasic, Tihomir; Masic, Lucija Peterlin</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130-151</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The modulation of DNA topol. by DNA gyrase and topoisomerase IV, both of which are type IIA topoisomerases and found in most bacteria, is a function vital to DNA replication, repair and decatenation.  Despite the potential for resistance development, DNA gyrase and/or topoisomerase IV have been proven to be and remain highly attractive targets in antibacterial drug discovery due to their potential for dual targeting.  The search for new GyrA and/or ParC inhibitors that can overcome the increasing spread of multidrug-resistant bacteria has been successfully focused in the last decades on the modification of the known fluoroquinolone scaffold as primarily guided by ligand-based design via classical structure-activity relationship studies and the optimization of physicochem. properties.  This focus has resulted in several novel fluoroquinolones that have been introduced into clin. practice since 2000, and several of these new compds. are currently in different phases of clin. trials.  Due to increasing resistance to fluoroquinolones, a significant part of DNA gyrase research has shifted to the discovery of new GyrB and/or ParE inhibitors, which are commonly identified through fragment-based design as well as virtual screening techniques and structure-based hit optimization programs.  This research often results in lead compds. with potent inhibitory activity and promising antibacterial activity profiles.  Nevertheless, it is important to understand how different physicochem. properties (e.g., logD and total polar surface area) and different structural motifs influence the compds.' permeability to ensure the efficient discovery of potent, small-mol. antibacterials particularly against Gram-neg. strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqli6ENt9H6UrVg90H21EOLACvtfcHk0ljB5hxJrb_hpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlyrt78%253D&md5=5de1f9a0b3d72cbf42792c91d6d98bb6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568026613666131113153251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026613666131113153251%26sid%3Dliteratum%253Aachs%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3DMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%26atitle%3DProspects%2520for%2520developing%2520new%2520antibacterials%2520targeting%2520bacterial%2520type%2520IIa%2520topoisomerases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D130%26epage%3D151%26doi%3D10.2174%2F1568026613666131113153251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzelka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span> </span><span class="NLM_article-title">In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span><span class="refDoi"> DOI: 10.1128/AAC.50.4.1228-1237.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2FAAC.50.4.1228-1237.2006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1228-1237&author=N.+Maniauthor=C.+H.+Grossauthor=J.+D.+Parsonsauthor=B.+Hanzelkaauthor=U.+Muhauthor=S.+Mullinauthor=Y.+Liaoauthor=A.+L.+Grillotauthor=D.+Stamosauthor=P.+S.+Charifsonauthor=T.+H.+Grossman&title=In+vitro+characterization+of+the+antibacterial+spectrum+of+novel+bacterial+type+II+topoisomerase+inhibitors+of+the+aminobenzimidazole+class&doi=10.1128%2FAAC.50.4.1228-1237.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.4.1228-1237.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.4.1228-1237.2006%26sid%3Dliteratum%253Aachs%26aulast%3DMani%26aufirst%3DN.%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DMuh%26aufirst%3DU.%26aulast%3DMullin%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DGrillot%26aufirst%3DA.%2BL.%26aulast%3DStamos%26aufirst%3DD.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520the%2520antibacterial%2520spectrum%2520of%2520novel%2520bacterial%2520type%2520II%2520topoisomerase%2520inhibitors%2520of%2520the%2520aminobenzimidazole%2520class%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1228%26epage%3D1237%26doi%3D10.1128%2FAAC.50.4.1228-1237.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">East, S. P.; Czaplewski, L. G.; Haydon, D. J.</span><span> </span><span class="NLM_article-title">Ethyl Urea Inhibitors of the Bacterial Type II Topoisomerases DNA Gyrase (GyrB) and Topoisomerase IV (ParE)</span>. In  <span class="citation_source-book">Designing Multi-Target Drugs</span>; <span class="NLM_publisher-name">RSC Publishing</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">21</span>, pp  <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1039%2F9781849734912-00335" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=335-352&author=S.+P.+East&author=L.+G.+Czaplewski&author=D.+J.+Haydon&title=Designing+Multi-Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2F9781849734912-00335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849734912-00335%26sid%3Dliteratum%253Aachs%26aulast%3DEast%26aufirst%3DS.%2BP.%26atitle%3DEthyl%2520Urea%2520Inhibitors%2520of%2520the%2520Bacterial%2520Type%2520II%2520Topoisomerases%2520DNA%2520Gyrase%2520%2528GyrB%2529%2520and%2520Topoisomerase%2520IV%2520%2528ParE%2529%26btitle%3DDesigning%2520Multi-Target%2520Drugs%26pub%3DRSC%2520Publishing%26date%3D2012%26volume%3D21%26spage%3D335%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Axford, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrau, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gannon, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunniss, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offermann, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narasinga Rao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomaides-Brears, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyndall, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydon, D. J.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6598</span><span class="NLM_x">–</span> <span class="NLM_lpage">6603</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2Fj.bmcl.2013.10.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=24239017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWnsL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6598-6603&author=L.+C.+Axfordauthor=P.+K.+Agarwalauthor=K.+H.+Andersonauthor=L.+N.+Andrauauthor=J.+Atherallauthor=S.+Barkerauthor=J.+M.+Bennettauthor=M.+Blairauthor=I.+Collinsauthor=L.+G.+Czaplewskiauthor=D.+T.+Daviesauthor=C.+T.+Gannonauthor=D.+Kumarauthor=P.+Lancettauthor=A.+Loganauthor=C.+J.+Lunnissauthor=D.+R.+Mitchellauthor=D.+A.+Offermannauthor=J.+T.+Palmerauthor=N.+Palmerauthor=G.+R.+Pittauthor=S.+Pommierauthor=D.+Priceauthor=B.+Narasinga+Raoauthor=R.+Saxenaauthor=T.+Shuklaauthor=A.+K.+Singhauthor=M.+Singhauthor=A.+Srivastavaauthor=C.+Steeleauthor=N.+R.+Stokesauthor=H.+B.+Thomaides-Brearsauthor=E.+M.+Tyndallauthor=D.+Watsonauthor=D.+J.+Haydon&title=Design%2C+synthesis+and+biological+evaluation+of+%CE%B1-substituted+isonipecotic+acid+benzothiazole+analogues+as+potent+bacterial+type+II+topoisomerase+inhibitors&doi=10.1016%2Fj.bmcl.2013.10.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors</span></div><div class="casAuthors">Axford, Lorraine C.; Agarwal, Piyush K.; Anderson, Kelly H.; Andrau, Laura N.; Atherall, John; Barker, Stephanie; Bennett, James M.; Blair, Michael; Collins, Ian; Czaplewski, Lloyd G.; Davies, David T.; Gannon, Carlie T.; Kumar, Dushyant; Lancett, Paul; Logan, Alastair; Lunniss, Christopher J.; Mitchell, Dale R.; Offermann, Daniel A.; Palmer, James T.; Palmer, Nicholas; Pitt, Gary R. W.; Pommier, Stephanie; Price, Daniel; Narasinga Rao, B.; Saxena, Rashmi; Shukla, Tarun; Singh, Amit K.; Singh, Mahipal; Srivastava, Anil; Steele, Christopher; Stokes, Neil R.; Thomaides-Brears, Helena B.; Tyndall, Edward M.; Watson, David; Haydon, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6598-6603</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a new class of benzothiazole small mols. (e.g. I) that inhibit bacterial DNA gyrase and topoisomerase IV are described.  Antibacterial properties have been demonstrated by activity against DNA gyrase ATPase and potent activity against Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, and Haemophilus influenzae.  Further refinements to the scaffold designed to enhance drug-likeness included analogs bearing an α-substituent to the carboxylic acid group, resulting in excellent soly. and favorable pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDcM3TGLzV17Vg90H21EOLACvtfcHk0lgg6Dk5-PmLmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWnsL3J&md5=c65277685571a1e7a0689d33785e0926</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.058%26sid%3Dliteratum%253Aachs%26aulast%3DAxford%26aufirst%3DL.%2BC.%26aulast%3DAgarwal%26aufirst%3DP.%2BK.%26aulast%3DAnderson%26aufirst%3DK.%2BH.%26aulast%3DAndrau%26aufirst%3DL.%2BN.%26aulast%3DAtherall%26aufirst%3DJ.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBlair%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DDavies%26aufirst%3DD.%2BT.%26aulast%3DGannon%26aufirst%3DC.%2BT.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DLancett%26aufirst%3DP.%26aulast%3DLogan%26aufirst%3DA.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DMitchell%26aufirst%3DD.%2BR.%26aulast%3DOffermann%26aufirst%3DD.%2BA.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPalmer%26aufirst%3DN.%26aulast%3DPitt%26aufirst%3DG.%2BR.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DNarasinga%2BRao%26aufirst%3DB.%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DShukla%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DSteele%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DN.%2BR.%26aulast%3DThomaides-Brears%26aufirst%3DH.%2BB.%26aulast%3DTyndall%26aufirst%3DE.%2BM.%26aulast%3DWatson%26aufirst%3DD.%26aulast%3DHaydon%26aufirst%3DD.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520%25CE%25B1-substituted%2520isonipecotic%2520acid%2520benzothiazole%2520analogues%2520as%2520potent%2520bacterial%2520type%2520II%2520topoisomerase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6598%26epage%3D6603%26doi%3D10.1016%2Fj.bmcl.2013.10.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Stokes, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomaides-Brears, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamble, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunniss, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peasley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydon, D. J.</span><span> </span><span class="NLM_article-title">Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5977</span><span class="NLM_x">–</span> <span class="NLM_lpage">5986</span><span class="refDoi"> DOI: 10.1128/AAC.00719-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2FAAC.00719-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=24041906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A280%3ADC%252BC3sbosl2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=5977-5986&author=N.+R.+Stokesauthor=H.+B.+Thomaides-Brearsauthor=S.+Barkerauthor=J.+M.+Bennettauthor=J.+Berryauthor=I.+Collinsauthor=L.+G.+Czaplewskiauthor=V.+Gambleauthor=P.+Lancettauthor=A.+Loganauthor=C.+J.+Lunnissauthor=H.+Peasleyauthor=S.+Pommierauthor=D.+Priceauthor=C.+Smeeauthor=D.+J.+Haydon&title=Biological+evaluation+of+benzothiazole+ethyl+urea+inhibitors+of+bacterial+type+II+topoisomerases&doi=10.1128%2FAAC.00719-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases</span></div><div class="casAuthors">Stokes Neil R; Thomaides-Brears Helena B; Barker Stephanie; Bennett James M; Berry Joanne; Collins Ian; Czaplewski Lloyd G; Gamble Vicki; Lancett Paul; Logan Alastair; Lunniss Christopher J; Peasley Hilary; Pommier Stephanie; Price Daniel; Smee Carol; Haydon David J</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5977-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The type II topoisomerases DNA gyrase (GyrA/GyrB) and topoisomerase IV (ParC/ParE) are well-validated targets for antibacterial drug discovery.  Because of their structural and functional homology, these enzymes are amenable to dual targeting by a single ligand.  In this study, two novel benzothiazole ethyl urea-based small molecules, designated compound A and compound B, were evaluated for their biochemical, antibacterial, and pharmacokinetic properties.  The two compounds inhibited the ATPase activity of GyrB and ParE with 50% inhibitory concentrations of <0.1 μg/ml.  Prevention of DNA supercoiling by DNA gyrase was also observed.  Both compounds potently inhibited the growth of a range of bacterial organisms, including staphylococci, streptococci, enterococci, Clostridium difficile, and selected Gram-negative respiratory pathogens.  MIC90s against clinical isolates ranged from 0.015 μg/ml for Streptococcus pneumoniae to 0.25 μg/ml for Staphylococcus aureus.  No cross-resistance with common drug resistance phenotypes was observed.  In addition, no synergistic or antagonistic interactions between compound A or compound B and other antibiotics, including the topoisomerase inhibitors novobiocin and levofloxacin, were detected in checkerboard experiments.  The frequencies of spontaneous resistance for S. aureus were <2.3 × 10(-10) with compound A and <5.8 × 10(-11) with compound B at concentrations equivalent to 8× the MICs.  These values indicate a multitargeting mechanism of action.  The pharmacokinetic properties of both compounds were profiled in rats.  Following intravenous administration, compound B showed approximately 3-fold improvement over compound A in terms of both clearance and the area under the concentration-time curve.  The measured oral bioavailability of compound B was 47.7%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTB7u8-ATVsmBFwe7cAcrfPfW6udTcc2eaQ9KbQNj9xVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbosl2ruw%253D%253D&md5=6ede7459b1d20c528f016a29446253c4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FAAC.00719-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00719-13%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DN.%2BR.%26aulast%3DThomaides-Brears%26aufirst%3DH.%2BB.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBerry%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DGamble%26aufirst%3DV.%26aulast%3DLancett%26aufirst%3DP.%26aulast%3DLogan%26aufirst%3DA.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DPeasley%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DSmee%26aufirst%3DC.%26aulast%3DHaydon%26aufirst%3DD.%2BJ.%26atitle%3DBiological%2520evaluation%2520of%2520benzothiazole%2520ethyl%2520urea%2520inhibitors%2520of%2520bacterial%2520type%2520II%2520topoisomerases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D5977%26epage%3D5986%26doi%3D10.1128%2FAAC.00719-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchester, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boriack-Sjodin, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dangel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Illingworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uria-Nickelsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eakin, A. E.</span><span> </span><span class="NLM_article-title">Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8712</span><span class="NLM_x">–</span> <span class="NLM_lpage">8735</span><span class="refDoi"> DOI: 10.1021/jm401208b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401208b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8712-8735&author=G.+S.+Basarabauthor=J.+I.+Manchesterauthor=S.+Bistauthor=P.+A.+Boriack-Sjodinauthor=B.+Dangelauthor=R.+Illingworthauthor=B.+A.+Shererauthor=S.+Sriramauthor=M.+Uria-Nickelsenauthor=A.+E.+Eakin&title=Fragment-to-hit-to-lead+discovery+of+a+novel+pyridylurea+scaffold+of+ATP+competitive+dual+targeting+type+II+topoisomerase+inhibiting+antibacterial+agents&doi=10.1021%2Fjm401208b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401208b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401208b%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26aulast%3DBist%26aufirst%3DS.%26aulast%3DBoriack-Sjodin%26aufirst%3DP.%2BA.%26aulast%3DDangel%26aufirst%3DB.%26aulast%3DIllingworth%26aufirst%3DR.%26aulast%3DSherer%26aufirst%3DB.%2BA.%26aulast%3DSriram%26aufirst%3DS.%26aulast%3DUria-Nickelsen%26aufirst%3DM.%26aulast%3DEakin%26aufirst%3DA.%2BE.%26atitle%3DFragment-to-hit-to-lead%2520discovery%2520of%2520a%2520novel%2520pyridylurea%2520scaffold%2520of%2520ATP%2520competitive%2520dual%2520targeting%2520type%2520II%2520topoisomerase%2520inhibiting%2520antibacterial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8712%26epage%3D8735%26doi%3D10.1021%2Fjm401208b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yule, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narramore, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishwick, C. W.</span><span> </span><span class="NLM_article-title">Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1016%2Fj.ejmech.2014.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=25137573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleiur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=31-38&author=I.+A.+Yuleauthor=L.+G.+Czaplewskiauthor=S.+Pommierauthor=D.+T.+Daviesauthor=S.+K.+Narramoreauthor=C.+W.+Fishwick&title=Pyridine-3-carboxamide-6-yl-ureas+as+novel+inhibitors+of+bacterial+DNA+gyrase%3A+Structure+based+design%2C+synthesis%2C+SAR+and+antimicrobial+activity&doi=10.1016%2Fj.ejmech.2014.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity</span></div><div class="casAuthors">Yule, Ian A.; Czaplewski, Lloyd G.; Pommier, Stephanie; Davies, David T.; Narramore, Sarah K.; Fishwick, Colin W. G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of antibacterial drugs based on novel chemotypes is essential to the future management of serious drug resistant infections.  We herein report the design, synthesis and SAR of a novel series of N-ethylurea inhibitors based on a pyridine-3-carboxamide scaffold targeting the ATPase sub-unit of DNA gyrase.  Consideration of structural aspects of the GyrB ATPase site has aided the development of this series resulting in derivs. that demonstrate excellent enzyme inhibitory activity coupled to potent Gram pos. antibacterial efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa7ay8GaYorVg90H21EOLACvtfcHk0lj58B0ximeHPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleiur%252FL&md5=0b6959bec14a8d28d3321db46b33b4fa</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DYule%26aufirst%3DI.%2BA.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DD.%2BT.%26aulast%3DNarramore%26aufirst%3DS.%2BK.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26atitle%3DPyridine-3-carboxamide-6-yl-ureas%2520as%2520novel%2520inhibitors%2520of%2520bacterial%2520DNA%2520gyrase%253A%2520Structure%2520based%2520design%252C%2520synthesis%252C%2520SAR%2520and%2520antimicrobial%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D31%26epage%3D38%26doi%3D10.1016%2Fj.ejmech.2014.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Huang, L.; Liu, S.; Lunney, E. A.; Planken, S. P.</span><span> </span><span class="NLM_article-title">Substituted 2-Amino-fused Heterocyclic Compounds as JNK Modulators and Their Preparation, Pharmaceutical Compositions, and Use in the Treatment of Diabetes and Related Diseases</span>. PCT International Patent WO 2007125405A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=L.+Huang&author=S.+Liu&author=E.+A.+Lunney&author=S.+P.+Planken&title=Substituted+2-Amino-fused+Heterocyclic+Compounds+as+JNK+Modulators+and+Their+Preparation%2C+Pharmaceutical+Compositions%2C+and+Use+in+the+Treatment+of+Diabetes+and+Related+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26atitle%3DSubstituted%25202-Amino-fused%2520Heterocyclic%2520Compounds%2520as%2520JNK%2520Modulators%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diabetes%2520and%2520Related%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wang, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J. M.</span><span> </span><span class="NLM_article-title">N-heterocyclic carbene-palladium(II)-1-methylimidazole complex-catalyzed Suzuki-Miyaura coupling of benzyl carbamates with arylboronic acids</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">11438</span><span class="NLM_x">–</span> <span class="NLM_lpage">11444</span><span class="refDoi"> DOI: 10.1039/C5OB01782C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1039%2FC5OB01782C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=26446833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2hurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=11438-11444&author=X.+X.+Wangauthor=M.+J.+Luoauthor=J.+M.+Lu&title=N-heterocyclic+carbene-palladium%28II%29-1-methylimidazole+complex-catalyzed+Suzuki-Miyaura+coupling+of+benzyl+carbamates+with+arylboronic+acids&doi=10.1039%2FC5OB01782C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">N-Heterocyclic carbene-palladium(II)-1-methylimidazole complex-catalyzed Suzuki-Miyaura coupling of benzyl carbamates with arylboronic acids</span></div><div class="casAuthors">Wang, Xiao-Xia; Luo, Mao-Jun; Lu, Jian-Mei</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">11438-11444</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The Suzuki-Miyaura coupling of benzyl carbamates with arylboronic acids was achieved in an environmentally benign medium.  Using water as the sole solvent, such transformation took place very well to give the desired diarylmethane derivs. in good to almost quant. yields in the presence of a well-defined NHC-Pd(II)-Im complex under mild conditions.  It is worth noting here that this is the first example of benzyl carbamates used in the coupling reaction, thus affording a new method for the formation of diarylmethanes by palladium-catalyzed C-O bond activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqboah4eCZxF7Vg90H21EOLACvtfcHk0lgy08O8Q2nliQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2hurfF&md5=b13dccfb187bab48e10b7e55152eea23</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC5OB01782C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB01782C%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BX.%26aulast%3DLuo%26aufirst%3DM.%2BJ.%26aulast%3DLu%26aufirst%3DJ.%2BM.%26atitle%3DN-heterocyclic%2520carbene-palladium%2528II%2529-1-methylimidazole%2520complex-catalyzed%2520Suzuki-Miyaura%2520coupling%2520of%2520benzyl%2520carbamates%2520with%2520arylboronic%2520acids%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D11438%26epage%3D11444%26doi%3D10.1039%2FC5OB01782C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Matsukura, M.</span><span> </span><span class="NLM_article-title">Preparation of Pyridine Derivatives Having [(Phosphonooxy)methyl]pyridinium Group as Antifungal Agents</span>. PCT International Patent WO 2010150761A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Matsukura&title=Preparation+of+Pyridine+Derivatives+Having+%5B%28Phosphonooxy%29methyl%5Dpyridinium+Group+as+Antifungal+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMatsukura%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Pyridine%2520Derivatives%2520Having%2520%255B%2528Phosphonooxy%2529methyl%255Dpyridinium%2520Group%2520as%2520Antifungal%2520Agents%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hata, K.; Yamamoto, E.; Okubo, M.</span><span> </span><span class="NLM_article-title">Physicochemical Properties and Nonclinical Pharmacokinetics of E1211: A Water-Soluble Prodrug of E1210</span>. In  <span class="citation_source-book">51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)</span>; Poster F1-1376, Chicago, IL,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Hata&author=E.+Yamamoto&author=M.+Okubo&title=51st+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy+%28ICAAC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHata%26aufirst%3DK.%26atitle%3DPhysicochemical%2520Properties%2520and%2520Nonclinical%2520Pharmacokinetics%2520of%2520E1211%253A%2520A%2520Water-Soluble%2520Prodrug%2520of%2520E1210%26btitle%3D51st%2520Interscience%2520Conference%2520on%2520Antimicrobial%2520Agents%2520and%2520Chemotherapy%2520%2528ICAAC%2529%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergquist, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becherer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashim, M. A.</span><span> </span><span class="NLM_article-title">Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1446</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span><span class="refDoi"> DOI: 10.1038/bjp.2008.267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1038%2Fbjp.2008.267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=18587422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVajsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1446-1456&author=X.+Yaoauthor=D.+L.+Andersonauthor=S.+A.+Rossauthor=D.+G.+Langauthor=B.+Z.+Desaiauthor=D.+C.+Cooperauthor=P.+Wheelanauthor=M.+S.+McIntyreauthor=M.+L.+Bergquistauthor=K.+I.+MacKenzieauthor=J.+D.+Bechererauthor=M.+A.+Hashim&title=Predicting+QT+prolongation+in+humans+during+early+drug+development+using+hERG+inhibition+and+an+anaesthetized+guinea-pig+model&doi=10.1038%2Fbjp.2008.267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model</span></div><div class="casAuthors">Yao, X.; Anderson, D. L.; Ross, S. A.; Lang, D. G.; Desai, B. Z.; Cooper, D. C.; Wheelan, P.; McIntyre, M. S.; Bergquist, M. L.; MacKenzie, K. I.; Becherer, J. D.; Hashim, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1446-1456</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug-induced prolongation of the QT interval can lead to torsade de pointes, a life-threatening ventricular arrhythmia.  Finding appropriate assays from among the plethora of options available to predict reliably this serious adverse effect in humans remains a challenging issue for the discovery and development of drugs.  The purpose of the present study was to develop and verify a reliable and relatively simple approach for assessing, during preclin. development, the propensity of drugs to prolong the QT interval in humans.  Sixteen marketed drugs from various pharmacol. classes with a known incidence-or lack thereof-of QT prolongation in humans were examd. in hERG (human ether a-go-go-related gene) patch-clamp assay and an anesthetized guinea-pig assay for QT prolongation using specific protocols.  Drug concns. in perfusates from hERG assays and plasma samples from guinea-pigs were detd. using liq. chromatog.-mass spectrometry.  Various pharmacol. agents that inhibit hERG currents prolong the QT interval in anesthetized guinea-pigs in a manner similar to that seen in humans and at comparable drug exposures.  Several compds. not assocd. with QT prolongation in humans failed to prolong the QT interval in this model.  Anal. of hERG inhibitory potency in conjunction with drug exposures and QT interval measurements in anesthetized guinea-pigs can reliably predict, during preclin. drug development, the risk of human QT prolongation.  A strategy is proposed for mitigating the risk of QT prolongation of new chem. entities during early lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRuiQ1CyjedrVg90H21EOLACvtfcHk0lgy08O8Q2nliQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVajsLw%253D&md5=1dbf4f50957b26496c4efa213e3f7e5c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.267%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DX.%26aulast%3DAnderson%26aufirst%3DD.%2BL.%26aulast%3DRoss%26aufirst%3DS.%2BA.%26aulast%3DLang%26aufirst%3DD.%2BG.%26aulast%3DDesai%26aufirst%3DB.%2BZ.%26aulast%3DCooper%26aufirst%3DD.%2BC.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DMcIntyre%26aufirst%3DM.%2BS.%26aulast%3DBergquist%26aufirst%3DM.%2BL.%26aulast%3DMacKenzie%26aufirst%3DK.%2BI.%26aulast%3DBecherer%26aufirst%3DJ.%2BD.%26aulast%3DHashim%26aufirst%3DM.%2BA.%26atitle%3DPredicting%2520QT%2520prolongation%2520in%2520humans%2520during%2520early%2520drug%2520development%2520using%2520hERG%2520inhibition%2520and%2520an%2520anaesthetized%2520guinea-pig%2520model%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1446%26epage%3D1456%26doi%3D10.1038%2Fbjp.2008.267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sander, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Korff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rufener, C.</span><span> </span><span class="NLM_article-title">DataWarrior: An open-source program for chemistry aware data visualization and analysis</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1021/ci500588j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500588j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=460-473&author=T.+Sanderauthor=J.+Freyssauthor=M.+von+Korffauthor=C.+Rufener&title=DataWarrior%3A+An+open-source+program+for+chemistry+aware+data+visualization+and+analysis&doi=10.1021%2Fci500588j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis</span></div><div class="casAuthors">Sander, Thomas; Freyss, Joel; von Korff, Modest; Rufener, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">460-473</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug discovery projects in the pharmaceutical industry accumulate thousands of chem. structures and ten-thousands of data points from a dozen or more biol. and pharmacol. assays.  A sufficient interpretation of the data requires understanding which mol. families are present, which structural motifs correlate with measured properties, and which tiny structural changes cause large property changes.  Data visualization and anal. software with sufficient chem. intelligence to support chemists in this task is rare.  In an attempt to contribute to filling the gap, we released our inhouse developed chem. aware data anal. program DataWarrior for free public use.  This paper gives an overview of DataWarrior's functionality and architecture.  Exemplarily, a new unsupervised, 2-dimensional scaling algorithm is presented, which employs vector-based or nonvector-based descriptors to visualize the chem. or pharmacophore space of even large data sets.  DataWarrior uses this method to interactively explore chem. space, activity landscapes, and activity cliffs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_PNPlIkf72LVg90H21EOLACvtfcHk0lin4MRxu9nokw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFWnuw%253D%253D&md5=5c849901b5cb4549d870d81f5eeaca0a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fci500588j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500588j%26sid%3Dliteratum%253Aachs%26aulast%3DSander%26aufirst%3DT.%26aulast%3DFreyss%26aufirst%3DJ.%26aulast%3Dvon%2BKorff%26aufirst%3DM.%26aulast%3DRufener%26aufirst%3DC.%26atitle%3DDataWarrior%253A%2520An%2520open-source%2520program%2520for%2520chemistry%2520aware%2520data%2520visualization%2520and%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D460%26epage%3D473%26doi%3D10.1021%2Fci500588j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Andes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ogtrop, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, W. A.</span><span> </span><span class="NLM_article-title">In vivo pharmacodynamics of a new oxazolidinone (linezolid)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3484</span><span class="NLM_x">–</span> <span class="NLM_lpage">3489</span><span class="refDoi"> DOI: 10.1128/AAC.46.11.3484-3489.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;key=10.1128%2FAAC.46.11.3484-3489.2002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3484-3489&author=D.+Andesauthor=M.+L.+van+Ogtropauthor=J.+Pengauthor=W.+A.+Craig&title=In+vivo+pharmacodynamics+of+a+new+oxazolidinone+%28linezolid%29&doi=10.1128%2FAAC.46.11.3484-3489.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.11.3484-3489.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.11.3484-3489.2002%26sid%3Dliteratum%253Aachs%26aulast%3DAndes%26aufirst%3DD.%26aulast%3Dvan%2BOgtrop%26aufirst%3DM.%2BL.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DCraig%26aufirst%3DW.%2BA.%26atitle%3DIn%2520vivo%2520pharmacodynamics%2520of%2520a%2520new%2520oxazolidinone%2520%2528linezolid%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3484%26epage%3D3489%26doi%3D10.1128%2FAAC.46.11.3484-3489.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bur, D.; Gude, M.; Hubschwerlen, C.; Panchaud, P.</span><span> </span><span class="NLM_article-title">Preparation of Antibacterial (Isoquinolin-3-yl)urea Derivatives</span>. PCT International Patent WO 2011121555A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+Bur&author=M.+Gude&author=C.+Hubschwerlen&author=P.+Panchaud&title=Preparation+of+Antibacterial+%28Isoquinolin-3-yl%29urea+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBur%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520Antibacterial%2520%2528Isoquinolin-3-yl%2529urea%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EI1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EI1','PDB','1EI1'); return false;">PDB: 1EI1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMN','PDB','5MMN'); return false;">PDB: 5MMN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMP','PDB','5MMP'); return false;">PDB: 5MMP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMO','PDB','5MMO'); return false;">PDB: 5MMO</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i124"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01834">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_67080"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01834">10.1021/acs.jmedchem.6b01834</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental details on cloning of DNA gyrase and topo IV genes, protein production and purification, expressed sequence for the GyrB24 (<i>E. coli</i>) crystallography construct, crystallization conditions, data collection and refinement statistics, gyrase and topo IV supercoiling and relaxation inhibition assay, ATPase inhibition assay, MIC testing, hK<sub>V</sub>11.1 (“hERG”) assay, logD and p<i>K</i><sub>a</sub> determination, neutropenic murine thigh infection model, pharmacokinetics in the mouse and in the rat, conversion of <b>68</b> in vitro in blood, and procedures for synthesis of <b>5</b>–<b>16</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01834/suppl_file/jm6b01834_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01834/suppl_file/jm6b01834_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01834/suppl_file/jm6b01834_si_001.pdf">jm6b01834_si_001.pdf (593.36 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01834/suppl_file/jm6b01834_si_002.csv">jm6b01834_si_002.csv (5.8 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">We will release the atomic coordinates and experimental data upon article publication. PDB code for <i>E. coli</i> GyrB with bound <b>27</b> is 5MMN; for <i>E. coli</i> GyrB with bound <b>36</b> is 5MMP; and for <i>E. coli</i> GyrB with bound <b>58</b> is 5MMO.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01834&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01834%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-9%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01834" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799149d6b8c3c7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
